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Abstract 
 
Proteinase-activated receptor 2 (PAR-2) belongs to a novel family of G-protein 
coupled  receptors  that  are  unique  in  their  activation  mechanism  by  which  a 
proteolytic cleavage at N-terminus by a proteinase reveals a ‘tethered ligand’ to 
activate the receptor. Albeit at a low level, PAR-2 is extensively expressed in 
normal and pathological brains, including the hippocampus. Qualitative studies 
into the expression of PAR-2 in several disease conditions, including ischaemia, 
HIV-associated  dementia,  Parkinson’s  disease,  Alzheimer’s  disease,  as  well  as 
multiple  sclerosis,  have  suggested  that  PAR-2  plays  either  degenerative  or 
protective role depending on in which cell type an increase in PAR-2 expression 
is  observed.  However,  its  potential  roles  in  modulating  neuronal  excitability, 
synaptic transmission as well as network activities remain to be determined. 
 
Utilising the whole-cell patch clamp recording technique, I demonstrate, for the 
first  time,  that  the  activation of  PAR-2  leads  to  a  depolarisation  of  cultured 
hippocampal neurones following application of SLIGRL (100M), a selective PAR-
2 activating peptide (5.52 ± 1.48mV, n=16, P<0.05) and paradoxically a reduction 
of spontaneous action potential (AP) frequency (29.63 ± 5.03% of control, n=13, 
P<0.05).  Pharmacological  manipulation  reveals  that  the  PAR-2-mediated 
depolarisation is most likely dependent on astrocytic glutamate release, which 
takes effect on ionotropic glutamate receptors. In addition, an overt depression 
of synaptic transmission among the cultured neurones upon PAR-2 activation is 
more likely to cause the reduction of spontaneous APs.  
 
In further experiments, I show, for the first time, that the activation of PAR-2 
induces a long term depression (LTD) of glutamatergic synaptic transmission at 
the  Schaffer  collateral-to-CA1  synapse  in  acute  hippocampal  slices  following 
SLIGRL (100M) application (80.75 ± 2.54% of control at 30 minute, n=12, P<0.05). 
Additionally, this novel form of LTD is independent of metabotropic glutamate 
receptors  but  mediated  by  NR2B  subunit-containing  N-methyl-D-aspartic  acid 
(NMDA)  receptors.  It  is  also  suggested  from  these  experiments  that  glial-
neuronal signalling is contributing to this novel form of LTD. 
 
In the final set of experiments, by monitoring field  potentials in the stratum 
pyramidale of the CA3 area in acute hippocampal slices, I demonstrate that PAR-3 
2 activation depresses the frequency of epileptiform activities induced by the 
application of 4-AP/0 Mg
2+, an in vitro model of epilepsy (1.53 ± 0.21Hz to 1.18 ± 
0.17Hz, n=13, P<0.05, 100M SLIGRL). In contrast, PAR-2 activation has no effect 
on the frequency of epileptiform activities induced by bicuculline (0.14 ± 0.03Hz 
to 0.13 ± 0.03Hz, n=6, P>0.05, 100M SLIGRL).  
 
In  summary,  in  this  thesis,  I  demonstrate  that  PAR-2  modulates  neuronal 
excitability and depresses excitatory synaptic transmission in the hippocampus. 
These data indicate that PAR-2 may play a regulatory role in neuronal signalling 
at  single  cell  level  by  controlling  neuronal  intrinsic  properties,  as  well  as  at 
synaptic level by tuning excitatory synaptic strength, which ultimately affects 
global excitability in the neural circuits as a whole. Therefore, this investigation 
suggests  a  novel  physiological/pathophysiological  role  for  PAR-2  in  the  brain. 
These data may reveal valuable clues for the development of drugs targeting a 
novel and potentially promising candidate. 
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MPTP  1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
ms  millisecond  19 
mV  milivolt 
NF  nuclear factor 
nM  nanomolar 
NMDA  N-methyl-D-aspartic acid 
OHSC  organotypic hippocampal slice cultures  
O-LM  oriens-lacunosum moleculare 
pA  picoampere 
PAR-1(2 or 4)  proteinase-activated receptor 1 (2 or 4) 
PAR-1(2 or 4)-AP  proteinase-activated receptor 1 (2 or 4) activating peptide 
PAR-2-IP  proteinase-activated receptor 2 inactive peptide 
PCR  polymerase chain reaction 
PI  phosphatidylinositol 
PIP2  phosphatidylinositol 4, 5-bisphosphate 
PKA  protein kinase A 
PKC  protein kinase C 
PLC  phospholipase C 
pM  picomolar 
PP  perforant path 
PPF  paired-pulse facilitation 
PTP  post-tetanus potentiation 
PTX  pertussis toxin 
Raf-1  proto-oncogene serine/threonine-protein kinase 1 
RC  resistance and capacitance  
SEM  standard error of mean 
SIC  slow inward current 
SNARE  soluble NSF attachment protein receptors 
SNpc  substantia nigra pars compacta 
Src  sarcoma  
STD  short term depression 
STF  short term facilitation 
STP  short term plasticity 
TNF  tumor necrosis factor 
tPA  tissue-type plasminogen activator 
TRP  transient receptor potential 
TTX  tetrodotoxin 20 
uPA  urokinase-type plasminogen activator 
A  microampere 
g  microgram 
m  micrometre 
M  micromolar 
 1  Introduction 
1.1 General Introduction 
It is widely estimated that 550 genes in the human genome encode proteolytic 
enzymes, termed proteinases or proteases (Southan, 2001; Puente et al., 2003). 
Therefore, it is not surprising that proteinases take part in a variety of biological 
processes  from  digesting  dietary proteins  and  peptides  in  the  gastrointestinal 
tract  to  destroying  antigen  and  aging  cells  in  macrophages.  Interestingly, 
proteolytic  events  occur  on  the  cell  membrane  as  well,  initiating  signal 
transduction through proteinase activated receptors (PARs).  
PARs belong to a novel G-protein coupled receptor family which is unique in its 
activation  mechanism.  A  proteolytic  cleavage  in  the  N-terminus  unveils  a 
sequence to act as “tethered ligand”. This “tethered ligand” then binds to the 
second  extracellular  loop  of  the  receptor,  leading  to  the  receptor  activation 
(Macfarlane et al., 2001; Ossovskaya & Bunnett, 2004; Bushell, 2007; Luo et al., 
2007; Hansen et al., 2008; Ramachandran & Hollenberg, 2008). Whilst PARs are 
widely expressed in the mammalian body with extensive studies so far focusing 
on  the  cardiovascular,  gastrointestinal,  and  immune  systems,  PARs  are  also 
expressed in the central nervous system (CNS) (Noorbakhsh et al., 2003; Bushell 
et al., 2006; Luo et al., 2007), yet PARs involvement in the brain function under 
either physiological or pathophysiological conditions is poorly characterised. 
This thesis therefore makes an initial attempt to elucidate if the activation of 
PARs  modulates  fundamental  properties  in  the  neuronal  function  such  as 
neuroexcitability,  synaptic  transmission  and  synaptic  plasticity  in  the 
hippocampus, a well organized brain structure with readily experimental access.  22 
1.2 G-protein coupled receptors 
As presented in figure 1.1, G-protein coupled receptors (GPCRs), also described 
as  seven-transmembrane  (7TM)  receptors,  represent  the  largest  receptor 
superfamily  to  transfer  extracellular  stimuli  into  intracellular  cascades  of 
biochemical reactions through the signal transduction system of a cell in the 
animal kingdom (Findlay et al., 1993; Baldwin, 1994; Pierce et al., 2002). It is 
estimated that there are more than 1000 GPCRs encoded by the human genome 
(Premont  &  Gainetdinov,  2007).  Ligands  for  these  receptors  are  relatively 
diverse including biogenic amines, amino acids, ions, lipids, peptides to proteins, 
light,  odorants,  pheromones,  nucleotides,  opiates,  cannabinoids,  endorphins 
(Premont  &  Gainetdinov,  2007).  Despite  this  diversity  of  ligands,  the 
characteristic activation mechanism for GPCRs is relatively uniform (Strader et 
al., 1994; McCudden et al., 2005). The binding of an appropriate ligand to the 
second extracellular loop, in some cases, to the N-terminus or transmembrane 
domains,  of a GPCR initiates conformational changes in the intracellular domain 
of the GPCR (Wess et al., 2008), resulting in the substitution of GDP by GTP from 
the  α-subunit  of  the inactive  heterotrimeric  (αβγ)  guanine  nucleotide-binding 
protein (G protein), which in turn dissociate the G protein to Gα-GTP and βγ 
dimer. This ‘activated’ G protein, through the dissociated Gα-GTP and βγ dimer, 
interacts with downstream effectors in the cytoplasm.  
It is widely acknowledged that GPCRs coupled to at least 16 heterotrimeric G 
protein  subtypes  (Premont  &  Gainetdinov,  2007;  Tuteja,  2009),  leading  to 
diverse  second  messenger  cascades  in  the  cytoplasm.  They  are  functionally 
grouped into four major classes as Gs, Gi, Gq/11 and G12/13. Gs primarily activates 
adenylate  cyclase,  which  in  turn,  increases  the  cytoplasmic  concentration  of 
cAMP,  which  in  turn  upregulates  the  activity  of  cAMP-dependent  kinase  or 
protein kinase A (PKA)(Gilman, 1995). In contrast, Gi mainly inhibits adenylate 
cyclase activity, which therefore reduces the production of cytoplasmic cAMP 
from ATP, which in turn downregulates the activity of PKA (Gilman, 1995). Gq/11 
subunit  stimulates  phospholipase  C  (PLC),  and  PLC  cleaves  a  membrane 
phospholipid,  the  phosphatidylinositol  4,5-bisphosphate  (PIP2)  into  diacyl 
glycerol (DAG) and inositol 1,4,5-triphosphate (IP3). Then, IP3 primarily binds to 
IP3 receptors, which are Ca
2+ channels in the endoplasmic reticulum (ER), leading 23 
to Ca
2+ release from the ER to increase cytoplasmic Ca
2+ concentration (Majerus, 
1992).  Furthermore,  Ca
2+  and  DAG  together  activate  protein  kinase  C  (PKC), 
which phosphorylates other downstream molecules (Tanaka & Nishizuka, 1994). 
Finally, G12/13 regulates cellular responses through guanine nucleotide exchange 
factors (GEFs) (Dhanasekaran & Dermott, 1996), which are activators of small 
GTPases, notably the Ras GTPases superfamily, such as Ras, Rho, and Ran, which 
regulate cell growth, differentiation, and vesicle transport (Wennerberg et al., 
2005).  For  a  single GPCR,  it  may interact  primarily  with  only one class  of  G 
proteins, whereas it can interplay with all four G protein subtypes, which leads 
to  a  broad  spectrum  of  cellular  responses  (see  figure  1.1).  It  should  also  be 
noticed  that  GPCRs  could  activate  signalling  pathways  independent  of  (or 
parallel  to)  all  G  proteins  (Premont  &  Gainetdinov,  2007).  Notably,  the  β-
arrestin  pathway,  where  GPCR-β-arrestin  directly  recruits  several  signalling 
proteins,  such  as  Src  family  tyrosine  kinases  and  components  of  mitogen-
activated  protein  kinases  (MAPKs),  has  been  well  documented  (Luttrell  & 
Lefkowitz, 2002; Lefkowitz & Shenoy, 2005; Shenoy & Lefkowitz, 2005). 
A striking feature of all GPCRs is that their responsiveness to a given agonist is 
plastic  (Freedman  &  Lefkowitz,  1996;  Premont  &  Gainetdinov,  2007).  When 
exposed  to  prolonged  or  repeated  agonist  stimulation,  GPCRs  desensitise, 
whereas it resensitises when not exposed to agonist for some time (Huganir & 
Greengard, 1990). It has been demonstrated that the G protein-coupled receptor 
kinase (GRK)-arrestin system is primarily responsible for this feature (Hausdorff 
et al., 1990; Gainetdinov et al., 2004). That is the GRK recognises the activated 
GPCR and phosphorylates the C-terminus of the GPCR. Once phosphorylated, the 
GPCR is recognised by arrestin, and the binding of GPCR with arrestin prevents 
the GPCR to activate more G proteins and therefore terminates its signalling 
(Premont  &  Gainetdinov,  2007).  The  arrestin  binding  also  facilitates  GPCR 
internalisation  and  trafficking.  In  addition,  GPCRs  have  been  documented  to 
behave  functionally  as  hetero-/homo-  dimers  or  oligomers  to  transduce 
extracellular signals into cytoplasm, which attracts intensive investigations into 
its mechanism and functional consequences in recent years (Bai, 2004; Prinster 
et al., 2005; Wess et al., 2008).  
In summary, GPCRs are widely found on the cell membrane with common seven 
transmembrane  domains  structure.  Characteristic  activation  mechanisms  and 24 
signalling pathways of GPCRs have been described. GPCRs are major mediators 
of  transmembrane  information  flow.  They  are  key  controllers  of  a  variety  of 
physiological  processes  such  as  neurotransmitter  release,  secretion,  cellular 
metabolism,  growth,  and  differentiation.  Therefore,  bearing  these  features, 
GPCRs are celebrated targets for the majority of medicine development. 25 
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Figure 1-1 Summary of ligands, structure, activation mechanism, and signalling pathways of 
GPCR.  
Adapted and modified from Marinissen et al.,2001 (Marinissen & Gutkind, 2001). 26 
1.3 Proteinase activated receptors 
PARs  also  described  as  protease  activated  receptors,  are  a  recently 
characterised, novel family of GPCRs. Rather than being activated by the free 
ligand  occupying  the  ligand-biding  site,  it  is  mobilised  through  a  proteolytic 
cleavage in the N-terminus of the receptor by a serine proteinase, exposing a 
newly formed N-terminus to act as a “tethered ligand” that interacts with the 
receptor  in  the  second  extracellular  loop.  To  date,  four  PARs  have  been 
discovered, with distinct cleavage sites as well as “tethered ligand”, which give 
rise to differential molecular and cellular responses  (Macfarlane et al., 2001; 
Ossovskaya & Bunnett, 2004; Bushell, 2007; Luo et al., 2007; Hansen et al., 2008; 
Ramachandran & Hollenberg, 2008) 
1.3.1 Cloning of PARs 
The discovery of the first PAR was largely based on extensive research into the 
regulation of blood clot formation and platelet aggregation in the cardiovascular 
system  by  a  serine  proteinase,  thrombin.  Thrombin  was  the  product  of 
prothrombin by factor Xa and was regarded as a key player in the coagulation 
cascade linking tissue damage to wound healing (Davie et al., 1991). In addition, 
several  studies  demonstrated  that  thrombin  alone  had  a  direct  effect  on 
different  cell  types  other  than  blood  cells,  including  endothelial  cells, 
monocytes, lymphocytes and smooth muscle cells (Chen et al., 1976; Bizios et 
al., 1986; Daniel et al., 1986; Shuman, 1986; Hattori et al., 1989). Meanwhile, 
parallel studies suggested that the protelytic property of thrombin was required 
as proteinase inhibitors abolished thrombin’s action (Shuman, 1986). Based on 
these  experimental  data,  the  existence  of  a  thrombin  receptor  on  the  cell 
membrane  was  proposed,  however  initial  screens  failed  to  identify  any  such 
receptor (Okumura et al., 1978; Gronke et al., 1987). 
1.3.1.1  Cloning of PAR-1 
In 1991, two laboratories cloned the hamster and the human thrombin receptor 
respectively  (Rasmussen  et  al.,  1991;  Vu  et  al.,  1991a),  later  termed  as 
proteinase  activated  receptor  1  (PAR-1),  by  expressing  mRNA  from  thrombin-27 
responsive cells in oocytes of Xenopus. The putative protein contained 425 or 
427  amino  acids  for  human  or  hamster  respectively.  Hydropathy  analysis 
revealed  the  receptor  to  be  a  member  of  the  seven  transmembrane  domain 
receptor family. A remarkable feature of the receptor was its relatively long (75 
amino acid) extracellular N-terminus, which includes a thrombin cleavage site. 
Furthermore,  the  PAR-1  response  to  thrombin  was  abolished  by  hirudin,  a 
specific thrombin antagonist, confirming the selective nature of the receptor to 
thrombin (Vu et al., 1991a). In the following years, PAR-1 was also cloned in rat 
(Zhong et al., 1992) and mouse (Soifer et al., 1994). 
1.3.1.2  Cloning of PAR-2 
As not all the actions of thrombin could solely be attributed to PAR-1 receptor 
activation (Vouret-Craviari et al., 1992), it was widely believed that a second 
thrombin receptor must exist. By screening the mouse genome library using a 
mixture  of  two  60-oligomers  corresponding  to  the  second  and  sixth 
transmembrane domains of the bovine substance K receptor (Masu et al., 1987), 
Nystedt  and  co-authors  cloned  a  DNA  sequence  encoding  a  protein  of  395 
residues  with  seven  transmembrane  domain  structure  (Nystedt  et  al.,  1994; 
Nystedt et al., 1995b). A putative proteinase cleavage site was deduced in its 
long  N-terminus.  This  receptor  shared  30%  amino  acids  with  human  PAR-1 
receptor, and was 28% identical with mouse PAR-1 receptor. Surprisingly, rather 
than been stimulated by thrombin, the receptor was highly sensitive to another 
proteinase, trypsin. Similar to PAR-1, cleavage of a trypsin cleavage site in the N 
terminus was shown to be required for the receptor activation (Nystedt et al., 
1994). This receptor was accordingly termed as proteinase activated receptor 2 
(PAR-2). Subsequently, the human PAR-2 receptor was cloned in the following 
year (Nystedt et al., 1995a). 
1.3.1.3  Cloning of PAR-3 
The cloning of PAR-2 opened doors for hunting for more members of the PARs 
family. Indeed, platelets in the PAR-1 deficient mice still responded strongly to 
thrombin (Connolly et al., 1996). PAR-3 was subsequently cloned by polymerase 
chain  reaction  (PCR)  using  degenerate  primers  corresponding  to  conserved 
domains  in  PAR-1  and  PAR-2  to  screen  platelet  RNA  from  rat.  Then,  this  rat 28 
sequence was used to obtain mouse and human cDNA clones  (Ishihara et al., 
1997). The human PAR-3 shares 27% sequence homology with human PAR-1, and 
28% with human PAR-2.  
1.3.1.4  Cloning of PAR-4 
Coughlin’s group found the thrombin responses in platelet from PAR-3 deficient 
mice was largely delayed, but not absent (Kahn et al., 1998). As PAR-1 played no 
roles in mouse platelet aggregation (Connolly et al., 1994; Connolly et al., 1996), 
it  indicated  another  receptor  was  activated  in  response  to  thrombin.  Two 
laboratories using the strategy of GenBank BLAST (Basic Local Alignment Search 
Tool)    based  on  the  conserved  Expressed  Sequence  Tag  (ETS)  among  PARs, 
discovered the PAR-4 in mouse and human respectively (Kahn et al., 1998; Xu et 
al., 1998).  
1.3.2 Structural features of PARs 
Each PAR has a proteinase cleavage site within its long N-terminus,  although 
distinctive  sequence  location  and  sensitivity  to  a  variety  of  proteinase  differ 
among  PARs  as  illustrated  in  Figure  1.2.  Taking  human  PARs  for  instance, 
proteinase  cleavage  site  in  PAR-1  is  LDPR
41↓S
42FLLRN  (↓  indicates  specific 
cleavage position), SKGR
34↓S
35LIGKV for PAR-2, LPIK
38↓T
39FRGAP for PAR-3, and 
PAPR
47↓G
48YPGQV for PAR-4. The cleavage sites in PAR-1, PAR-3 and PAR-4 are 
preferentially sensitive to thrombin, whereas, PAR-2 is preferentially to trypsin. 
In addition, PAR-1 and PAR-3 have a hirudin-like domain in their N-terminals as 
demonstrated in Figure 1.2. This feature is distinct as this domain is not found in 
either PAR-2 or PAR-4. Experiments indicated the hirudin-like domain facilitated 
receptor-thrombin  interaction  by  reducing  kinetic  barrier,  leading  to 
conformational change in the catalytic site of thrombin to perform proteolysis 
(Vu et al., 1991b; Ishii et al., 1993). The lack of a hirudin-like domain in PAR-2 
also explains its irresponsiveness to thrombin. 
Apart from the features in the N-terminus, the second extracellular loop in PARs 
is highly conserved in the four members across species. It has been confirmed 
the  second  extracellular  loop  alone  has  the  ability  to  recognise  “proteinase 29 
identity” (Lerner et al., 1996). Together with the N-terminus cleavage site, they 
jointly confer the specificity of proteinase binding (Bahou & Demetrick, 1997). 
Finally, the intracellular C-terminus of PARs has been shown to participate in 
PARs desensitisation and trafficking.  
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Figure 1-2 Structural features of PARs.  
A.  Schematic  structure  of  PARs  during  rest  (Left)  and  activation  (Right)  B.  Functional 
important  domains  on  PARs.    Adapted  and  modified  from  Ossovskaya  VS&Bunnett  NW, 
2004 (Ossovskaya & Bunnett, 2004) 30 
1.3.3 Mode of activation of PARs 
The  default  mechanism  by  which  the  proteinases  cleave  and  activate  PARs 
endogenously  is  identical.  Proteinases  interact  with  PAR,  recognise  the 
conserved domains in the N-terminal, and cleave at the proteinase cleavage site, 
unveiling a new N-terminal to serve as “tethered ligand”, which binds to the 
second  extracellular  loop,  initiating  cellular  signalling.  In  addition  to  their 
endogenous activation mode, all PARs with the exception of PAR-3, have been 
demonstrated  to  be  activated  by  synthetic  short  peptides,  which  mimic  the 
amino acid sequence of the “tethered ligand” (Vu et al., 1991a; Nystedt et al., 
1994). These synthetic peptides with relatively high selectivity offer valuable 
tools  to  test  function  of  specific  PAR  member  in  biological  systems  usually 
expressing  more  than  one  PAR.  Furthermore,  they  provide  an  accessible 
experimental strategy to bypass the dilemma of destroying the integrity of PARs 
by  using  proteinases,  such  as  thrombin  and  trypsin.  (see  figure  1.3)    More 
importantly, synthetic “scrambled” peptides which are in reverse order of the 
amino acid sequence of activating peptide and not able to activate PARs, have 
been  developed  to  use  as  “control  peptides”  in  investigating  PARs  function. 
However, It has been noticed that in certain circumstances, the PAR activating 
peptides can stimulate a receptor other than any one of the four PARs (Vergnolle 
et al., 1998; Hollenberg et al., 2004). These data suggest it is necessary to use 
both PAR activating peptide and its corresponding PAR inactive peptide to study 
a given PAR rigorously (Ramachandran & Hollenberg, 2008).  
Recently, two structurally different, potent, selective, and metabolically stable 
small-molecule PAR-2 agonists, AC-55541 and AC-264613, were discovered and 
characterised  in  vitro  by  in  cellular  proliferation  assays,  phosphatidylinositol 
hydrolysis assays, and Ca
2+ mobilisation assays from cell culture preparations, 
with potencies ranging from 200 to 1000 nM for AC-55541 and 30 to 100 nM for 
AC-263613 (Gardell et al., 2008; Seitzberg et al., 2008). Although these PAR-2 
agonist molecules were only tested in expression systems, they may be useful in 
probing the physiological functions of PAR-2 receptor as alternatives for short 
peptides in brain tissues.   31 
As PARs are regularly co-expressed, it has been proposed that the interactions 
among PAR members within proximity would share a single proteinase agonist or 
react as activation facilitators. This appeared to be the case for PAR-3 and PAR-
4 located in mouse platelets (Nakanishi-Matsui et al., 2000). In mouse platelet, 
PAR-3  and  PAR-4  are  receptors  for  thrombin  with  differential  affinity.  PAR-3 
responds to low concentration of thrombin, whereas PAR-4 activation needs high 
dose (Nakanishi-Matsui et al., 2000). However, when PAR-3 alone was expressed, 
or  even  overexpressed  in  COS  cells,  it  did  not  respond  to  thrombin  at  all 
(Nakanishi-Matsui et al., 2000). Interestingly, when co-expressed PAR-3 and PAR-
4, the signalling to thrombin through PAR-4 increased 6 to 15 fold, whereas PAR-
4 response to its activating peptide was not changed (Nakanishi-Matsui et al., 
2000). This suggested a novel way that PAR-3 does not mediate signalling itself 
but plays as a co-factor for the cleavage and activation PAR-4 by thrombin. 32 
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Figure 1-3 Schematic demonstration of activation mechanisms of PARs.  
Adapted and modified from Bushell,2007 (Bushell, 2007) 33 
  PAR-1  PAR-2  PAR-3  PAR-4 
Proteinase cleavage site  R
41↓S
42FLLRN (Human) 
R
41↓S
42FFLRN (Rat) 
R
41↓S
42FFLRN (Mouse) 
R
34↓S
35LIGKV (Human) 
R
36↓S
37LIGRL (Rat) 
R
34↓S
35LIGRL (Mouse) 
K
38↓T
39FRGAP (Human) 
K
37↓
 S
38FNGGP (Mouse) 
R
47↓G
48YPGQV (Human) 
R
58↓ G
59FPGKP (Rat) 
R
59↓G
60 YPGKF (Mouse) 
Proteinase agonists  Thrombin 
Plasmin 
Trypsin 
FXa 
FVⅡa 
APC 
Granzyme A 
Gingipians-R 
Trypsin 
Tryptase 
Kallikrein-4, -5, -6,-14 
FXa 
FVⅡa 
MT-SP1 
Proteinase-3 
Acrosien 
Gingipians-R 
Thrombin  Thrombin 
Trypsin 
Kallikrein-14 
Cathepsin G 
FXa 
FVⅡa   
Gingipians-R 
 
 
Activating peptide  TFLLR-NH2 
SFLLR-NH2 
SLIGRL-NH2 
SLIGKV-NH2 
2-furoyle-LIGRLO-NH2 
None  AYPGKF-NH2 
Other agonists    PAR-2 molecule agonists 
AC-55541, AC-264613 
   
Antagonist  RWJ-56110 
RWJ-58259 
SCH-205831 
SCH530348 
BMS-200261 
P1pal-12 pepducin 
FSLLRY-NH2 
LSIGRL-NH2 
N
1-3-methylbutyryl-N
4-6- 
aminohexanoyl-piperazine 
(ENMD-1068) 
None  trans-cinnamoyl-YPGKF-NH2 
P4pal-12 pepducin 
PAR knockout mouse  YES  YES  YES  YES 
   
Table 1-1 Summary of pharmacology of PARs.34 
1.3.4 Cellular signalling of PARs 
1.3.4.1  PAR-1 signalling 
PAR-1 has been confirmed to couple with three groups of G proteins as Gi, Gq/11, 
and  G12/13 as  discussed  in  the  following.  The  signalling  through  Gαi  pathway, 
which  inhibits  adenylyl  cyclase  and  suppresses  formation  of  cAMP,  was 
demonstrated  in  several  cell  types  including  HEL  cells  (Brass  et  al.,  1991), 
osteosarcoma cells (Babich et al., 1990), vascular smooth muscle cells (Kanthou 
et  al.,  1996),  fibroblasts  (Hung  et  al.,  1992),  platelets  (Kim  et  al.,  2002), 
astrocytes (Wang et al., 2002), and endothelial cells (Vanhauwe et al., 2002). 
Another major pathway for PAR-1 signalling is through Gαq/11, which stimulates 
PLC-β.  PLC-β  generates  IP3,  which  mobilises  intracellular  Ca
2+
  and  DAG  that 
activates PKC. Coupling of PAR-1 to Gαq/11 was evidenced by the blockade of 
PAR-1  mediated  Ca
2+  signalling  by  using  antibody  against  Gαq/11  subunit  in 
fibroblast cells (Baffy et al., 1994) and through co-immunoprecipitation of Gαq/11 
with  PAR-1  (Ogino  et  al.,  1996).  Gαq/11 coupling  to  PAR-1  was  found  also  in 
astrocytes (Wang et al., 2002), and astrocytoma cells (LaMorte et al., 1993). The 
interaction  between  PAR-1  and  Gα12/13  emerged  in  platelets  and  astrocytoma 
cells.  Gα12/13  interacts  with  Rho  guanine-nucleotide  exchange  factors  (GEFs), 
permitting Rho-mediated control of cell shape and migration by  activating Rho-
kinases (Offermanns et al., 1994; Aragay et al., 1995). The Gβγ subunits released 
from  the  coupling  of  PAR-1  to  heterogeneous  G  proteins  also  initiate  signal 
transduction, notably, the activation of phosphatidylinositol (PI) 3-kinase which 
leads  to  changes  in  cytoskeletal  structure,  cell  motility,  survival,  and 
mitogenesis (Wang et al., 2002). 
Apart  from  classical  G  protein  signalling,  PAR-1  activates  other  multiple 
intracellular kinase cascades in a G protein dependent or independent manner. 
One  important  substrate  of  PAR-1  is  the  MAPKs.  The  MAPK  family  has  been 
characterised  in  mammalian  cells  with  several  MAPK  signalling  molecules, 
including extracellular-regulated kinases (ERKs), c-Jun N-terminal kinases (JNKs), 
and p38 MAP kinase (Widmann et al., 1999). They share a common activation 
mechanism by which a MAP kinase kinase Kinase (MAPKKK) phosphorylates and 
activates MAP kinase kinase (MAPKK), which in turn phosphorylates and activates 
MAP kinase. Then specific MAP kinase targets molecules in the cytoplasm and     35 
nucleus,  leading  to  a  biological  response  such  as  mitogenesis,  cytoskeleton 
change,  and  cell  survival.  PAR-1  has  been  confirmed  to  activate  ERKs  in 
astrocytes (Wang et al., 2002), intestinal epithelial cells (Buresi et al., 2002), 
and  fibroblasts  (Vouret-Craviari  et  al.,  1993).  PAR-1  also  activates  p38  MAP 
kinase for example in fibroblasts (Sabri et al., 2002; Wang et al., 2006a), and 
human endothelial cells (Banfi et al., 2009). JNK has also been recently shown to 
involved in PAR-1 signaling in astrocytes (Wang et al., 2006b). PAR-1 signalling to 
the  nuclear  factor  (NF)-κB  has  also  been  reported  (Rahman  et  al.,  2002; 
Tantivejkul et al., 2005), but the underlying mechanisms are still under debate. 
1.3.4.2  PAR-2 signalling 
Compared to extensive studies into PAR-1-mediated signalling, PAR-2 signalling 
was less investigated. However, it was widely reported that both trypsin and 
PAR-2 activating peptide (PAR-2-AP), elevated intracellular Ca
2+ concentration 
subsequent  to  the  release  of  IP3  alongside  with  DAG  in  numerous  cell  types 
including transfected cell lines, ovary cells, tumor cells, neurons, and astrocytes 
(Nystedt et al., 1995a; Bohm et al., 1996; Ubl et al., 1998; Bushell et al., 2006). 
These data suggested that PAR-2 coupled to Gq/11. The PAR-2 coupling to Gi is 
disputed. One report showed the PAR-2 signalling was not affected when treated 
with pertussis toxin (PTX), a Gi blocker, in enterocytes, suggesting PAR-2 did not 
signal  through  Gi  pathway  (DeFea  et  al.,  2000).  However,  another  report 
challenged  this  suggestion,  and  demonstrated  the  Ca
2+  signalling  in  Xenopus 
oocytes in response to trypsin was PTX sensitive (Schultheiss et al., 1997). So far, 
the coupling of PAR-2 with G12/13 has not been reported. 
A  novel  aspect  of  PAR-2  signalling  is  its  ability  to  activate  cellular  kinase 
cascades in a β-arrestin dependent, G protein independent mechanism. PAR-2 
activators strongly activated ERK1/2 but p38 MAP kinase moderately (Belham et 
al., 1996). Further studies demonstrated that trypsin and PAR-2-AP stimulated 
the  formation  of  a  multiprotein  complex,  containing  internalised  PAR-2,  β-
arrestin,  Raf-1,  and  activated  ERK,  which  was  required  in  ERK1/2  activation 
(DeFea  et  al.,  2000).  A  recent  report  showed  PAR-2  promoted  β-arrestin 
dependent  dephosphorylation  and  activation  of  the  actin  filament-severing 
protein (cofilin) independently of Gq/11 signalling (Zoudilova et al., 2007). These 
findings indicate PAR-2 may signal through ‘dual’ mechanisms, and act via both     36 
Gq/11 and β-arrestin simultaneously to exert a large variety of cellular functions. 
In  keratinocytes  (Macfarlane  et  al.,  2005)  and  smooth  muscle  cells 
(Bretschneider  et  al.,  1999),  the  intracellular  Ca
2+  concentration  induced  by 
PAR-2 activation was an important determinant of NF-κB activation.  
1.3.4.3  PAR-3 and PAR-4 signalling 
PAR-3 does not appear to signal on its own. However, it indeed plays a role as a 
co-activator for PAR-4 activation. One intriguing aspect of this is the possible 
ability  of  PAR-3  to  form  heterodimers  with  other  PARs,  PAR-1  for  instance, 
jointly exerting regulatory role for signal transduction (McLaughlin et al., 2007). 
PAR-4  activation  led  to  the  aggregation  of  platelets  in  mouse  and  human 
platetes (Kahn et al., 1998) and presumably via Gq/11 as PAR-4 resulted in the 
formation of intracellular IP3 when transiently transfected into COS cells (Xu et 
al., 1998). PAR-4 signalling through ERK1/2 was documented in smooth muscle 
cells (Bretschneider et al., 2001). A recent study reported PAR-4 upregulated 
p38 MAP kinase in endothelial cells (Fujiwara et al., 2005). 
1.3.5 Expression  and  localisation  of  PARs  in  the  brain  under 
disease conditions 
Various pathological processes have been shown to modulate the expression of 
PARs in the brain.  
 
1.3.5.1  Ischaemia 
Different  experimental  models  of  ischaemia,  both  in  vitro  and  in  vivo,  have 
demonstrated a differential regulation of PARs in the brain. PAR-1 and PAR-3 are 
upregulated in rat hippocampal slices culture in an in vitro ischaemia model, 
oxygen-glucose deprivation (Striggow et al., 2001). In one in vivo study, PAR-2 
expression  was  strongly  upregulated  at  8-24  hours  after  transient  middle 
cerebral artery occlusion in neurones in the cortex in mice (Jin et al., 2005). In 
another report, the mRNA expression level of PAR1-4 was analysed in a transient 
focal ischaemia in rat brain, induced by microinjection of endothelin near the 
middle cerebral artery (Rohatgi et al., 2004a). Interestingly, PAR-1 mRNA was 
strongly  downregulated,  whereas,  PAR-2  mRNA  was  only  decreased  modestly     37 
(Rohatgi  et  al.,  2004a).  PAR-3  was  upregulated  transiently  and  then 
downregulated,  and  PAR-4  mRNA  levels  showed  the  most  striking  (2.5-fold) 
increase  12  hr  after  ischaemia  (Rohatgi  et  al.,  2004a).  This  group  further 
demonstrated  a  de  novo  expression  of  PAR-1  and  PAR-3  in  microglia  in  the 
penumbra  zone of  the  infarct in  rat  12  or  48  hours  after  endothelin-induced 
middlecerebral artery occlusion (Rohatgi et al., 2004a).  
 
1.3.5.2  Parkinson’s disease 
One  Japanese  group  reported  the  upregulation  of  PAR-1  in  astrocytes  in 
Parkinson’s brain (Ishida et al., 2006). This group examined PAR-1 expression in 
substantia nigra pars compacta (SNpc) of brains from patients with Parkinson’s 
disease.  PAR-1  was  exclusively  found  in  astrocytes  in  these  samples. 
Interestingly,  the  numbers  of  astrocytes  expressing  PAR-1  increased  in  the 
specimens of Parkinson’s disease but not in healthy controls (Ishida et al., 2006).  
 
1.3.5.3  HIV infection 
Human immunodeficiency virus (HIV) infection has several implications in the 
brain,  in  which  PARs  expression  is  altered.  During  HIV  encephalitis,  the 
expression of PAR-1 is upregulated at both mRNA and protein levels in astrocytes 
in humans in vivo (Boven et al., 2003). Furthermore, PAR-2 is upregulated on 
neurones in conjunction with neuroinflammation in brain tissue from patients 
with HIV infection associated dementia (Noorbakhsh et al., 2005).  
 
1.3.5.4  Alzheimer’s disease 
Two  studies  demonstrated  the  altered  levels  of  PARs  expression  during 
Alzheimer’s  disease  (Pompili  et  al.,  2004;  Afkhami-Goli  et  al.,  2007).  Direct 
post-mortem study examining the brain tissue from patients with Alzheimer’s 
disease  revealed  that  PAR-2  expression  was  downregulated  in  neurones  but 
upregulated  in  proximal  astrocytes  in  Alzheimer’s  specimens  compared  to 
healthy controls (Afkhami-Goli et al., 2007). Furthermore, one study utilising an 
in  vitro  model  of  Alzheimer’s  disease  by  trimethyltin  administration 
demonstrated  that  all  PARs  particularly  PAR-1  expression  at  both  mRNA  and     38 
protein levels increased significantly in hippocampal astrocytes (Pompili et al., 
2004). 
 
1.3.5.5  Multiple sclerosis and experimental autoimmune encephalomyelitis 
PAR-2 expression is increased on astrocytes and infiltrating macrophages in brain 
white matter from human multiple sclerosis samples (Noorbakhsh et al., 2006). 
Similar observation is reported in experimental autoimmune encephalomyelitis 
(EAE) in mouse (Noorbakhsh et al., 2006).  
 
1.3.5.6  Radiation damage 
Expression of PAR-2 is investigated in a study into the consequences of single 
exposure  to  nuclear  radiation.  Significant  PAR-2  immunoactivity  in  cell 
membrane is discovered in deeper cortical layers (Olejar et al., 2002). At the 
same time, diffuse cytoplasmic PAR-2 immunoactivity is demonstrated in cortex 
and  hippocampus  (Olejar  et  al.,  2002).  Increased  cytoplasmic  and  polarised 
membrane  positivity  is  also  noticed  on  the  neurones  of  hypothalamic  nuclei 
(Olejar et al., 2002). 
 
In  conclusion,  a  variety  of  pathological  conditions  differentially  altered  the 
expression of PAR1-4 in brain depending on diseases themselves or experimental 
disease models that were used and which cell type was studied. More precisely, 
the cell type specific, concentration/time course dependent dynamic expression 
profiles  under  pathological  conditions  indicates  either  harmful  or  protective 
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1.3.6 Dual  functions  of  PARs  in  the  brain  under  disease 
conditions 
1.3.6.1  PARs in neurodegeneration 
Numerous  studies  have  demonstrated  neurodegenerative  role  of  PARs  in  a 
variety of conditions in the brain. Although most of current knowledge about 
PAR-mediated  neurodegeneration  is  from  PAR-1,  PAR-2  and  PAR-4  have  been 
shown to participate in this process as well.  
1.3.6.1.1  Ischaemia 
 
Ischaemia has been shown to regulate PARs expression (Striggow et al., 2001; 
Rohatgi et al., 2004a; Jin et al., 2005), and actually, PARs directly contribute to 
ischaemia-induced cell death. It is widely accepted that thrombin,  the PAR-1 
activator, is released into the brain tissue during the damage of the blood-brain 
barrier,  which  is  a  characteristic  feature  of  brain  ischaemia,  such  as  stroke. 
Thrombin has been shown to be able to kill cultured hippocampal neurones and 
astrocytes  mediated  by  PAR-1  activation  (Donovan  et  al.,  1997).  It  has  been 
shown that thrombin activity is increased in the ischaemic areas of the brain (Xi 
et al., 2003). At high concentrations, thrombin deceases neuronal survival, and 
even causes neuronal cell death in a concentration dependent manner (50-500nM) 
in  hippocampal  slice  culture  following  oxygen  and  glucose  deprivation,  an  in 
vitro model of ischaemia (Striggow et al., 2000). It is further demonstrated that 
blocking thrombin activity by selective inhibitor, hirudin, attenuated ischaemic 
damage  before  in  vitro  ischaemia  was  induced  (Striggow  et  al.,  2000; 
Karabiyikoglu  et  al.,  2004).  In  vivo  studies  further  reported  that  PAR-1 
contributed  to  the  infarct  volume  in  the  brain  after  transient  focal  cerebral 
ischaemia, which was significantly reduced in PAR-1 knockout mice (Junge et al., 
2003). Similar neuronal damage caused by PAR-1 activation was reported, and 
also  prevented  in  PAR-1  knockout  mice  after  unilateral  cerebral 
hypoxia/ischaemia (Olson et al., 2004).  
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1.3.6.1.2  Alzheimer’s disease 
 
A high level of thrombin has been detected in brain tissues from Alzheimer’s 
disease patients, especially in senile plaques, some diffuse amyloid deposits and 
neurofibrillary tangles (Akiyama et al., 1992). The presence of thrombin in the 
Alzheimer’s  brain  was  also  documented  by  other  groups  (Arai  et  al.,  2006; 
Grammas  et  al.,  2006).  It  was  further  demonstrated  that  thrombin  in 
Alzheimer’s  brain  induced  rapid  tau  hyperphosphorylation  and  aggregation  in 
hippocampal neurones via PAR-1 and PAR-4, resulting in delayed synaptophysin 
reduction  and  apoptotic  neuronal  death  (Suo  et  al.,  2003).  A  recent  report 
showed  PAR-4  is  involved  in  regulation  of  beta-secretase  cleavage  of  the 
Alzheimer amyloid precursor protein (Xie & Guo, 2005). All these studies suggest 
the activation of PAR-1 and PAR-4 contribute to the pathogenesis of Alzheimer’s 
disease.  
 
1.3.6.1.3  Parkinson’s disease 
 
PAR-1 expression is up-regulated in astrocytes in substantia nigra pars compacta 
of Parkinson disease brains (Ishida et al., 2006). It was further demonstrated 
that PAR-1 contributes to the pathogenesis of Parkinson’s disease. Using a mouse 
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (MPTP)  model  of  Parkinson's 
disease, Hamill and colleagues found after MPTP injection,
 PAR-1 knockout mice 
showed  significantly  higher  residual
  levels  of  dopamine,  the  dopamine 
transporter,  tyrosine  hydroxylase
  and  diminished  microgliosis  compared  with 
wild-type  controls  (Hamill  et  al.,  2007).  Furthermore,  PAR-1  antagonist  BMS-
200261 exerted comparable
 levels of dopaminergic neuroprotection from MPTP-
induced toxicity (Hamill et al., 2007). These data indicate that PAR-1 activation
 
can  contribute  to  dopaminergic  terminal  damage  in  this  model
  of  early 
Parkinson's disease.  
 
1.3.6.2  Mechanisms underlying PAR-mediated neurodegeneration 
Glutamate  receptors,  in  particular  NMDA  receptors  and  Ca
2+-permeable  AMPA 
receptors play a crucial role in maintaining homeostasis in brain morphology and 
activity. It is widely accepted that excessive activation of glutamate receptors is 
toxic  to  neurones  via  an  excessive  influx  of  Ca
2+.  This  mechanism  has  been     41 
confirmed  to  associate  with  several  neurodegenerative  diseases,  such  as 
ischaemic  insults,  Alzheimer’s  disease,  and  HIV-associated  dementia 
(Hardingham  &  Bading,  2003;  Liu  &  Zukin,  2007).  Interestingly,  activation  of 
PAR-1  in  astrocytes  induced  the  release  of  glutamate  (Lee  et  al.,  2007; 
Shigetomi et al., 2008). The elevated extracellular glutamate in turn activates 
NMDA receptors on the neighboring neurones (Lee et al., 2007). Furthermore, it 
has been demonstrated that activation of PAR-1 on neurones potentiates NMDA 
receptor function (Gingrich et al., 2000). These data suggest PAR-1 activation 
may  further  strengthen  the  NMDA  receptor  mediated  neuronal  toxicity  in 
neurodegeneration during pathological conditions such as ischaemia and stroke.  
 
Another possible mechanism underlying PAR mediated neurodegeneration may 
involve  neuroinflammation.  Up-regulation  of  inflammatory  cytokines,  such  as 
TNF-α, TNF-β, IL-1β, and IL-6, was observed in ischaemia, Alzheimer’s disease, 
Parkinson’s disease and multiple sclerosis (Campbell, 2004; Lucas et al., 2006).  
Interestingly,  the  up-regulation  of  cytokines  is  observed  in  a  variety  of 
neurodegenerative  conditions  involving  neuroinflammation,  such  as  HIV-
associated  encephalitis,  EAE  and  multiple  sclerosis,  has  been  reported 
accompanied  simultaneously  with  PAR’s  activation  (Boven  et  al.,  2003; 
Noorbakhsh  et  al.,  2005;  Noorbakhsh  et  al.,  2006).  In  one  study,  PAR-1 
activating peptide significantly  increased levels of IL-1β in human astrocytes, 
and supernatants of these cells were neurotoxic (Boven et al., 2003). Moreover, 
striatal implantation of the PAR-1-AP significantly induced brain inflammation 
and neurobehavioral deficits in mice (Boven et al., 2003). In the other study, 
macrophages from PAR-2 knockout mice showed higher expression of IL-10, and 
released  soluble  oligodendrocyte  cytotoxins  after  experimental  autoimmune 
encephalomyelitis (Noorbakhsh et al., 2006). Moreover, PAR-2 wildtype animals 
showed  markedly  greater  microglial  activation  and  T  lymphocyte  infiltration 
accompanied by worsened demyelination and axonal injury compared to controls 
(Noorbakhsh  et  al.,  2006).  Taken  together,  these  data  demonstrate  PAR-
mediated neuroinflammation is an important contributor to neuronal death in 
neruodegeneration in the brain.  
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1.3.6.3  PARs in neuroprotection 
The  neurodegenerative  effect  of  PARs  activation  is  well  documented  and 
summarized above. However, it is also noticed that under certain conditions, 
PAR activation turns out to be neuroprotective.  
 
Thrombin or PAR-1-AP at very low and moderate concentrations is suggested to 
be neuroprotective in the brain. Low concentration of thrombin at 50pM, or of 
PAR-1-AP  at  10µM,  induced  significant  neuroprotection  against  experimental 
ischaemia  (Striggow  et  al.,  2000).  Another  study  reported  that  pretreatment 
with a low dose of thrombin as preconditioning, attenuated brain edema induced 
by a subsequent intracerebral injection of a high dose of thrombin (Xi et al., 
1999).  It  was  further  demonstrated  that  the  thrombin  preconditioning  would 
offer protection from ischaemic brain damage in vivo (Masada et al., 2000). In 
addition,  in  vitro,  low  concentrations  of  thrombin  protect  neurones  and 
astrocytes  from  cell  death  induced  by  hypoglycemia  and  oxidative  stress 
(Vaughan et al., 1995). Furthermore, an anticoagulant and cytoprotector blood 
serine,  proteinase-activated  protein  C  protected  cultured  hippocampal  and 
cortical neurons against glutamate-induced excitotoxicity at low concentrations 
(0.01-10nM) via PAR-1 activation (Gorbacheva et al., 2008).  
 
Neuroprotective role of PARs has been demonstrated in several disease models 
as  well.  Thrombin  preconditioning  reduced  dopaminergic  terminal  loss  and 
ventricular  enlargement  as  compared  to  saline-treated  animals  in  6-
hydroxydopamine Parkinson's disease model (Cannon et al., 2005). These authors 
further demonstrated the protective effect of thrombin preconditioning in this 
Parkinson’s disease model was mediated PAR-1(Cannon et al., 2006). In another 
study, neuronal PAR-2 activation protected human neurones against the toxic 
effects  of  fibrillar  42-aa  form  of  beta-amyloid,  a  key  component  of 
neuropathogenesis in  Alzheimer’s disease (Afkhami-Goli et al., 2007).  During 
HIV infection induced dementia, PAR-2 activation has been confirmed to prevent 
neuronal
 cell death and induction of the tumor suppressor, p53, caused
 by the 
HIV-encoded protein, Tat, in brain tissue from human patients (Noorbakhsh et 
al., 2005). In addition, PAR-2-AP also inhibited Tat-induced
 neurotoxicity in a 
mouse  model  of  HIV  neuropathogenesis  (Noorbakhsh  et  al.,  2005).  PAR-2     43 
knockout mice displayed significantly increased infarct volume and the number 
of apoptosis cells at 24 hours of reperfusion in a model of acute focal ischemic 
brain injury (Jin et al., 2005). Reiser’s group has shown that activation of either 
PAR-1  or  PAR-2  prevents  ceramide-induced  apoptosis  in  cultured  rat 
hippocamapl  astrocytes,  providing  a  novel  mechanism  of  PAR-dependant 
protection (Wang et al., 2006a; Wang et al., 2007). PAR-1 or PAR-2 activation 
induced release of a chemokine,  growth-regulated oncogene/cytokine-induced 
neutrophil chemoattractant-1 (GRO/CINC-1) in primary rat astrocytes via c-Jun 
N-terminal  kinase  (JNK)  activation  (Wang  et  al.,  2006a;  Wang  et  al.,  2007). 
Interestingly,  GRO/CINC-1  inhibited  cytochrome  c  release  from  mitochondria 
through chemokine receptor CXCR2 in a feedback manner to protect astryocytes 
from apoptosis (Wang et al., 2006a; Wang et al., 2007). One recent publication 
from our group further demonstrated that PAR-2 activation protects neurones in 
organotypic  hippocampal  slice  cultures  (OHSC)  against  kainate  acid-induced 
neuronal  death  via  activation  of  chemokine  receptor  CXCR2  and  mGluRs  in 
response to astrocytic release of gliotransmitter (Greenwood & Bushell, 2010). In 
addition,  it  is  demonstrated  that  PAR-2-mediated  neuroprotection  in  OHSC 
involves MAPK signalling pathways because PAR-2 activation significantly reduces 
both p38 MAPK and ERK activities in OHSC and co-application of antagonists for 
p38  MAPK  and  ERK  can  mimic  PAR-2-mediated  neuroprotection  in  OHSC 
(Greenwood & Bushell, 2010).   
 
In summary, duality of function of PARs has been widely documented. However, 
the  determining  factors  of  this  duality  still  remain  to  be  elucidated.  Initial 
suggestion, though not definite, is the final actions of PAR-1 in neurones, either 
degenerative or protective, depend on the magnitude and duration of activator 
exposure, such as thrombin, and PAR-1-AP. Low concentration or brief exposure 
leads  to  neuroprotection,  whereas  medium  or  high  concentration  results  in 
degeneration.  Similarly,  the  ultimate  consequence  of  PAR-2  activation  seems 
depending on the cell type in which the activation occurs. PAR-2 activation in 
astrycytes is neurodegenerative, and in contrast, its activation in neurones is 
protective (Bushell, 2007; Greenwood & Bushell, 2010).  
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1.3.7 Limitations in PAR research 
As PARs activate a variety of second messenger cascades in different tissues and 
cell types, it is not surprising that the signal transduction mediated by PARs, 
ultimately  gives  rise  to  a  wide  range  of  physiological  and  pathophysiological 
responses.  However,  quantitative  and  specific  analysis  of  individual  PAR 
involvement in various processes was compromised by the following limitations: 
 
Firstly,  the  system  where  PAR  takes  its  function  is  complex.  PARs’  signalling 
needs  a  focal  coherent  interaction  involving  multiple  proteinases,  proteinase 
inhibitors, cofactors in a timing dependent manner. In many situations, the full 
components of this system remain unclear.  
 
Secondly, selective, potent and readily accessible antagonists for all PARs are 
not available although much progress has been made. Indeed, compounds such 
as RWJ-56110 and RWJ-58259 were developed by the Johnson & Johnson team as 
potential PAR-1 antagonists to, at least, locally block thrombosis in arterial stent 
adducts (Andrade-Gordon et al., 1999; Zhang et al., 2001). Another compound 
SCH-205831 or PAR-1 antagonist 55, which competitively inhibits PAR-1-AP biding 
site on PAR-1, was reported to be antithrombotic in human (Chackalamannil et 
al., 2005). Moreover, BMS-200261, another PAR-1 antagonist, which blocks the 
cleavage  of  Arg41  of  PAR-1  by  proteinases  (Bernatowicz  et  al.,  1996),  fully 
blocked PAR-1-induced Ca
2+ signalling in astrocytes  (Nicole et al., 2005), and 
reduced dopaminergic terminal damage in a mouse model of Parkinson’s disease 
(Hamill et al., 2007). Very recently a new compound SCH530348 was described 
as a hope for orally available PAR-1 antagonist to target thrombosis (Camerer, 
2007).  Developing  antagonists  for  PAR-2  has  been  much  challenging.  A  few 
peptides, such as FSLLRY-NH2 and LSIGRL-NH2, were made but potency was too 
low (Al-Ani et al., 2002). A recent progress was achieved by reporting a novel 
PAR-2  antagonist  molecule  N
1-3-methylbutyryl-N
4-6-aminohexanoyl-piperazine 
(ENMD-1068) attenuated PAR-2-mediated joint inflammation (Kelso et al., 2006). 
Antagonist  peptides  for  PAR-4,  trans-cinnamoyl-YPGKF-NH2  was  also 
demonstrated by Hollenberg’s group in 2001(Hollenberg & Saifeddine, 2001).  
     45 
Novel strategies to antagonize PARs were attempted by 1) targeting the receptor 
intracellular  loops  with  cell-penetrating  membrane-tethered  peptides  termed 
pepducins (Covic et al., 2002a; Covic et al., 2002b; Kuliopulos & Covic, 2003). 2) 
disrupting proteolysis of PAR by antiserum or PAR specific monoclonal antibody 
(Kelso et al., 2006).  
 
These PAR antagonists have greatly facilitated PAR research, but limitations are 
still clear: 1) lack of selectivity 2) low potency 3) non-PAR actions 4) cost  
 
Thirdly,  to  develop  selective  serine  proteinase  inhibitors  has  been  proved 
difficult.  Furthermore,  even  after  a  selective  proteinase  inhibitor  was 
established, it would still be a challenge to interpretate PAR actions, because in 
most cases, PAR could be activated by more than one activator. Inversely, a 
given  proteinase  could  activate  more  than  one  PAR.  For  example,  upon  the 
discovery of PAR-1 and PAR-2, it is evidenced clear that although trypsin at low 
concentration (<10U/ml, 20nM) activate selectively PAR-2, high concentration of 
trypsin (<=50U/ml, 100nM) also mobilises PAR-1 (Hollenberg & Compton, 2002).    
  
Finally, the endogenous activators for PARs in the brain are  largely based on 
speculation.  Indeed,  several  studies  have  suggested  possible  endogenous 
activators for PARs in the brain, but whether they actually signal through PARs is 
far  from  certain.  Thrombin  expression  in  situ  in  the  brain  is  wide  spread 
(Yoshida  &  Shiosaka,  1999;  Rohatgi  et  al.,  2004b).  Tissue-type  plasminogen 
activator (tPA),  urokinase-type  plasminogen  activator  (uPA) and  plasmin  have 
functional  roles  in  ischaemia,  synaptic  plasticity,  neurodegeneration  and 
neuroregeneration  (Xi  et  al.,  2003;  Sheehan  &  Tsirka,  2005).  Signalling  of 
thrombin  or  thrombin-like  proteinase  endogenously  was  hypothesized  through 
PAR-1. Meanwhile, trypsin expression in situ in the brain is also demonstrated 
(Lohman et al., 2008). Trypsin-like proteinase have also been detected in the 
brain  including  mast  cell  tryptase  (Ibrahim  et  al.,  1996;  Mitsui  et  al.,  1999; 
Kempuraj et al., 2006),  trypsin Ⅳ/ mesotrypsin (Toth et al., 2007), kallikrein 
6/neurosin (Oikonomopoulou et al., 2006), Kallikrein 8/neuropsin (Mitsui et al., 
1999),  neuropsin  (Shimizu  et  al.,  1998;  Matsumoto-Miyai  et  al.,  2003),  and 
neurotrypsin  (Gschwend  et  al.,  1997;  Reif  et  al.,  2007).  These  trypsin-like 
proteinases  modulate  several  physiological  functions  in  the  brain  including     46 
synaptogenesis,  synaptic  transmission,  synaptic  plasticity  and  learning  and 
memory.  However,  the  target  of  trypsin  and  trypsin-like  proteinases 
endogenously in the brain, PAR-2 or not, is under investigation. 
1.4 Electrical properties of a central neurone 
Typically,  normal  brain  function,  from  complex  cognitive  task  to  simple 
movement  control,  is  achieved  by  coherent  flow  of  information  encoded  by 
heterogeneous neuronal activities, which are, in physical nature, proved to be 
electrical  activities.  The  fundamental  unit  of  these  electrical  flows  is  the 
neurone,  characterised  by  its  ability  to  initiate,  propagate,  and  terminate 
electrical signals in a timely order. Furthermore, this property of a neurone is 
determined  by  its  capability  to  allow  charged  ions  to  cross  its  excitable 
membrane  in  a  precisely  regulated  spatiotemporal  manner.  In  the  following 
section, the electrical properties of a central neurone are summarised. 
 
1.4.1 Neuronal excitability 
Neuronal excitability, in cellular neurophysiology, means the ability of neurone 
to generate an AP in response to stimulation (Hille, 2001b). It is attributed to 
the  presence  of  a  broad  range  of  voltage-dependent  ion  channels  across  the 
neuronal membrane, in particular the voltage-dependent Na
+ channels and the 
voltage-dependent K
+ channels (Hodgkin & Huxley, 1952d). Neuronal excitability 
is the intrinsic property of a neurone. Several factors have been considered to 
influence neuronal excitability (Armstrong & Hille, 1998). Notable, three main 
factors  determine  the  neuronal  excitability,  namely  membrane  potential, 
threshold level and voltage-dependent Na
+ channels. Membrane potential and 
threshold  level  are  dependent  on  each  other.  Depolarising  the  membrane 
towards the threshold level is a prerequisite of generating an AP. So, the closer 
the two are, the higher the excitability is. The further apart the two are, the 
lower the excitability is. Furthermore, activation of the voltage-dependent Na
+ 
channels, in most cases, is the initiator of AP. The more functional voltage-gated 
Na
+  channels  are  expressed  on  a  given  neurone,  the  larger  chance  that  the 
excitability of the neurone is higher.  
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1.4.2 Model equivalent circuit of a functional neurone 
The  plasma  membrane  of  a  neurone  is  a  semipermeable  lipid  bilayer 
characterised  in  fluid  mosaic  model  (Singer  &  Nicolson,  1972).  It  effectively 
separates  the  neuronal  plasma  from  the  extracellular  environment  both 
morphologically and electrically. In the majority of the time, the membrane of a 
neurone is of high electrical resistance because it is selectively impermeable to 
water  soluble  charged  ions.  As  both  extracellular  and  intracellular  fluids  are 
excellent  conductors,  this  configuration  confers  a  ‘membrane  capacitor’ 
property. Meanwhile, the lipid bilayer of a neuronal membrane is anchored with 
ion channels, that are permeable to specific charged ions to convey electricity 
current under certain condition, leading to a ‘membrane resistor’ property. Thus, 
a functional neurone in fact could fit into a simplified model electrical circuit as 
illustrated in figure 1.1. This simplified circuit can be used to explain the passive 
electrical properties of a given neurone. 
Vm
Rm Cm
Im
 
Figure 1-4 Schematic illustration of simplified model circuit of a neurone.  
Modified from page 7, Biophysics of computation: information processing in single neurons, 
Christof  Koch,  1999  (Koch,  1999)  From  an  electrical  aspect,  lipid  bilayers  of  a  neuronal 
membrane confer a classical RC circuit, where membrane resistance (Rm) and membrane 
capacitance  (Cm)  are  in  parallel.  Membrane  ion  flow  (Im)  is  driven  by  resting  membrane 
potential (Vm) as a battery.      48 
1.4.3 Resting membrane potential 
The resting membrane potential is the difference of electrical potential across 
the membrane due to separation of charge by the lipid bilayer in the absence of 
stimulus. In most cases, neuronal membrane is negatively charged intracellularly, 
and positive charged extracellularly. If  the extracellular potential is taken as 
reference as default, the membrane potential of a central neurone in the brain 
is  typically  about  -65mV.  Three  factors  contribute  to  the  establishment  of 
resting  membrane  potential  in  the  central  neurones.  1)  Disparity  of  ions 
distribution across inside and outside of neuronal membrane. That is Na
+ and Cl
- 
are more concentrated outside the cell, whereas K
+ and in particular, organic 
anions are much more concentrated inside the cell.  2) Differential permeability 
for  ions  at  resting  situation.  That  is  normally,  without  any  stimulation,  a 
neurone’s membrane is almost only permeable to K
+, but not Na
+ due to the 
opening of K
+ channels and blockade of Na
+ channels. 3) Proper function of Na-K-
ATPase. Na-K-ATPase pumps in two Na
+ ions to the plasma and pumps out three 
K
+ ions to extracellular fluid during each functional circle. Because Na-K-ATPase 
functions  against  concentration  gradient  and  generating  electrical  field,  it 
consumes energy which is supplied by ATP. 
 
1.4.4 Action potential 
An action potential (AP) is the ‘signature character’ of neuronal excitation and 
activity. It is also the coding unit of neural processing. An AP is characterised by 
transient alteration and re-establishment of the neuronal membrane potential in 
response to stimulus as illustrated in figure 1.5. The distinctive feature of an AP 
is  its  all-or-none  property  (Hodgkin,  1937a,  b).  That  is,  the  shape  and  the 
amplitude of an AP do not change in response to the intensity of stimulus as long 
as the stimulus is suprathreshold. If a stimulus is subthreshold, a neurone can 
not generate an AP. In addition, an AP actively propagates across neurone’s axon, 
without compromise of its shape and amplitude. AP’s all-or-none phenomenon is 
in vast contrast with the electrotonic potential, which diminishes with distance. 
However,  AP’s  all-or-none  phenomenon  has  been  complemented  by  the 
observation  that  APs  can  both  actively  and  passively  backpropagate  into 
dendrites with diminishing amplitude across distance (Stuart et al., 1997).     49 
 
As illustrated in figure 1.5, the mechanism underlying the generation of an AP 
has been rigorously investigated and summarised by Hodgkin and Huxley in 1952 
with the establishment of Hodgkin-Huxley model(Hodgkin & Huxley, 1952b, a, c, 
d). Briefly, the time course of an AP can be divided into five parts: the rising 
phase, the peak phase, the falling phase, and the hyperpolarisation phase. The 
rising phase is mediated by gradual activation of voltage-dependent Na
+ channels 
in a positive feedback manner. That is, a suprathreshold stimulus initiates the 
opening  of  voltage-dependent  Na
+  channels,  resulting  in  initial  Na
+  influx. 
Therefore, this Na
+ influx depolarises the membrane further and drives more 
voltage-dependent Na
+ channels to open. The mass Na
+ influx, squeezed by both 
electrical potential and concentration gradient, gives rise to the faster kinetic 
character of the depolarising phase of AP compared to the repolarising phase. 
The opening of voltage-dependent Na
+ channels gradually reaches the maximum 
as positive feedback slows. Furthermore, because of the gradual inactivation of 
voltage-dependent  Na
+  channels  and  accordingly  the  activation  of  voltage 
dependent K
+ channels, the AP reaches its peak and begins to decay swiftly. The 
falling phase is determined by the activation of voltage-dependent K
+ channels 
together with the inactivation of voltage-dependent Na
+ channels. The switch of 
neuronal membrane permeability towards K
+ drives efflux of K
+ to redepolarise 
membrane potential to restore its resting level. Because the redepolarisation 
reduces the opening of voltage dependent K
+ channels in a negative feedback 
manner, the falling phase is kinetically slower compared with the rising phase of 
an AP. The hyperpolarisation phase of an AP is caused by excessive opening of K
+ 
channels because the voltage dependent K
+ channels do not close immediately 
when  membrane  potential  comes  back  to  its  resting  level.  Hyperpolarisation 
sustains  until  the  normal  permeability  of  K
+  is  restored.  In  addition,  the 
involvement  of  hyperpolarisation  activated  cation  channels  (Robinson  & 
Siegelbaum, 2003), G-protein coupled inwardly rectifying K
+ (GIRK) channels and 
Ca
2+ activated K
+ channels (Lujan et al., 2009) in restoring membrane potential 
after hyperpolarization have been demonstrated.     50 
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Figure 1-5 Schematic demonstration of an action potential. 
Modified from page 28, Ion channels of excitable membranes, Bertil Hille, 2001 (Hille, 2001a) 
 
1.5 Synaptic transmission 
Neurones make contact with each other, and play the central role of structural 
and functional unit of neural activity within a highly interactive and coordinated 
circuitry. A contact between neurones is termed a ‘synapse’, which originates 
from ‘synaptein’, combing the Greek "syn-" ("together") and "haptein" ("to clasp"), 
first  used  by  British  neurophysiologist  Charles  Sherrington  in  the  early  20
th 
century.  Interactions  among  neurones  take  place  at  synapses  in  the  form  of 
transmitting electrical signals from one neurone to the other. To date, two main 
forms of synaptic transmission are characterised as either electrical or chemical.  
 
1.5.1 Chemical synaptic transmission 
Chemical synaptic transmission is known as classical synaptic transmission. It has 
four phases: 
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1)  AP  initiated  from  presynaptic  neurone  activates  voltage-dependent  Ca
2+ 
channels located within presynaptic terminal, permitting Ca
2+ influx. 
2) Ca
2+ elevation triggers neurotransmitters released from presynaptic terminal. 
3)  Neurotransmitters  cross  over  the  synaptic  cleft,  acting  on  postsynaptic 
terminal.  
4)  The  postsynaptic  terminal  responds  with  the  change  of  local  membrane 
potential. 
 
In  this  process,  the  electrical  signal  coded  in  the  pattern  of  AP  is  first 
“translated”  into  chemical  signals  carried  by  neurotransmitters,  and  “re-
translated”  back  to  electrical  signal  in  the  form  of  membrane  potential 
alteration.  Therefore,  it  is  also  termed  as  electrical-chemical-electrical 
transmission. 
 
1.5.1.1  Transmitter release 
The  critical  phase  of  chemical  synaptic  transmission  is  the  release  of 
neurotransmitters. Features of transmitter release were outlined as following: 
Firstly, transmitter release is characterised by a mechanism involving exocytosis 
and recycling of synaptic vesicles. Transmitter release could be divided into four 
steps: 1) Docking. Vesicles containing neurotransmitters approach and tether the 
active  zone  of  presynaptic  terminal.  2)  Priming.  This  step  includes  all  the 
protein and lipid modification and rearrangement in the active zone to make 
synaptic vesicles “readily releasable” and competent to fusion (Lloyd & Bellen, 
2001). 3) Fusion. With the Ca
2+ influx triggered by activation of Ca
2+ channel, 
synaptic  vesicles  fuse  with  presynaptic  membrane,  leading  to  release  of 
neurotransmitters  into  synaptic  cleft.  These  three  steps  discussed  above 
comprise  the  whole  process  of  “excocytosis”.  4)  Recycling.  Vesicles  recycled 
back to presynaptic terminal, reloaded with neurotransmitters, and transported 
back to releasable pool.  
 
Secondly,  the  process  of  docking,  priming,  fusion  is  tightly  regulated  by  the 
interaction among SNARE complex and other proteins such as complexin, and 
synaptotagmin, which has been postulated as the “SNARE” hypothesis (Sollner et 
al., 1993; Sudhof & Rothman, 2009).      52 
 
Thirdly,  the  release  of  neurotransmitters  is  characterised  by  quantal  release 
theory  (Katz,  1971).  As  described  above,  neurotransmitters  are  stored  and 
released  from  synaptic  vesicles  upon  neural  impulse.  Thus  functionally,  each 
synaptic vesicle represents a release unit, which is termed as a “quantum”. The 
amount of synaptic vesicles released following one AP is regarded as “quantal 
content”. Likewise, the amount of neurotransmitter molecules loaded in single 
vesicle is described as “quantal size”. From analysis in nerve-muscle synapses, it 
is confirmed that the amount of vesicles released in response to a nerve impulse, 
the  “quantal  content”  vary  significantly.  However,  the  amount  of 
neurotransmitters  in  a  single  vesicle,  the  “quantal  size”  is  more  consistent. 
Therefore,  the  magnitude  of  a  postsynaptic  potential  in  response  to  a  given 
impulse depends largely on the “quantal content” (Del Castillo & Katz, 1954).  
 
1.5.1.2  Postsynaptic potential 
Neurotransmitters  released  from  presynaptic  terminal  diffuse  through  the 
synaptic cleft, and interact with specific receptors located on the postsynaptic 
terminal.  This leads to the conformation change of receptor proteins, which 
subsequently opens ion channels (receptor and ion channel can coexist in the 
same protein complex or not) to change membrane conductivity to specific ions. 
Consequently,  the  ion  influx/efflux  results  in  membrane  potential  change  in 
postsynaptic terminal, namely postsynaptic potential.  
 
Depending on the time course, the postsynaptic potential can be divided into a 
fast or a slow response (Hille, 1994). A fast response, with a latency of 0.5-
1.0ms  after  presynaptic  AP,  is  mediated  by  ionotropic  receptors,  which  are 
ligand-gated  ion  channels  with  the  ability  to  change  membrane  conductance 
rapidly by swift conformation modification. In contrast, a slow response, with a 
latency of second to minute scale, is mediated by metabotropic receptors, which 
are not ion channels but indirectly coupled to ion channels on the membrane 
with signal transduction through G-protein-mediated second messenger systems.  
 
Postsynaptic  potentials  can  be  excitatory.  That  is  excitatory  postsynaptic 
potential  (EPSP),  where  the  postsynaptic  response  depolarises  the  membrane     53 
potential.  Postsynaptic  potential  could  also  be  inhibitory.  That  is  inhibitory 
postsynaptic  potential  (IPSP),  where  a  hyperpolarising  response  is  observed. 
However,  a  given  neurotransmitter  could  give  rise  to  either  excitatory  or 
inhibitory  postsynaptic  response,  depending  on  which  type  of  receptor  is 
activated as well as the resting membrane potential of the postsynaptic neurone 
(Ben-Ari, 2002). Thus, for simplicity, neurotransmitters leading to EPSPs in most 
cases  are  termed  as  excitatory  neurotransmitters,  whereas  those  resulting  in 
IPSPs are classified as inhibitory neurotransmitters. In the brain, most prevalent 
excitatory  neurotransmitter  is  glutamate.  And  the  most  important  inhibitory 
neurotransmitter is γ–aminobutyric acid (GABA). In the brain, an EPSP is largely 
mediated by the Na
+ and/or Ca
2+ influx through ligand-gated cation channels, 
such as α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor, 
N-methyl-D-aspartic acid (NMDA) receptors and kainate receptors. A fast IPSP is 
mainly  from  Cl
-  influx  through  opening  of  GABAA  receptors.  Opening  of  K
+ 
channels by Gi-coupled GABAB receptors contribute to slow IPSP.  
 
1.5.1.3  Integration of synaptic inputs 
In the brain, where, when and how could a given postsynaptic neurone fire an AP 
depends on where, when and how the postsynaptic potentials it receives, either 
excitatory or inhibitory, are processed in a spatial and temporal manner. This 
process is synaptic integration (London & Hausser, 2005). Synaptic convergence, 
the number of presynaptic neurones innervating a given neurone, and divergence, 
the number of postsynaptic neurones innervated by a particular neurone, lay the 
structural foundation of this tuning (Bartos et al., 2007).  
 
EPSPs and IPSPs are local electrotonic potentials, without “all or none” nature, 
and can be summated. Single EPSP or IPSP generally is about 1mV. In order to 
make a neurone fire AP, the postsynaptic depolarisation must be strong enough 
to overcome threshold, normally around 10mV (depolarisation from -65mV to -
55mV  in a  healthy  neurone).  Thus,  spatial  and temporal  summation of  EPSPs 
and/or IPSPs decides the magnitude and time course of gross synaptic inputs, 
which in turn dictates the output of postsynaptic neurone in the pattern of AP 
firing.   
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Synaptic  summation  can  be  divided  into  temporal  summation  and  spatial 
summation  (Bartos  et  al.,  2007).  In  case of  temporal  summation, a  series  of 
continuous post synaptic potentials come closely after each other before the last 
potential decays at a single synapse, thus the amplitude of a given potential will 
be “added”, either more depolarised with an EPSP or less depolarised with an 
IPSP, into the previous one. On the contrary, spatial summation refers to the 
postsynaptic  computation  where  synaptic  potentials  originated  from  multiple 
synapses,  arrives  simultaneously  at  a  given  neurone.  Generally,  spatial 
summation is linear, as the algebraic summation of post synaptic potentials from 
multiple  synapses.  Thus,  in  the  spatial  summation  scenario,  the  membrane 
potential of postsynaptic neurone equals the algebraic sum of EPSPs and IPSPs. 
However,  it  must  to  be  noticed  that  the  discussion  about  spatial  summation 
above is based on one assumption that an IPSP is hyperpolarising. Indeed, in 
most cases it is the case. However, IPSP can take its inhibitory function through 
an effect termed shunting inhibition, for instance in inhibitory interneurones in 
the brain  (Alger & Nicoll, 1979; Gulledge & Stuart, 2003; Vida et al., 2006). 
Because the reversal potential of Cl
- is about -65mV or less in interneurones, if 
the  membrane  potential  is  also  -65mV,  opening  of  Cl
-  channels  by 
neurotransmitters  will  not  result  in  Cl
-  influx  with  hyperpolarising  potential. 
However, if an EPSP coincidently arrives to depolarise the membrane potential 
towards less negative, the opening of Cl
- channels will “offset” the magnitude of 
EPSP with Cl
- influx. Thus, the IPSP is still inhibitory although not hyperpolarising 
in the shunting inhibition scenario. This form of spatial summation is non-linear.  
 
To  sum  up,  synaptic  integration  includes  temporal  summation  and  spatial 
summation of synaptic inputs. They coexist and function simultaneously to steer 
a particular neurone to fire APs or not in response to EPSPs and IPSPs in a circuit. 
 
1.5.2  Electrical synaptic transmission 
Unlike electrical-chemical-electrical transduction in classical chemical synpases, 
the  information  flow  among  neurones  could  pass  through  direct  electrical 
coupling established by the electrical synapses in the brain (Eccles, 1982; Jessell 
& Kandel, 1993). Electrical synapse, also know as gap junction, permit charged 
ions, and transmitters to flow freely through gap-junction channel, connexons,     55 
between  two  tightly  close  neurones  with  only  2-3nm  distance,  much  shorter 
compared to chemical synapse with 20-40nm (Bennett, 1997; Bennett & Zukin, 
2004).  
 
Compared to chemical synapse, transmission at electrical synapse does not delay, 
but  without  gain,  and  in  most  cases,  biderectional.  Electrical  synapse  and 
chemical  synapse  can  coexist  at  one  single  synaptic  formation  (Shapovalov, 
1980).  Functionally,  electrical  synapses  are  particularly  important  in  local 
inhibitory  circuits  comprised  of  GABA-releasing  interneurones  to  generate 
gamma oscillation (Galarreta & Hestrin, 2001).     56 
 
1.6 Synaptic circuits in the hippocampus 
1.6.1 Overview of the hippocampus 
The hippocampus belongs to the ‘limbic system’ in the mammalian brain.  The 
necessity  of  the  hippocampus  in  storing  and  retrieving  memory  as  well  as 
participating  spatial  navigation  has  been  extensively  documented  (Bliss  & 
Collingridge,  1993;  Wilson  &  McNaughton,  1993;  Malenka  &  Bear,  2004; 
McNaughton  et  al.,  2006).  The  hippocampus  is  one  of  the  most  widely 
investigated regions in the brain thanks to its relatively clear principle cell layers 
with  their  highly  organized  excitatory  output  as  well  as  their  local  domain-
specific inhibitory inputs from interneurones. Experimentally, the hippocampus 
is  of  readily  access  for  neuroscientists,  whose  interests  range  from  synaptic 
physiology,  neural  plasticity,  spatial  learning  and  memory  and  artificial 
remodeling to clinical conditions such as epilepsy, schizophrenia, Alzheimer’ s 
disease, and autism (Bliss & Lomo, 1973; Best & White, 1999; Burke & Barnes, 
2006; Boyer et al., 2007; Squire & Kandel, 2009).    
 
1.6.2 Excitatory circuits in the hippocampus 
A ‘banana shape’ structure located deeply within the medial temporal lobe of 
the mammal’s brain, the hippocampus has three main subdivisions: CA1, CA3 (CA: 
cornus ammonis) and the dentate gyrus (DG). Furthermore, the hippocampus is 
unique  in  conveying  largely  unidirectional  flow  of  information  through  well 
characterised  excitatory  trisynaptic  pathways  (Bliss  &  Gardner-Medwin,  1973; 
Malenka & Nicoll, 1999; Andersen, 2007b). (see figure 1.3). Briefly, considering 
the most simplified scenario, pyramidal cells in the layer II of the entorihnal 
cortex (EC) send axon projections, among many destinations, into the DG. These 
projections are termed as perforant path (PP), which contributes to the major 
hippocampal input. Subsequently, information flows from the DG into the CA3 
area of the hippocampus through mossy fibres (MF), which are axon projections 
from granule cells in the DG into the CA3. Likewise, the pyramidal cells in the 
CA3 innervate the CA1 area of the hippocampus by long axon projections called     57 
Schaffer collaterals (SC) to allow information to flow from the CA3 into the CA1. 
To complete this loop, CA1 pyramidal cells project axons into subiculum, which 
directs projections back to the EC. Apart from this trisynaptic pathway, both 
through  the  PP,  the  pyramidal  cells  in  layer  II  of  the  EC  also  send  direct 
excitatory  input  into  the  CA3,  and  the  pyramidal  cells  in  layer  III  of  the  EC 
innervate the CA1 directly(Amaral et al., 2007; Andersen, 2007b). Some axons of 
pyramidal cells in the CA1 also terminate directly into deep layers of EC (Amaral 
et  al.,  2007;  Andersen,  2007b).  In  summary,  beginning  from  the  superficial 
layers and finishing in the deep layers of the entorhinal cortex, information flow 
completes  a  cycle  and  is  processed  in  the  hippocampus  through  this  main 
excitatory EC-DG-CA3-CA1-EC pathway. 
 
Figure  1-6  Classical  illustration  of  the  hippocampus  showing  the  excitatory  trisynaptic 
pathway.  
Adapted  and  modified  from  classical  illustration  of  hippocampal  formation  showing  the 
excitatory trisynaptic pathway as drawn by Santiago Ramon y Cajal (Ramón y Cajal, 1952, 
1955).  Insert  shows  the  schematic  representation  of  main  excitatory  pathways  and  the 
direction of information flow. Source: http://en.wikipedia.org/wiki/Hippocampus 
  
1.6.3 Inhibitory circuits in the hippocampus 
Although pyramidal cells are the dominant cells in the hippocampus, there are 
indeed a large number of heterogeneous GABAergic interneurones, roughly 10% 
of  the  total  hippocampal  neuronal  population,  located  across  different 
hippocampal regions and layers, which provide general inhibition and modulate 
network activity (Freund & Buzsaki, 1996; Jonas et al., 2004; Ascoli et al., 2008;     58 
Klausberger  &  Somogyi,  2008).  GABAergic  interneurones  are  recognised  and 
classified  by  their  firing  signature,  biochemical  markers,  morphology, 
innervating  pattern,  and  location  in  the  hippocampus,  however  overlapping 
among classifications is common  (Ascoli et al., 2008; Klausberger & Somogyi, 
2008). Because my project, during its time course, is focused solely in the CA1 
region of the hippocampus, only are interneurones in the CA1 discussed below.  
 
One of the most studied subgroup of interneurones in the CA1 of hippocampus is 
fast-spiking, parvalbumin-expressing basket cells. These basket cells actually are 
pyramidal shape and reside in or close to the pyramidal cell layer. Their short 
range axons innervate mostly the soma and proximal dendrites of thousands of 
pyramidal cells to provide local inhibition. At the same time, a particular basket 
cell receives excitatory input from thousands of pyramidal cells, which indicates 
its high capacity of convergence and potentially critical role in controlling local 
pyramidal  cells  in  feedforward  manner  and  regulating  the  synchronisation  of 
network  activity  (Cobb  et  al.,  1995;  Andersen,  2007a;  Bartos  et  al.,  2007; 
Klausberger & Somogyi, 2008).  Indeed, it has been demonstrated that basket 
cells are the key factor to ‘phase lock’ AP firing in pyramidal cells to synchronise 
their activity in theta oscillation (Cobb et al., 1995). Further studies have shown 
the fast inhibitory effect of basket cells promotes gamma oscillation (Bartos et 
al., 2002) and shunting inhibition of basket cells consolidates gamma oscillation 
(Vida et al., 2006). 
 
The second group of fast-spiking, parvalbumin-expressing interneurones in the 
CA1  is  axo-axonic  cells,  also  termed  as  chandelier  cells,  which  exclusively 
innervate the initial segment of axons of pyramidal cells. Like basket cells, they 
locate in or adjacent to the pyramidal cell layer. Because the initial segment of 
a axon is critical in generating AP in the pyramidal cells (Stuart et al., 1997), the 
axo-axonic  cells  are  thought  to  have  ultimate  control  over  the  output  of 
pyramidal cells and involved in the synchronisation of theta and ripple oscillation 
(Howard et al., 2005).  
 
Bistratified cells are also located in the CA1 pyramidal cell layer. In contrast to 
fast-spiking,  parvalbumin-expressing  basket  cells  and  axo-axonic  cells, 
bistratified  cells  innervate  dendrites  of  pyramidal  cells  to  provide  dendritic     59 
inhibition  (Buhl  et  al.,  1996;  Halasy  et  al.,  1996;  Klausberger  et  al.,  2004). 
Bistratified  cells  have  been  found  to  fire  at  a  phase  when  the  dendrites  of 
pyramidal  cells  are  hyperpolarised  (Klausberger  et  al.,  2004).  Together  with 
basket cells, bistratified cells provide precise ‘phase locking’ of theta oscillation 
in vivo (Klausberger et al., 2004).  
 
Apart  from  pyramidal  cell  layer,  cell  bodies  of  GABAergic  interneurones 
distribute  in  the  stratum  oriens,  stratum  radiatum,  and  stratum  lacunosum-
moleculare of the hippocampus. One distinct group of these interneurones is 
somatostatin-containing  O-LM  cells,  with  cell  bodies  in  the  stratum  oriens, 
dendrites parallel to pyramidal cell layers in the stratum oriens-alveus, axons in 
the stratum lacunosum-moleculare. O-LM cells innervate distal dendrites of CA1 
pyramidal  cells.  O-LM  cells  fire  preferentially  in  theta  frequency,  and  are 
important in maintaining gamma oscillation (Tort et al., 2007). Notably, O-LM 
cells has been found to express an “anti-hebbian” form of long term potentiation 
(see more in Chapter 1.7) (Lamsa et al., 2007; Oren et al., 2009). 
 
In conclusion, GABAergic interneurones in the hippocampus provide feedforward 
and feedback inhibition in local circuits in both tonic and phasic means. The 
coherent  activity  of  heterogeneous  groups  of  interneurones  in  a  timing 
dependent  manner  plays  the  key  role  in  initiating,  maintaining,  and 
consolidating network oscillation.      60 
 
1.7 Synaptic plasticity 
It  is  widely  observed  that  the  efficacy  of  synaptic  transmission  between 
neurones  could  be  strengthened  or  weakened  depending  on  a  variety  of 
electrical or chemical stimuli in a time scale from a few milliseconds to a few 
days in different areas of the brain both in vitro and in vivo (Bliss & Collingridge, 
1993;  Bortolotto  et  al.,  1999;  Kemp  &  Bashir,  2001;  Zucker  & Regehr,  2002; 
Whitlock  et  al.,  2006).  This  phenomenon  has  been  described  as  synaptic 
plasticity  comprising  short-term  plasticity  (STP),  long-term  potentiation  (LTP) 
and  long-term  depression  (LTD).  Synaptic  plasticity  has  been  a  plausible 
candidate  of  molecular  and  cellular  basis  for  learning  and  memory  as 
information  maybe  stored  and  retrieved  by  transforming  differential 
spatiotemporal  patterns  of  neural  activity  into  synaptic  changes  in  different 
locations, circuits and neurones in the brain (Bliss & Collingridge, 1993; Martin et 
al., 2000; Holtmaat & Svoboda, 2009; Wang & Morris, 2010). The term “synaptic 
plasticity” was first introduced by Dr. Jerzy Konorski in the late 1940s (Konorski, 
1948).  Subsequently  refined  by  Dr.  Donald  Hebb  in  1949  with  proposed 
mechanism known widely as Hebb’s postulate (Hebb, 1949): 
 
‘When an axon of cell A is near enough to excite a cell B and repeatedly or 
persistently takes part in firing it, some growth process or metabolic change 
takes place in one or both cells such that A’s efficiency, as one of the cell firing 
B, is increased’. 
 
Since  its  first  introduction,  Hebb’s  rule  has  been  verified  in  most  types  of 
activity-dependent synaptic plasticity in the brain. Hebbian LTP, which typically 
requires  the  depolarisation  of  postsynaptic  NMDA  receptors,  has  been 
characterised  with  three  dogmas:  input  specificity,  associativity,  and 
cooperativity (Bliss & Collingridge, 1993). But exceptions do exist as the non-
Hebbian  LTP,  where  LTP  induction  is  independent  of  the  activation  of  NMDA 
receptors, and the anti-Hebbian form, where LTP is prevented by postsynaptic 
depolarisation  during  afferent  activity,  have  been  reported  (Urban  & 
Barrionuevo, 1996; Lamsa et al., 2007; Kullmann & Lamsa, 2008). In the synapse 
made by mossy fibres onto pyramidal neurones in hippocampal CA3 area, non-    61 
Hebbian LTP was observed as a result of sustained presynaptic activation (Urban 
& Barrionuevo, 1996). In the synapse made by pyramidal cells onto interneurones 
in  the  oriens  of  CA1  area,  anti-Hebbian  LTP  was  reported  in  response  to 
activation  of  Ca
2+  permeable  AMPA  receptors  during  hyperpolarization  of 
postsynaptic membrane (Lamsa et al., 2007). 
 
1.7.1 Short-term plasticity 
Short-term plasticity is short-term increase or decrease of synaptic strength that 
lasts for at most a few minutes. Such short lasting changes in synaptic efficacy 
may be expressed in two opposite directions as short-term facilitation or short-
term depression. 
 
1.7.1.1  Short-term facilitation 
Experimentally, short-term facilitation (STF) is easily been observed upon two 
closely paired stimuli paradigm, termed paired-pulse, with an interval of, usually 
among 10ms to 300ms. The synaptic response of the second pulse can be several 
times  stronger  in  relative  to  the  first  one  at  the  Schaffer  collateral-to-CA1 
synapse.  Short-term facilitation is, by its origin, presyanptic (Zucker & Regehr, 
2002). It reflects an increase in the probability of release of readily vesicles and 
can  be  attributed  to  the  transient  accumulation  of  presynaptic  Ca
2+,  as  Ca
2+ 
influx triggered by the second AP is added into the residual Ca
2+ which has not 
been depleted after the first pulse  (Wu & Saggau, 1994). Another interesting 
observation  about  short-term  facilitation  is  that  the  basal  level  of  release 
probability will decide the magnitude of facilitation (McNaughton, 1982). The 
closer the basal release probability to 1, the less scope there is for subsequent 
facilitation. 
1.7.1.2  Short-term depression 
Short-term  depression  (STD)  also  occurs  upon  paired  pulse  paradigm  in  some 
synapses.  The  most  widely  accepted  mechanism  for  STD  is  termed  as  the 
‘depletion model’ (Zucker & Regehr, 2002). That is the STD is the result of a 
decrease of available vesicles in readily releasable pools in presynaptic terminals     62 
in  response  to  closely  paired  stimuli.  The  desensitization  of  responsible 
postsynaptic receptors is believed to contribute partially. 
1.7.2 Long-term potentiation 
Long term potentiation (LTP), as long lasting increase of synaptic transmission, 
was first described in the perforant path from entorhinal cortex into the dentate 
gyrus in an anaesthetised rabbit (Bliss & Gardner-Medwin, 1973; Bliss & Lomo, 
1973).  Subsequently,  it  is  routinely  observed  in  all  excitatory  pathways  onto 
principal cells in the hippocampus and many other regions in the brain including 
neocortex, striatum, and cerebellum (Wilson & Racine, 1983; Calabresi et al., 
1992;  Shibuki  &  Okada,  1992).  Recently,  LTP  has  also  been  discovered  in 
excitatory synapses onto inhibitory interneurones in the hippocampus (Mahanty 
& Sah, 1998; Perez et al., 2001; Kullmann & Lamsa, 2007; Lamsa et al., 2007).  
 
LTP  has  three  distinct  properties  in  input-specificity,  associativity,  and 
cooperativity (Bliss & Collingridge, 1993). Input-specificity refers to the fact that 
LTP does not spread. Only the pathway that has been activated expresses LTP 
even with other pathways in proximity. Associativity describes that a weak input 
may induce LTP as long as a separate strong input simultaneously stimulate the 
same target neurone. Cooperativity describes the existence of a threshold of 
input intensity for inducing LTP. LTP can be either induced by  strong tetanus 
stimulation in a single pathway or by the summation of several small stimuli. 
Among  these  three  LTP  properties,  input-specificity  is  relevant  to  the  LTP 
expression, whereas, associativity and cooperativity are within the scope of LTP 
induction.  
 
Based on whether or not NMDA receptor antagonist could block its induction, LTP 
can be classified as NMDA receptor dependent or NMDA receptor independent. In 
the  hippocampus,  the  LTP  in  the  Schaffer  collateral-to-CA1  pyramidal  cell 
synapses  is  the  most  studied  type  of  NMDA  receptor  dependent  LTP  (Bliss  & 
Collingridge, 1993). On the other hand, the LTP in the mossy fiber synapses onto 
CA3 pyramidal cells are typically NMDA receptor independent (Harris & Cotman, 
1986; Nicoll & Schmitz, 2005). Schaffer collateral LTP is routinely induced by 
tetanus stimulation (100 pulses within 1 second for a tetanus, 1 to 3 tetani) or     63 
theta  burst  stimulation  (10  sets  of  burst  of  four  stimuli  in  100Hz,  200ms 
interburst interval). The induction of Schaffer collateral LTP classically follows 
the  Hebb’s  postulate  with  the  NMDA  receptor  functioning  as  a  “coincidence 
detector”  to  pair  presynaptic  stimulation  with  postsynaptic  depolarisation 
(Collingridge et al., 1988; Kauer et al., 1988; Huang et al., 1992). Associativity, 
and cooperativity could be easily explained by the role of the NMDA receptor in 
Schaffer collateral LTP induction. The voltage dependent Mg
2+ blockade of NMDA 
receptors in postsynaptic membrane installs the LTP threshold in cooperativity. 
Associativity  is  reflected  by  the  fact  that  the  requirement  of  removing  Mg
2+ 
blockade  of  NMDA  receptors  can  be  achieved  by  depolarising  postsynaptic 
terminals  experimentally  by  a  voltage  step  or  convergent  excitatory  inputs. 
Apart from NMDA receptor’s voltage dependent Mg
2+ blockade, its permeability 
to Ca
2+ plays a key role in the Schaffer collateral LTP as Ca
2+ influx has been 
confirmed to be necessary for its induction (Lynch et al., 1983).  
 
The  time  course  of  LTP  can  be  divided  into  four  phases  as  post-tetanus 
potentiation (PTP), short-term potentiation (STP), early-LTP, and late-LTP (Bliss 
& Collingridge, 1993; Malenka & Nicoll, 1999). Post-tetanus potentiation (PTP), 
immediately  following  tetanus  stimulation,  is  believed  to  be  the  response  of 
enhanced  transmitter  release  corresponding  to  residual  Ca
2+  accumulation 
presynaticly  during  tetanus  stimulation.  This  phase  is  presynaptic,  and  NMDA 
receptor  independent.  Short-term  potentiation  (STP),  usually  lasting  30-60 
minutes  after  tetanus,  can  be  isolated  by  the  presence  of  protein  kinase 
inhibitors or routinely acquired by weak stimulation protocol. Early-LTP with the 
duration of less than 3-6 hours requires protein kinases such as CaMKⅡ and PKC 
(Malinow et al., 1988; Malenka et al., 1989). Late-LTP, usually lasts more than 3 
hours, and is protein synthesis dependent (Frey et al., 1988).  
 
1.7.3 Long-term depression 
Long term depression (LTD) is the long lasting reduction of synaptic transmission 
opposite to LTP. This phenomenon was first recorded in a study that in the CA1 
region  of  hippocampus,  a  LTP-inducing  stimulation  surprisingly  resulted  in  a 
depressed  synaptic  efficacy  in  a  separate,  non-stimulated  pathway,  a 
phenomenon described later as “heterosynaptic LTD”, by Lynch and co-workers     64 
in  1977  (Lynch  et  al.,  1977).  Another  report  in  1980  described  that  a  low 
frequency stimulation effectively reversed established LTP in the hippocampus 
(Barrionuevo et al., 1980) which was later termed as “depotentiation”.  Both 
phenomenon were largely neglected until the early 1990s, that a new form of 
“homosynaptic  LTD”  was  discovered  by  Mark  Bear’s  group  and  confirmed  by 
Robert Malenka’s group in 1992 that low frequency stimulation of 900 stimuli in 
1 Hz produced a prolonged reduction of synaptic transmission in the CA1 region 
of hippocampus, without any initial LTP-inducing paradigm (Dudek & Bear, 1992; 
Mulkey & Malenka, 1992).  
 
An intriguing aspect of homosynaptic LTD is its developmental dependency. One 
study showed the standard low frequency stimulation (LFS) protocol, 900 stimuli 
in 1 Hz, routinely produced LTD in the CA1 region of hippocampal slices from 2 
weeks  old  animal,  whereas  LTD  magnitude  decreased  by  half  in  5  weeks  old 
animals (Dudek & Bear, 1993). This age-dependency was reproducible as another 
group independently showed LTD can be induced by LFS in animals younger than 
40 days, however no LTD was acquired in animals between 40 days to 16 weeks 
(Kemp et al., 2000). The loss of LTD induced by LFS is not likely due to the lack 
of ability to depress the Schaffer collateral-to-CA1 synapse as paired-pulse low 
frequency stimulation produced LTD in aged animals (Kemp et al., 2000) as well 
as stimuli of 5-10Hz for 15 mins (Berretta & Cherubini, 1998). In summary, these 
data suggest LTD induction may require differential machineries responsible for 
LTD induction over development and upon stimulation protocols.   
 
1.7.3.1  NMDA receptor dependent LTD 
LTD can be classified as NMDA receptor-dependent or not depending on whether 
or not DL-AP5 or other NMDA receptor antagonists block its induction. The LTD 
induced  by  LFS  (900  stimuli,  1Hz)  in  CA1  region  of  hippocampus  has  been 
confirmed as NMDA receptor dependent (Dudek & Bear, 1992; Mulkey & Malenka, 
1992). NMDA receptor dependent LTD is also found in visual cortex (Kirkwood & 
Bear,  1994),  perirhinal  cortex  (Ziakopoulos  et  al.,  1999),  and  barrel  cortex 
(Feldman et al., 1998).  
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It has been confirmed the induction of NMDA receptor dependent LTD requires a 
rise  of  postsynaptic  Ca
2+  concentration.  Chelating  Ca
2+  postsynaptically  by 
ethylene  glycol  tetraacetic  acid  (EGTA)  or  1,2-bis  (o-aminophenoxy)  ethane-
N,N,N',N'-tetraacetic acid (BAPTA) blocked LTD induction (Brocher et al., 1992; 
Mulkey & Malenka, 1992). In addition, Mulkey and Malenka also demonstrated 
that  reducing  extracellular  Ca
2+  resulted  in  the  induction  of  LTD  by  a  LTP-
inducing paradigm (Mulkey & Malenka, 1992). Theses data suggest both LTD and 
LTP induction requires a rise of postsynaptic Ca
2+ concentration. Lisman’s study 
further proposed that because the postsynaptic enzymes such as phosphatases 
and  protein  kinases  have  differential  affinity  for  Ca
2+,  low  level  of  Ca
2+  may 
activate phosphatases to induce LTD, whereas, high level of Ca
2+ may activate 
protein kinases to yield LTP (Lisman, 1989). To conclude these observations, it is 
further hypothesized that the spatiotemporal distribution and/or magnitude of 
Ca
2+ transient postsynapticly may confer the polarity of long lasting changes of 
synaptic strength (Bliss & Collingridge, 1993; Bliss et al., 2007).  
 
As LFS-induced LTD in the hippocampal CA1 region has been shown to be NMDA 
receptor dependent, it is therefore, of interest to look into if the feature of 
developmental  dependency  of  LFS-induced  LTD  in  the  CA1  is  a  result  of  the 
composition shift of NMDA subunits during development (Dudek & Bear, 1993; 
Monyer et al., 1994; Kemp et al., 2000). Evidence supporting this hypothesis 
came as one report discovered that overexpression of embryonic dominant NR2D 
subunit  resulted  in  a  loss  of  LTD  in  juvenile  mice  (Okabe  et  al.,  1998). 
Furthermore, an interdependency of NR2D and NR2B was noticed in this study 
with downregulation of NR2B accompanied with NR2D overexpression in 2 to 3 
weeks mice (Okabe et al., 1998), suggesting a potential role of NR2B in LFS-
induced LTD in juvenile mice. 
 
Subsequently,  more  studies  investigated  the  possibility  that  specific  NMDA 
receptor  subunit  is  responsible  for  LTD.  The  critical  role  for  NR2B  subunit  is 
demonstrated  by  a  knockout-mice  study  that  mice  lacking  the  NR2B  subunit- 
containing  NMDA  receptors  did  not  express  LTD  (Kutsuwada  et  al.,  1996). 
However, pharmacological experiments provide conflicting data that one report 
using  NR2B  selective  inhibitor,  ifenprodil,  enhances  LTD  (Hendricson  et  al.,     66 
2002), whereas, another report, using the same drug, shows blockade of LTD (Liu 
et al., 2004).  
 
1.7.3.2  mGlu receptor dependent LTD 
The involvement of mGlu receptors in LTD was first evidenced by the discovery 
that  the  group  I/II  mGluR  antagonist,  MCPG,  blocked  the  induction  of 
depotentiation by LFS protocol (900 stimuli, 1 Hz) following established LTP in 
the CA1 region of hippocampus (Bashir et al., 1993; Bashir & Collingridge, 1994). 
Furthermore, several studies have demonstrated the requirement of activation 
of mGluRs in de novo LTD in the CA1 region of the hippocampus under certain 
conditions. In one study, MCPG also blocks the induction of LTD in hippocampal 
CA1 pyramidal neurones in neonatal rats induced by a stimulation of 5Hz for 3 
minutes  (Bolshakov &  Siegelbaum,  1994).  In  another  study,  MCPG  blocked  de 
novo LTD following the same stimulation of 5Hz for 3 minutes in hippocampal 
CA1 region from both neonatal (6-7 days old) and juvenile (11-35 days old) rats 
(Oliet et al., 1997). Subsequent studies demonstrate more evidence of mGluR 
involvement in LTD. A potent non-selective mGluR antagonist, LY341495 blocked 
depotentiation but not de novo LTD, suggesting they may not share a common 
induction  mechanism  (Fitzjohn  et  al.,  1998).  LTD  induced  by  low  frequency 
stimulation of paired-pulse at 1Hz (PP-LFS) in adult (Kemp & Bashir, 1999) and 
juvenile anmimals (Huber et al., 2000) were shown to require mGluRs.  
 
Interestingly, NMDA receptor-dependent LTD induced by LFS is also present in 
the same synapses in the hippocampal CA1 but these two forms of LTD have 
been  suggested  to  utilise  distinct  induction  pathways:  mGluR  dependent  LTD 
requires the Ca
2+ influx from T-type Ca
2+ channel, and protein kinase C, whereas, 
NMDA receptor dependent LTD requires Ca
2+ influx through NMDA receptors and 
the  activity  of  protein  phosphatases  (Oliet  et  al.,  1997).  It  has  been  further 
suggested  that  the  requirement  of  NMDA  receptors  and  mGlu  receptors  in 
induction of LTD may be mutually exclusive as where there is a role for NMDA 
receptors, there is no role for mGluRs and vice versa (Bortolotto et al., 1999; 
Kemp & Bashir, 2001).  
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In  addition  to  mGluR  dependent  LTD  induced  by  synaptic  activity,  there  is 
another  form  of  long  lasting  depression  of  synaptic  transmission  caused  by 
groupⅠmGluR agonist DHPG in areas such as CA1 (Palmer et al., 1997; Fitzjohn 
et al., 1999; Fitzjohn et al., 2001) and DG (Camodeca et al., 1999). This form of 
chemically-induced  LTD  is  blocked  by  group  I  or  broad-spectrum  mGluR 
antagonists but not by NMDA receptor antagonists (Palmer et al., 1997; Fitzjohn 
et al., 1999; Fitzjohn et al., 2001). The induction of DHPG-induced LTD is Ca
2+-
independent with a postsynaptic locus. Inhibiting postsynaptic G proteins activity 
by loading a G protein inhibitor into CA1 pyramidal cells prevents the induction 
of DHPG-induced LTD (Watabe et al., 2002), suggesting a postsynaptic induction. 
Furthermore, chelating Ca
2+ postsynaptically with BAPTA does not block DHPG-
induced LTD induction, suggesting a Ca
2+-independent mechanism (Fitzjohn et 
al., 2001). A rapid protein synthesis in postsynaptic dendrites has also attributed 
to  the  induction  of  DHPG-induced  LTD  (Huber  et  al.,  2000).  The  locus  of 
expression of DHPG-induced LTD is debatable. Several evidences have indicated 
a  presynaptic  locus.  Fitzjohn  and  co-workers  demonstrated  that  paired-pulse 
facilitation and the coefficient of variation of EPSCs were increased, with the 
reduction of frequency of miniature EPSCs but not amplitude (Fitzjohn et al., 
2001). Furthermore, DHPG-induced LTD is also not associated with changes in 
sensitivity to focally uncaged L-glutamate (Rammes et al., 2003). These data 
support  the  argument  that  the  locus  of  expression  of  DHPG-induced  LTD  is 
presynaptic. However, there is also evidence that removal of AMPA and NMDA 
receptors  in postsynaptic  terminal  is  responsible  for the  expression  of  DHPG-
induced  LTD,  indicating  a  postsynaptic  mechanism  (Snyder  et  al.,  2001), 
indicating a postsynaptic expression locus.     68 
1.8 Neurone-astrocyte interaction 
Astrocytes are traditionally regarded as chemical and physiological insulators in 
the  central  nervous  system,  facilitating  AP  propagation,  buffering  glutamate 
induced neurotoxicity, and releasing neurotrophins to support neuronal growth 
(Galambos, 1961; Barres, 2008; Allen & Barres, 2009). This doctrine has been 
challenged  by  increasing  evidence  that  astrocytes  could  not  only  respond  to 
synaptic activity in their own right but also modulate synaptic communication 
actively both in culture and in intact brain slices (Agulhon et al., 2008; Perea et 
al., 2009; Hamilton & Attwell, 2010). 
 
Astrocytes  are  passive  cells  without  the  ability  to  generate  APs.  However, 
temporal  fluctuation  of  intracellular  Ca
2+  concentration  has  been  widely 
accepted as a “signature” of excitability in astrocytes (Cornell-Bell et al., 1990; 
Perea et al., 2009). The elevation of Ca
2+ could be evoked by at least three 
means (Agulhon et al., 2010). Firstly, Ca
2+ elevation can be induced as a result 
of  the  mobilisation  of  intracellular  Ca
2+  store  by  the  binding  of  the  second 
messenger IP3 with IP3 receptors located in the ER in response to stimulation or 
spontaneously (Pasti et al., 1997; Bezzi et al., 1998; Kang et al., 1998; Kulik et 
al., 1999; Araque et al., 2002). Secondly, upon repetitive depolarisation of the 
astrocytic  membrane,  intracellular  Ca
2+  concentration  elevates  as  a  result  of 
Ca
2+  influx  through  voltage  dependent  Ca
2+  channels  or  transient  receptor 
potential  (TRP)  channels  which  are  both  confirmed  to  be  expressed  on  the 
astrocytic membrane (Cahoy et al., 2008). Thirdly, mechanical stimulation gives 
rise to Ca
2+ elevation, possibly through mechanically sensitive receptors (Koizumi 
et al., 2003). Among these mechanisms, nevertheless, Ca
2+ elevation in response 
to  the  mobilisation  of  intracellular  Ca
2+  store  is  by  far  the  most  studied 
mechanism  underlying  the  ‘glial  excitability’  (Perea  et  al.,  2009).  This 
mechanism is morphologically supported by the fact that astrocytes express most 
of  the  GPCRs  expressed  in  neurones  which  are  mostly  receptors  for 
neurotransmitters and Gq-coupled GPCRs(Porter & McCarthy, 1997).  
 
The neurone-astrocyte communication is in fact bidirectional. On the one hand, 
several studies have demonstrated that astrocytes vividly respond to synaptic 
activities by transient intracellular Ca
2+ fluctuation both in culture and in intact     69 
brain  slices.  It  has  been  confirmed  that  the  firing  of  glutamatergic  neuronal 
afferents  triggers  Ca
2+  waves  in  acute  and  cultured  organotypic  slices  of  rat 
hippocampus (Dani et al., 1992; Pasti et al., 1997). Furthermore, intracellular 
Ca
2+ was shown to increase upon stimulation at the Schaffer collaterals, and this 
effect was blocked by TTX as well as MCPG, suggesting a neuronal origin and 
mGluR dependency (Porter & McCarthy, 1996). More recently, Perea and Araque 
demonstrated  that  Ca
2+  elevations  were  evoked  by  glutamate  released  from 
Schaffer collaterals and by acetylcholine, but not glutamate, released by alveus 
stimulation (Perea & Araque, 2005). In addition, neurotransmitters other than 
glutamate,  such  as  acetylcholine  and  noradrenaline  were  also  confirmed  to 
evoke astrocytic Ca
2+ signal (Kulik et al., 1999; Araque et al., 2002). These data 
confirm astrocytes could answer synaptic activity in a fashion of Ca
2+ fluctuation 
in  intact  tissue.  On  the  other  hand,  astrocytes  could  modulate  the 
communication among neurones directly. Astrocytes release several neuroactive 
molecules such as glutamate, ATP, and D-serine, which can influence synaptic 
transmission (Agulhon et al., 2008; Perea et al., 2009).  
 
Several studies showed glutamate release from astrocytes in a Ca
2+-dependent 
manner. An early study confirmed that astrocytes released glutamate in a Ca
2+ -
dependent manner in response to coactivation of the AMPA/kainate and mGluRs 
on  astrocytic  membrane  both  in  culture  and  slices  (Bezzi  et  al.,  1998).  In 
another study direct stimulation of astrocytes potentiated miniature inhibitory 
postsynaptic  currents  (mIPSCs)  in  pyramidal  neurons,  and  this  effect  was 
abolished  by  chelating  astrocytic  Ca
2+  with  BAPTA  or  by  antagonists  of  the 
ionotropic  glutamate  receptors,  suggesting  a  mechanism  of  Ca
2+-dependent 
glutamate  release  from  astrocytes  (Kang  et  al.,  1998).  Furthermore,  when 
astrocytes within the immediate vicinity of CA1 pyramidal cells were stimulated 
in hippocampal slices, the intracellular astrocytic Ca
2+ wave coincided with a 
significant  increase  in  the  frequency  of  AMPA  spontaneous  EPSCs,  and  the 
increased  frequency  of  AMPAR  currents  was  sensitive  to  the  group  I  mGluR 
antagonists,  suggesting  Ca
2+-dependent  glutamate  released  from  astrocytes 
activated  presynaptic  group  I  mGluRs  to  facilitate  glutamatergic  transmission 
(Fiacco et al., 2007). Similarly, NMDA receptor-mediated slow inward currents 
(SICs)  were  recorded  from  CA1  pyramidal  cells  when  DHPG  was  used,  in  the 
presence  of  TTX,  to  activate  Gq-coupled  group  1  metabotropic  glutamate     70 
receptors on astrocytes to elevate astrocytic Ca
2+ concentration (Fellin et al., 
2004)  Recently,  Lee  and  co-workers  reported  activation  of  P2Y  receptor, 
bradykinin  receptors  and  PAR-1,  all  stimulated  glutamate  release  from 
astrocytes, potentiating NMDA current in neurons in proximity (Lee et al., 2007). 
Using PAR-1 as a model system, they further demonstrated that PAR-1 mediated 
glutamate release from astrocytes was Ca
2+-dependent in vitro, and astrocytic 
PAR-1 activation activated NMDA receptors on neurones in proximity in culture 
and induced APV-sensitive SICs in brain slices (Lee et al., 2007). Collectively, 
these  evidences  strongly  support  the  growing  acceptance  of  Ca
2+-dependent 
release of glutamate from astrocytes. 
 
However, conflicting results were also reported favouring the argument that the 
glutamate  release  from  astrocytes  was  not  Ca
2+-dependent.  Different  mouse 
models  have  been  genetically  engineered  to  allow  astrocyte-specific 
manipulation of intracellular Ca
2+ concentrations (Fiacco et al., 2007; Petravicz 
et al., 2008; Agulhon et al., 2010). In one mouse model, the transgenic mice 
were introduced a Gq-coupled receptor MrgA1, which is normally not expressed 
in  the  brain,  selectively  into  astrocytes  (Fiacco  et  al.,  2007).  Specifically 
elevating intracellular astrocytic Ca
2+ concentration did not increase neuronal 
Ca
2+,  produce  neuronal  SICs,  or  affect  excitatory  synaptic  activity,  which 
questioned  the  developing  consensus  that  glutamate  release  by  astrocytes  in 
vivo is Ca
2+-dependent (Fiacco et al., 2007). In addtion, in another mouse model 
where IP3 mediated Ca
2+ mobilisation was selectively prevented in astrocytes by 
deletion the gene PP3R2, which encodes the only astrocytic IP3 receptor on the 
ER, spontaneous EPSCs and tonic NMDA-mediated currents recorded from CA1 
pyramidal  cells  were  unaffected,  suggesting  the  removal  of  astrocytic  Ca
2+ 
increases  did  not  affect  excitatory  neuronal  activity  and  ambient  glutamate 
levels (Petravicz et al., 2008). Recently, utilising these two mouse lines, it was 
further  demonstrated  that  neither  increasing  nor  obliterating  astrocytic  Ca
2+ 
fluxes  affected  spontaneous  and  evoked  excitatory  synaptic  transmission 
together with short- or long-term synaptic plasticity at the Schaffer collateral-
to-CA1  synapse  (Agulhon  et  al.,  2010).  Collectively,  these  data  strongly 
challenge  the  developing  general  acceptance  of  the  Ca
2+  dependency  of 
glutamate release from astrocytes. 
     71 
How could this starkly contrasting conclusion among different labs be reconciled 
(Hamilton & Attwell, 2010; Kirchhoff, 2010)? Differences in experimental setups 
or method-induced artifacts may be responsible for the diverging results. For 
example,  the  introduction  of  an  exogeneous  Gq-coupled  receptor  MrgA1  in 
astrocytes  (Fiacco  et  al.,  2007)  would  not  necessarily  overlap  with  the 
endogenous astrocytes signalling pathways. But rather focus on methodological 
reasons, it is perhaps more reasonable to consider the possibility of differential 
release mechanisms for glutamate may exist within potentially different groups 
of astrocytes. Moreover, it is also possible that within a given  astrocyte, the 
requirement of Ca
2+ in releasing glutamate or other gliotransmitters would vary 
in  different  subcellular  regions  of  the  cell  (Kirchhoff,  2010).  In  other  words, 
there could be more than one mechanism within a given astrocyte in governing 
the  gliotransmitter  release.  Interestingly,  one  recent  study  has  demonstrated 
the possible existence of two forms of astrocytic calcium excitability, whereby 
the activation of astrocytic PAR-1 receptors but not P2Y1 receptors, although 
both elevated astrocytic Ca
2+, resulted in glutamate release, as APV-sensitive-
NMDA-mediated SICs were recorded (Shigetomi et al., 2008).  
 
Apart from glutamate, D-serine, which is exclusively released from astrocytes 
has been demonstrated to modulate synaptic transmission and plasticity, and 
postulated  as  the  endogenous  ligand  for  the  glycine  site  of  NMDA  receptors 
(Schell  et  al.,  1995;  Mothet  et  al.,  2000;  Panatier  et  al.,  2006).  Recent 
literature further suggested that tonic D-serine release enhanced NMDA receptor 
activity in neurones, and the binding of D-serine to glycine site in NMDA receptor 
was required in LTP induction in cultured hippocampal neurones (Yang et al., 
2003). In addition, the degree of glycine site occupancy in NMDA receptors by D-
serine affected the activation of NMDA receptor, thereby affecting long term 
synaptic plasticity (Panatier et al., 2006). The concept that astrocytic release of 
D-serine  regulates  normal  synaptic  function  was  strongly  boosted  by  a  very 
recent paper reporting that the release of D-serine from astrocytes was required 
for establishing LTP at the Schaffer collateral-to-CA1 synapse (Henneberger et 
al.,  2010).  Collectively,  these  data  support  the  hypothesis  that  astrocytic 
release of D-serine is important in regulating synaptic transmission and plasticity. 
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ATP  has  also  been  demonstrated  as  a  key  player  in  astrocyte-to-neurone 
communication,  inducing  heterosynatpic  depression  of  excitatory  transmission 
(Koizumi et al., 2003; Zhang et al., 2003; Pascual et al., 2005; Serrano et al., 
2006).  It  was  first  shown  in  hippocampal  cultures  that  the  activation  of 
presynaptic  P2  receptors  depressed  glutamatergic  synaptic  transmission  in  an 
ATP-dependent  manner  as  a  result  of  astrocytic  Ca
2+  wave  in  response  to 
mechanical stimulation (Koizumi et al., 2003). This discovery was independently 
confirmed by the following report that neuronal activity activated astrocytes to 
tonically release ATP, thus suppressing glutamatergic synapses via presynaptic 
P2Y  receptors  in  culture  and  slices  (Zhang  et  al.,  2003).  The  adenosine,  the 
product  of  ATP  degradation,  was  also  found  in  modulating  heterosynaptic 
depression in hippocampal slices by activating presynaptic A1 receptors (Serrano 
et  al.,  2006).  The  involvement  of  ATP  in  mediating  tonic  heterosynaptic 
depression was further evidenced by using transgenic mice to selectively impair 
gliotransmitter release by inducing a dominant-negative SNARE domain (Pascual 
et al., 2005). Collectively, these data demonstrated that astrocytic released ATP 
or  its  degradation  product,  adenosine,  depresses  glutamatergic  synaptic 
transmission by activating presynaptic P2 or A1 receptors in the hippocampus. 
 
In summary, as presented in figure 1.7, it appears that astrocytes not only listen 
to,  and  respond  to  synaptic  activity  but  also  bear  the  ability  to  release 
“gliotransmitters” to modulate synaptic activity. This bidirectional glia-neurone 
interaction  has  given  rise  to  the  concept  of  “tripartite  synapses”,  where  in 
addition to pre and post synaptic neurones, there is a functional component of 
astrocytes. The functional cross talk among these three parties shed light on 
synaptic transmission and plasticity (Agulhon et al., 2008; Perea et al., 2009; 
Hamilton & Attwell, 2010).      73 
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Figure 1-7 Schematic illustration of the concept of tripartite synapse. 
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1.9 Conclusion and aims 
Albeit low level, PAR-2 is extensively expressed in normal and pathological brain, 
including the hippocampus. During pathological conditions, an increase of PAR-2 
expression  has  been  documented  in  diseases  such  as  ischaemia,  Parkinson’s 
disease, HIV-associated dementia, Alzheimer’s disease, and multiple sclerosis, 
suggesting that PAR-2 plays important roles in pathophysiological processes in 
the brain. Depending on the cell type in which increased PAR-2 expression is 
observed, PAR-2 has been proposed to play ‘dual face’ role, either degenerative 
(glial) or protective (neuronal). The hippocampus is the most studied region in 
the brain with detailed elucidation of its highly organized neural circuits. Acute 
slice  preparation  and  primary  hippocampal  culture  are  well  established 
experimental  models  in  investigating  neuronal  and  synaptic  functions  in  the 
hippocampus  in  vitro  with  readily  accessibility.  Therefore,  based  on  the  fact 
that PAR-2 is indeed expressed in the hippocampus as verified independently by 
a number of groups, and given the functional roles that it plays in a variety of 
pathological conditions in the brain, it is reasonable to examine whether PAR-2 
contributes to normal neuronal signalling under physiological conditions in the 
hippocampus, and if so, how this modulation behaves in terms of cellular and 
synaptic  physiology.  Furthermore,  does  PARs  activation  exert  same  or 
differential modulation of cellular neurophysiology in different neuronal circuits 
or neuronal types in the brain? 
 
In  conclusion,  the  central  hypothesis  of  my  PhD  is  that  PAR-2  serves  as 
‘molecular switches’ in normal neural signalling in the hippocampus, modulating 
neuronal  excitability,  basal  synaptic  transmission  and  plasticity,  as  well  as 
network activities.  
 
Therefore, the specific aim of my PhD research is to investigate: 
 
1.  HOW  DOES  PAR-2  ACTIVATION  AFFECT  EXCITABILITY  OF  HIPPOCAMPAL 
NEURONES?  
2.  HOW  DOES  PAR-2  ACTIVATION  MODULATE  SYNAPTIC  TRANSMISSION  AND 
SYNAPTIC PLASTICITY IN THE HIPPOCAMPUS?      75 
3.  HOW  DOSE  PAR-2  ACTIVATION  INFLUENCE  ACTIVITIES  AND  GROSS 
EXCITABILITY OF NEURAL NETWORKS IN THE HIPPOCAMPUS? 
4.  HOW DOSE PAR-2 MEDIATE MODULATORY ACTIONS IN THE HIPPOCAMPUS AT 
THE CELLULAR AND SYNAPTIC LEVELS? 
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2  Materials and Methods 
2.1 Primary hippocampal culture experiments 
2.1.1 Preparation of primary culture of hippocampal neurones 
Cultured  hippocampal  neurones  were  prepared  as  previously  described 
(Greenwood et al., 2007). As presented in figure 2.1, 1-2 days old, male and 
female, Sprague Dawley rat pups were killed by cervical dislocation according to 
U.K.  Home  Office  Schedule  1  guidelines  under  the  authority  of  U.K.  Animals 
(Scientific Procedures) Act, 1986. At least 3 rat pups were sacrificed in each 
culture preparation. The skull was opened through the midline by a sterilised No. 
22  scalpel  blade  (Swann  Morton  Limited,  UK).  The  whole  brain  was  rapidly 
removed by a spatula, placed on a piece of sterilised filter paper and bisected 
by  a  sterilised  No.11  blade  (Swann  Morton  Limited,  UK).  Hippocampi  were 
carefully dissected away from surrounding brain tissue from both hemispheres 
and  submerged  into  a  sterilised  preparation  buffer  filtered  by  0.2m  pore 
diameter syringe filter unit (Cronus, UK) of the following composition: 
NaCl (116mM) 
KCl (5.4mM) 
NaHCO3 (26mM) 
NaH2PO4 (1.3mM) 
MgSO4·7H2O (1mM) 
CaCl2·2H2O (1mM)     77 
Ethylenediaminetetraacetic acid (EDTA)  (0.5mM) 
Glucose (25mM) 
PH was adjusted to 7.4 
Hippocampi were then, transferred onto a sterilised lid of a 35mm diameter cell 
culture dish (BDbiosciences, UK), and finely chopped into pieces by a sterilised 
No.11 scalpel blade to increase surface area. Processed tissue was transferred 
into a 15ml centrifuge tube (Cronus, UK) filled with 5ml fresh preparation buffer 
supplemented with 1.5mg/ml papain (Sigma, UK) at 37 degree Centigrade for 20 
minutes  to  allow  enzymatical  dissociation  of  cells.  The  tissue  was  then 
transferred to 6ml fresh preparation buffer supplemented with 10mg/ml bovine 
serum  albumin  (BSA)  (Sigma,  UK),  to  stop  papain’s  digesting  activity,  and 
triturated  with  three  flame-polished  glass  Pasteur  pipettes  of  decreasing 
diameter  from  3mm  to  1mm.  The  tissue  suspension  was  then  centrifuged  at 
2000rpm for 3 minutes. A small pellet formed in the bottom of centrifuge tube 
following centrifuge, and was removed by a pipette (Gilson, UK) with minimal 
preparation buffer, and resuspended in a fresh 15ml centrifuge tube filled with 
Neurobasal-A  media  (Invitrogen,  UK)  supplemented  by  2%  (volume)  B-27 
(Invitrogen, UK) and 2mM L-glutamine (Invitrogen, UK) with a cell density of 5 X 
10
5 cells/ml.   
Following  enzymatical  and  mechanical  dissociation,  cells  were  plated  onto 
sterilised  13mm  diameter  glass  coverslips coated  with L-Lysine (200g/ml,  at 
least  1  hour  to  ensure  good  cell  adhesion)  at  a  density  of  3.5X10
5  cells/ml. 
Coverslips with cell suspension were maintained in 35mm diameter cell culture 
dishes (3 coverslips in 1 culture dish) in an incubator with an environment of 95%     78 
O2/ 5% CO2 at 37 degree Centigrade for at least 1 hour to allow cells to settle 
down. After this period, each culture dish was  supplied by 2ml Neurobasal-A 
media  supplemented  by  B-27  and  L-glutamine  with  same  concentrations 
described above. No antibiotic agent was employed in all culture preparations. 
After 5 days in culture, cytosine-D-arabinofuranoside was added with 10M final 
concentration to inhibit glial proliferation.  
Cultures were monitored daily with any culture infected by bacteria or fungi as 
indicated by the change of media colour from pink to yellow being disregarded. 
Health conditions of neurones were examined under microscope in terms of gross 
morphology, processes branching pattern, and cell settlement status (clustered 
or scattered). Unhealthy cultures were excluded in the following experiments.      79 
 
Figure 2-1 Schematic flow chart of primary hippocampal culture preparation.     80 
 
2.1.2 Patch clamp recordings in cultured hippocampal neurones 
2.1.2.1  Patch clamp recording setup 
As shown in figure 2.2, a recording platform (Gibraltar Burleigh, Canada) was 
mounted  with  a  submerged  recording  chamber  (Custom  design),  a 
micromanipulator  (EXFO  Burleigh  PCS-6000-150,  Canada)  and  an  upright 
microscope  (Olympus,  USA).  This  itself  was  fixed  on  an  anti-vibration  table 
(Intracel system 2000). A faraday cage covered the whole recording system to 
protect it from external electrical noises. All electrical equipment including the 
amplifier (Axoclamp 200B, Axon instrument, USA), the digitizer (Digidata 1322A, 
Axon instrument, USA), and the micromanipulator power supply (EXFO Burleigh 
PCS-6000-150,  Canada)  were  secured  in  an  equipment  rig  and  commonly 
grounded from the anti-vibration table.  
Filled glass pipettes were mounted into a head stage (Axon instrument, USA) 
with the intracellular solution making electrical contact with the silver chloride 
electrode. A silver chloride bath reference electrode was also connected to the 
head stage. Subsequently, the head stage was connected to the Axoclamp 200B 
amplifier. Neuronal activities in the experiments were captured by the amplifier 
and filtered by a built-in low pass Bessel filter at 2 KHz, digitised by a digitizer 
(Digidata  1322A,  Axon  instrument,  USA)  at  10  KHz  and  stored  in  a  personal 
computer (Dell, USA).  
2.1.2.2  Recording procedure 
Both voltage clamp and current clamp recording were performed in DIV (days in 
vitro) 13-16 days cultured neurones because of their matured status with stable     81 
intrinsic  properties.  Glass  micropipettes  (1.5mm  O.D.  x  0.86mm  I.D.  Harvard 
Apparatus, UK)  were pulled by an electrode puller (DMZ-Universal, Germany), 
and filled with an intracellular solution with the following composition with a 
final resistance of 3-5MΩ: 
KCl (150mM) 
MgCl2 (1mM) 
CaCl2 (1mM) 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (10mM) 
EGTA (0.5mM)  
Mg-ATP (3mM) 
GTP (0.3mM) 
pH was adjusted to 7.2 
Osmolarity was adjusted to 290mOsm 
Cultured neurones were continuously perfused by a HEPES based saline solution 
with the following composition: 
NaCl (140mM) 
KCl (5mM) 
MgCl2 (2mM)     82 
CaCl2 (2mM) 
HEPES (10mM) 
D-Glucose (10mM) 
pH was adjusted to 7.4 
Osmolarity was adjusted to 310mOsm. 
Whole cell voltage and current clamp recordings were obtained from cultured 
hippocampal  neurones  under  microscopic  visualization.  Briefly,  a  healthy 
neurone was chosen by its shiny, smooth cell surface. No positive pressure was 
employed  during  advancing  the  electrode  towards  the  targeted  cell.  A  10mV 
voltage  step  was  applied  through  the  pipette  to  generate  a current pulse  to 
calculate  the  electrode  resistance.  Once  the  electrode  tip  touched  the  cell 
membrane (seen by a robust reduction of the amplitude of the current pulse), a 
slight negative pressure was applied to the pipette to form a high resistance seal. 
A further application of  -70mV voltage command facilitated the formation of 
‘gigoseal’.  Once  the  ‘gigoseal’  was  achieved,  short  suctions  were  given  to 
rupture  the  membrane  patch  but  leaving  the  ‘gigoseal’  intact  to  obtain  the 
whole cell patch clamp configuration.  
During  pharmacological  manipulation,  chemical  agents  were  supplied  through 
the  perfusate.  Either  whole  cell  voltage  or  current  clamp  mode  was  chosen 
according to experimental design. In voltage clamp mode, holding currents and 
spontaneous synaptic currents were recorded, whereas in current clamp mode, 
membrane  potential  and  spontaneous  synaptic  potentials  were  monitored. 
During  each  experiment,  fast  capacitance  was  fully  compensated.  No  slow     83 
capacitance and series resistance compensation were applied. Input resistance 
was not monitored throughout the recording process.  
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Figure 2-2 Photograph showing the actual setup used in patch-clamp experiments.     84 
 
2.2 Acute hippocampal slice experiments 
2.2.1 Preparation of acute hippocampal slices 
Male and female Wistar rats (16-24 days old) were killed by cervical dislocation, 
followed  by  decapitation  in  accordance  with  U.K.  Home  Office  Schedule  1 
guidelines under the authority of the U.K. Animals (Scientific Procedures) Act, 
1986. 
The brain was removed quickly and immersed in ice-cold (0-4 degree Centigrade) 
oxygenated (95% O2, 5% CO2) artificial cerebrospinal fluid (ACSF) solution of the 
following composition (in mM): NaCl,124; KCl, 3; NaHCO3, 26; NaH2PO4, 1.25; 
MgSO4 1; D-glucose, 10; CaCl2, 2 (McNair et al., 2006). As shown in figure 2.3, 
the brain was further hemisected, and each part was glued to the stage of a 
vibrating microtome (Campden Instruments Ltd). Transverse whole brain slices 
(400m) were cut in the parasagittal plane and hippocampal regions dissected 
free  from  surrounding  brain  tissue  before  being  transferred  to  an  interface 
holding  chamber  in  a  humidified  and  oxygen-enriched  (95%  O2,  5%  CO2) 
atmosphere for at least 1 hour for equilibrium from slicing trauma. Subsequently, 
slices were transferred into a humidified and oxygen-enriched (95% O2, 5% CO2) 
atmosphere  interface  recording  chamber  maintanined  at  28-32  degree 
Centigrade and perfused by ACSF oxygenated by 95% O2 and 5% CO2 at a flow 
rate of 6-8ml/minute powered by a peristaltic pump (Minipuls 3, Gilson, France) 
for subsequent recording.      85 
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Figure 2-3 Process and orientation of parasagittal slice preparation.     86 
 
2.2.2 Extracellular  recording  in  acute  hippocampal  slice 
preparations 
2.2.2.1  Extracellular recording setup 
An  interface  recording  chamber  (HAAS-type,  Berlin),  a  binocular  (Zeiss, 
Germany),  two  micromanipulators  (Narishige,  Japan;  Leica,  Germany)  and  a 
lamp  were  secured  on  an  anti-vibration  table  (Intracel,  UK).  Alongside,  an 
amplifier  (AxoClamp  2B,  Axon  instrument,  USA),  a  digitizer  (Digidata  1320A, 
Axon instrument), a 50Hz line noise eliminator (Hum Bug, Quest scientific), an 
instrumental amplifier (Model 440, Brownlee precision) and a PC were secured 
into a rig. A photo of this setup is presented in figure 2.4. 
The  experimental  design  is  as  described  previously  (McNair  et  al.,  2006). 
Stimulating  current  was  delivered  through  a  bipolar  tungsten  stimulating 
electrode  of  3.5MΩ  resistance  (World  Precision  Instruments,  USA)  using  an 
isolated  constant  current  stimulator  (Model  D52A,  Digitimer  Ltd.,  UK).  The 
current  range  is  from  0-30mA.  Pulse  duration  is  0.1ms.  Recording  electrodes 
were  made  from  standard  walled  (1.2mm O.D.  X  0.69  I.D.)  borosilicate  glass 
capillaries  (Harvard  Apparatus,  UK)  on  a  Flaming/Brown  micropipette  puller 
(Model P-87, Sutter Instrument Co., USA). The electrodes (3-5MΩ) were filled 
with ACSF solution and were connected via a silver chloride pellet containing 
electrode holder to a headstage (HS2A, Axon Instrumental).  
Pre-amplification  (x100)  was  carried  out  by  AxoClamp  2B  amplifier  (Axon 
instruments, USA). Further amplification (x20) was carried out by a Brownlee 
instrumentation amplifier (Model 440, Brownlee Precision, USA) giving a total 
amplification of x2000. A Hum Bug 50/60Hz noise eliminator (Quest Scientific,     87 
UK) was used to eliminate 50Hz line frequency noise where necessary. Data were 
captured  by  Digidata  1320A  analogue-to-digital  acquisition  board  (Axon 
Instrument) and transferred directly to the hard-disc of a PC (Viglen Pentium 4) 
at a rate of 10 KHz. 
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Figure 2-4 Photograph showing the actual setup used in extracellular recording experiments.     88 
 
2.2.2.2  Extracellular recording procedure 
After at least 1 hour equilibration time for hippocampal slices, a single recording 
electrode was placed on the stratum radiatum in the CA1 region of hippocampal 
slice. A single stimulating electrode was placed in stratum radiatum of either 
side  of  recording  electrode  to  stimulate  Schaffer  collateral  pathway.  Small 
stimulating current pulses (0-30mA, 0.5ms) were administrated to test for the 
presence  of  field  excitatory  postsynaptic  potentials  (fEPSP)  responses.  Once 
synaptic  potentials  were  observed,  input-output  (I/O)  curve  was  obtained  by 
gradually  increasing  stimulating  current  and  monitoring  fEPSP  responses  (see 
figure  2.5).  The  stimulating  current  which  gave  the  half  maximum  fEPSP 
response  was  then  used  for  the  remainder  of  experiment.  Measurements  of 
synaptic response were typically monitored in terms of initial slope. The window 
for  slope  measurement  was  typically  in  the  range  of  2  to  6  ms  following 
stimulation.  
As  shown  in  figure  2.6,  fEPSPs  were  evoked  at  frequency  of  0.05  Hz  in  the 
stratum radiatum of area CA1. Paired-pulse facilitation (PPF) was investigated 
at  50ms  intersimulus  interval.  High-frequency  stimulation  paradigm  of  100Hz 
high  frequency  stimulation  (HFS)  for  1  second  was  used  to  induce  long  term 
potentiation (LTP). Synaptic efficacy was monitored at least 20 minutes before 
and 60 minutes after induction by recording fEPSP responses every 20s (traces 
were  averaged  for  every  minute  interval).  Slices  that  did  not  exhibit  stable 
fEPSP slopes during 20 minutes baseline recording were excluded from the study. 
For  studies  to  investigate  the  action  of  PARs  activation  during  in  vitro 
epileptiform activity, field epileptiform activities were recorded from in stratum 
pyramidale of area CA3 in response to the application of the potassium channel     89 
blocker 4-aminopyridine (4-AP, 100M) & 0 Mg
2+ or GABAA receptor antagonist 
bicuculline (20 M) via the perfusate.  
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Figure 2-5 Glutamatergic synaptic transmission in the CA1 region of rat hippocampus. 
A.   Example of an excitatory post synaptic potential (EPSP) recorded  
      in the stratum radiatum of area CA1 of rat hippocampus. Arrow  
      represents time of stimulation. Note the dashed line indicates slope measurement. 
B    A representative Input-output curve recorded in the same experiment. 
      Note the recorded pathway required approximately 28A to reach a half 
      maximum response (dotted line).     90 
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Figure 2-6 Schematic diagram illustrating the positions of electrodes for extracellular field 
recordings.  
  
2.3 Data analysis 
All data from patch-clamp recording in primary culture was analysed online and 
offline using the software package pClamp9 (Axon Instrument, USA). All data 
from extracellular recordings in acute hippocampal slices were analysed online 
and offline using the software packages WinLTP (Anderson & Collingridge, 2007), 
Excel 2003 (Microsoft, USA) and pClamp9 (Axon Instrument, USA). Epileptiform 
activities in chapter 5 were analysed using threshold based detection mode in 
pClamp9  (Axon  Instrument,  USA).  All  data  were  graphically  illustrated  using 
GraphPad Prism 5.0 (GraphPad Software, USA).  Data are presented as means ± 
standard error of the mean (SEM). The n value refers to the number of times a 
particular experiment was performed.     91 
Statistical significance was determined by Student t-test, paired Student t-test. 
Statistical test was performed using Graph Pad 5.0 (GraphPad Software, USA). If 
not indicated in the context, in chapter 3, either mean (for bar charts) or peak 
values (for time plots) of drug effect were compared with controls. In chapter 4 
and 5, either mean values (for bar charts) or values from the last minute of drug 
application period (for time plots) were tested with controls. A probability value 
of less than 0.05 was taken as indicating statistical significance.  
2.4 Drugs and Chemicals 
PAR  peptides,  namely,  PAR-2-APs,  SLIGRL-NH2    and  2-furoyl-LIGRL-NH2,  PAR-2 
inactive peptide (PAR-2-IP), LRGILS-NH2, PAR-1 activating peptide (PAR-1-AP), 
TFFLRL-NH2,  and  PAR-4  activating  peptide  (PAR-4-AP),  AYPGKF-NH2  were 
purchased from either the Peptides Synthesis Facility at the University of Calgary 
(Canada)  (http://wcm2.ucalgary.ca/peptides)  or  Peptides  Synthetics  (UK) 
(www.peptidesynthetics.co.uk). All the other chemicals employed in this thesis 
were obtained from Ascent Scientific (UK), Sigma-Aldrich (UK) or VWR (UK).  
All  drugs  were  dissolved  in  physiological  saline  employed  according  to 
experimental design (ACSF or HEPES based buffer). PAR peptides solutions were 
made  fresh  immediately  before  each  experiment.  All  the  other  drugs  were 
prepared in physiological saline by 1 in 1000 dilution from stock aliquots to the 
final working concentration.    92 
3  The  action  of  PAR  activation  on  neuronal 
excitability  and  synaptic  transmission  in 
cultured hippocampal neurones 
3.1 Introduction and aims 
As described in Chapter 1, PARs are expressed widely throughout the central 
nervous system. In the hippocampus, PARs have been confirmed to be expressed 
in neurones, astrocytes, oligodendrocytes, and microglia (Striggow et al., 2001; 
Noorbakhsh et al., 2003; Bushell et al., 2006; Luo et al., 2007). In recent years, 
PAR  involvement  during  pathological  conditions  in  the  brain  have  been 
extensively described (Noorbakhsh et al., 2003; Luo et al., 2007), however, their 
potential  modulatory  roles  in  regulating  intrinsic  neuronal  and  synaptic 
properties during physiological conditions are only partially understood. Indeed, 
cellular level study has shown PAR-1 involvement in normal neuronal signalling in 
the  brain  (Almonte  et  al.,  2007).  However,  much  less  is  known  about  PAR-2 
receptors in this context. 
Primary hippocampal cultured neurones are extensively utilised as an  in vitro 
system  to  investigate  neuronal  and  synaptic  properties  of  glutamatergic  and 
GABAergic neurones. Despite obvious shortcomings of this system in terms of a 
lack of normal patterns of brain connectivity and the need to obtain samples 
from immature tissues, the system nevertheless has many technical benefits. For 
instance, it is easy to identify and patch or image single neurone or glia. Being a 
reduced  system,  it  is  also  readily  accessible  to  pharmacological  and  other 
manipulations. Due to these factors, I decide to utilise this culture system in my 
experiments to provide an initial characterisation of PAR-2 receptor actions in 
central neurones.  
The specific aim of the experiments described in this chapter was to evaluate 
the possibility that PARs activation modulates neuronal excitability and synaptic 
transmission in cultured neurones. For this, I utilised whole cell patch clamp 
recording technique in dissociated hippocampal neurones.     93 
3.2 Characterisation of spontaneous activities in cultured 
hippocampal  neurones  under  whole-cell  voltage 
clamp configuration 
In order to evaluate whether PAR-2 activation has modulatory effect on synaptic 
transmission in the network formed by cultured hippocampal neurones,  whole-
cell voltage clamp recordings were made initially in 10 cultured hippocampal 
neurones from 5 separate culture preparations (~3-4 rats for each) to monitor 
spontaneous  synaptic  activities.  Upon  obtaining  whole-cell  recording 
configuration, membrane potentials of neurones was first monitored before the 
cell  was  voltage-clamped  at  -70mV.  All  neurones  with  a  resting  membrane 
potential  more  positive  to  -55mV  were  disregarded.  Mean  holding  current  in 
these experiments was -32.52 ± 11.52pA (n=10). As shown in one representative 
recording (Fig 3.1), the spontaneous whole cell synaptic currents consisted of 
two major activities. 1) Subthreshold excitatory post synaptic currents (EPSCs). 2) 
Superthreshold  EPSCs  compounded  with  AP  discharges.  This  activity  was 
characterised with the spatiotemporal summation of several EPSCs, which broke 
in the threshold, resulting in AP firing.      94 
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Figure  3-1  Characterisation  of  spontaneous  activities  in  cultured  hippocampal  neurones 
under voltage clamp. 
A. Representative current trace from a cultured hippocampal neurone (cell number 170507/1) 
clamped  at  -70mV.  Note  the  presence  of  both  spontaneous  inward  synaptic  currents* 
(EPSCs) and large events representing unclamped action potentials**. B. Excerpts of trace 
showing (B) a representative subthreshold EPSC and (C) a representative action potential 
event. D. Current trace showing summation of EPSCs (arrows) leading to an action potential 
event and loss of voltage clamp***.     95 
3.3 Trypsin  increases  holding  current  and  spontaneous 
activity  in  cultured  hippocampal  neurone  under 
voltage clamp 
PAR-2 is preferentially activated by the proteinase, trypsin (Macfarlane et al., 
2001; Ossovskaya & Bunnett, 2004). Thus, trypsin was used as a PAR-2 activator 
to test the effect of PAR-2 activation on cultured hippocampal neurones in initial 
experiments.  Whole-cell  voltage  clamp  recordings  were  carried  out  on  10 
cultured hippocampal neurones from 5 separate preparations. As presented in 
Fig 3.2B, application of 100nM trypsin of 5 minutes duration induced a significant 
yet reversible increase of holding current value from -27.84 ± 11.65pA to -548.62 
± 160.40pA (P=0.0055, n=10). Upon washout, the holding current recovered back 
to  -58.13  ±  13.54pA.  The  sustained  inward  current  upon  trypsin  application 
would be consistent with a membrane depolarisation where the cells were held 
under  physiological  current  clamp  conditions.  The  recordings  also  revealed  a 
significant  yet  reversible  increase  of  the  frequency  of  spontaneous  synaptic 
activities in these neurones from 5.51 ± 0.86Hz to 8.24 ± 1.05Hz (P=0.0092, n=10) 
in response to 100nM trypsin application as presented in Fig 3.2C. These data 
suggest that trypsin gives rise to an increase of frequency of synaptic inputs 
experienced by the recorded neurone.  
One  interpretation  of  this  result  is  that  the  membrane  depolarisation  and 
increased EPSC frequency is due to activation of PAR-2 receptors in response to 
trypsin  application.  However,  whilst  trypin  shows  relative  selectivity  towards 
PAR-2, it has been shown to activate other PARs, albeit at higher concentrations 
(Noorbakhsh  et  al.,  2003;  Ossovskaya  &  Bunnett,  2004).  Moreover,  the 
proteolytic  action  of  trypsin  on  the  cell  membrane  could  lead  to  bioactive 
processes  other  than  PARs  activation.  For  instance,  proteolytic  action  may  
release  soluble  ligands,  activate  enzyme  precursors,  and  inactivate  agonists 
(Ossovskaya & Bunnett, 2004). Thirdly, trypsin is potentially a stressor for the 
cultured neurones given its nature of digesting activity. Therefore, these data 
from  the  initial  experiments  suggest  that  the  trypsin-induced  membrane 
depolarisation  and  enhanced  synaptic  activities  in  cultured  neurones  may  be 
partially  mediated  by  PAR-2  activation,  but  the  alternative  explanations     96 
described above can not be ruled out. In subsequent experiments, I therefore 
switched to the use of PAR-2-AP, SLIGRL.  
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Figure 3-2 Action of trypsin on cultured hippocampal neurones. 
A. Representative recording (cell number 200607/3) illustrating the effect of 100nM trypsin 
on  holding  current  and  spontaneous  activities.  Excerpts  before  and  during  trypsin 
application as shown on an expanded time scale below. Note a n increase of the holding 
current immediately following trypsin (100nM) application and the substantial increase in 
the  occurrence  of  subthreshold  inward  synaptic  currents.  B.  Bar  chart  sum marising 
quantitative  analysis  of  holding  current  before  and  after  trypsin  application.  Note  that 
100nM  trypsin  results  in  a  significant  but  reversible  increase  in  holding  current  (n= 10, 
P=0.0055). C. Bar chart  showing a significant increase in the frequency of spontaneous 
inward synaptic currents following 100nM trypsin application (n=10, P=0.0092).     97 
3.4 Characterisation of spontaneous activities in cultured 
hippocampal  neurones  under  whole-cell  current 
clamp configuration 
The high levels of spontaneous APs observed in the cultured neurones recorded 
previously under voltage clamp conditions demonstrated space clamp problems 
and specifically, an inability to adequately clamp neurones sufficient to avoid AP 
discharge. I therefore switched recording configuration in all subsequent cellular 
studies to current clamp mode. This had the added advantage of maintaining the 
neurones under more physiological conditions.  
All  neurones,  with  membrane  potential  more  positive  than  -55mV,  were 
excluded from the data set. Initially, 7 cultured hippocampal neurones from 4 
separate preparations were recorded to characterise the electrical properties 
and  the  spontaneous  activities  in  these  cells.  The  mean  resting  membrane 
potentials of these neurones was -61.31 ± 0.56mV (n=7). As demonstrated by a 
representative  voltage  trace  in  Fig.  3.3,  the  cells  recorded  under  baseline 
conditions  displayed  spontaneous activities  consisted  of two  major events:  1) 
Subthreshold  excitatory  postsynaptic  potentials  (EPSPs),  which  had  a  mean 
amplitude of 8.46mV ± 0.58mV with a mean frequency of 0.72 ± 0.25 Hz (n=7) 2) 
Spontaneous overshooting APs with a mean amplitude of 88.12 ± 4.72mV with a 
mean frequency of 1.45 ± 0.25 Hz (n=7).      98 
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Figure  3-3  Characterisation  of  spontaneous  activities  in  cultured  hippocampal  neurones 
under current clamp. 
A. Representative voltage trace from a cultured hippocampal neurone (cell number 210607/2) 
at  resting  membrane  potential  (zero  current  injection).  Note  the  presence  of  both 
spontaneous subthreshold excitatory postsynaptic potentials (EPSPs) and suprathreshold 
EPSPs  giving  rise  to  action  potentials**.  B.  Excerpts  of  trace  above  showing  (B)  a 
representative  subthreshold EPSP and  C.  a  representative  suprathreshold EPSP  /  action 
potential.  
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3.5 Trypsin  depolarises  cultured  hippocampal  neurones 
and increases the occurrence of spontaneous action 
potentials 
Initially, trypsin was used to repeat the experiments conducted previously under 
voltage  clamp  conditions.  Bath  application  of  trypsin  (100nM)  significantly 
depolarised the membrane potential of the recorded neurones with the mean 
magnitude  of  15.50  ±  5.29mV  (n=7,  P=0.026,  figure  3.4C).  An increase of  AP 
frequency was also noticed following trypsin application. However, due to the 
high  variance,  this  effect  did  not  achieve  statistical  significance  (251.11  ± 
81.52% of control level, n=7, P=0.11, figure 3.4D). Given trypsin is reported to 
irreversiblely cleave and activate the functional PAR-2s on the cell membrane, a 
further  application  of  trypsin  was  introduced  to  test  whether  the  second 
application was able to evoke further membrane depolarisation and / or increase 
AP discharge. In contrast to the first application in which all cell respond with a 
depolarisation,  overtly,  the  second  application  resulted  in  neither  significant 
depolarisation (8.10 ± 4.90mV, n=7, P=0.1497, figure 3.4E) nor increase of AP 
frequency (174.14 ± 56.98% of control, n=7, P=0.2375, figure 3.4F). Dissecting 
into these cells more closely, only 3 of 7 cells responded to a second application 
with  4  out  of  all  7  neurones  showing  no  detectable  change  in  membrane 
potential (0.63 ± 0.99mV, n=4, figure 3.4B) or change in firing frequency (110.15 
± 26.77% of control, n=4, figure 3.4B). However, in 3 of 7 neurones examined, 
the  second  application  of  trypsin  (100nM)  produced  a  similar  magnitude  of 
depolarisation  (mean  magnitude  =  19.72  ±  6.92mV,  n=3)  and  increase  in  AP 
frequency (260.86 ± 121.66%, n=3). Again however, these effects did not achieve 
statistical significance, presumably due to low replicate numbers.     100 
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Figure 3-4 Effect of repeated trypsin application on membrane potential and action potential 
frequency. 
A. Representative current clamp recording upon application of 10nM trypsin and showing 
the characteristic depolarisation and increase in EPSP and action potential frequency. B.  
Following  a  10  minute  washout  period,  a  second  application  of  100nM  trypsin  did  not 
produce  any  detectable  response.  C-E.  Bar  chart  showing  pooled  data.  Note  that  a 
significant membrane depolarisation was observed (C) yet increase of firing frequency (D) 
did not achieve significant upon 1
st trypsin application. 2
nd application of trypsin did not 
cause significant membrane depolarisation (E) and increase of AP frequency (F).     101 
3.6 PAR-2  activating  peptide,  but  not  PAR-2  inactive 
peptide  depolarises  neuronal  membrane  and 
depresses spontaneous action potential firings 
In order to refine the experimental approach and discriminate the involvement 
of  PAR-2  receptors  over  other  PAR  subtypes,  the  synthetic  PAR-2  activating 
peptide  (PAR-2-AP),  SLIGRL-NH2,  was  used.  This  peptide  agent  has  been 
confirmed  previously  to  possess  high  selectivity  for  murine  PAR-2  (EC50=5M) 
(Nystedt et al., 1994; al-Ani et al., 1995; Nystedt et al., 1995b; Saifeddine et al., 
1996). It is utilised to overcome the disadvantage of lack of selectivity and the 
potential  ‘off-target’  effect  in  previous  experiments  with  trypsin.  100μM 
concentration,  which  has  been  used  in  expression  system  to  evoke  maximal 
response of PAR-2 (Nystedt et al., 1995b), and was similar to previous study in 
investigating  Ca
2+  mobilisation  by  PAR-2  activation  in  cultured  hippocampal 
neurones and astrocytes (Bushell et al., 2006),  was selected initially to test the 
effect  of  PAR-2  activation  in  cultured  hippocampal  neurones.  Under  current 
clamp  recording,  as  presented  in  figure  3.5,  bath  application  of  PAR-2-AP 
significantly depolarised the neuronal membrane with the mean magnitude of 
9.19  ±  1.22mV  (n=5,  P=0.0016).  Furthermore,  alongside  the  membrane 
depolarisation, a significant depression of spontaneous AP firings was observed 
(65.72 ± 4.62% compared to control level, n=5, P=0.013). These data suggested 
PAR-2 activation depolarised neuronal membrane in hippocampal culture under 
autonomous resting membrane potential conditions. However, the quantification 
of this depolarisation was hampered by the fact that the neurones being tested 
were of differential resting membrane potentials (range = -70mV to -60mV). To 
eliminate  this  variable,  neurones  were  monitored  under  an  equal  baseline 
membrane potential of -65mV (close to the recognised physiological value), by 
tonic current injection (<200pA). Under these conditions, three concentrations 
of PAR-2-AP were tested. Interestingly, bath application of PAR-2-AP (1, 10, and 
100M)  induced  depolarisation  of  neuronal  membrane  in  a  concentration-
dependent  manner  with  the  mean  magnitude  of  0.62  ±  0.86mV  (1M,  n=12, 
P=0.4872), 1.39 ± 0.58mV (10M, n=11, P=0.038), and 5.52 ± 1.48mV (100M, 
n=16, P=0.026) respectively as shown in figure 3.6B. This was accompanied by a 
concentration-dependent depression of spontaneous APs to 85.36 ± 11.84% (1M,     102 
n=7, P=0.9314), 75.79 ± 6.11% (10M, n=6, P=0.1403) and 29.63 ± 5.03% (100M, 
n=13, P=0.0001) of control (drug free) conditions respectively as shown in figure 
3.6C.  
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Figure  3-5  Action  of  the  PAR-2-AP,  SLIGRL,  on  cultured  hippocampal  neurones  under 
autonomous membrane potential. 
A. Representative recording (cell number 141107/1) illustrating the effect of 100M PAR-2-
AP on the holding current and spontaneous activities in a cultured hippocampal neurone. 
Excerpts before  and during PAR-2-AP application as shown on an expanded time scale 
below.  Note  the  sustained  depolarisation  immediately  following  PAR -2-AP  (100M) 
application and the substantial decrease in the occurrence of spontaneous action potentials. 
B. Bar chart summarising quantitative analysis of membrane potential before and after PAR-
2-AP  application  (n=5,  P=0.0016).  C.  Bar  chart  showing  a  significant  decrease  in  the 
frequency of spontaneous action potentials following 100M PAR-2-AP  application (n=5, 
P=0.013).      103 
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Figure 3-6 Action of the PAR-2-AP, SLIGRL on cultured hippocampal neurones clamped at -
65mV. 
A. Representative recording (cell number 121108/2) illustrating the effect of 100M PAR-2-
AP  on  holding  current  and  spontaneous  activities  in  a  cultured  hippocampal  neurone. 
Excerpts  before  and  during  PAR-2-AP  application  as  shown  on  an  expanded  time  scale 
below. Note that all cells received somatic current injection to set the membrane potential to 
-65mV prior to drug application. B. Time plot showing the action of 1, 10 and 100M PAR-2-
AP on mean membrane potential. Quantitative analysis revealed a concentration-dependent 
depolarisation (1M, n=12, P=0.4872; 10M, n=11, P=0.038; 100M, n=16, P=0.026). C. Time 
plot showing a concentration-dependent decrease in the frequency of spontaneous action 
potentials following the  application of 1, 10 and 100M PAR-2-AP  application (1M, n=7, 
P=0.9314; 10M, n=6, P=0.1403; 100M, n=13, P=0.0001).      104 
To further verify the membrane depolarisation and depression of spontaneous 
APs  were  indeed  a  result  of  selective  PAR-2  activation  rather  an  artefact 
introduced by the chemical nature of synthetic peptide, synthetic PAR-2 inactive 
peptide (PAR-2-IP), LRGILS-NH2, which has a scrambled (reversed) amino acid 
sequence  compared  to  PAR-2-AP  was  applied  as  a  ‘negative  control’.  Again, 
these experiments were conducted both under resting membrane conditions and 
with  the  cells  maintained  at  -65mV  through  somatic  current  injections.  As 
expected,  bath  application  of  100μM  PAR-2-IP  did  not  depolarise  neurones 
maintained at resting membrane potential (control: -63.04 ± 1.53mV, upon PAR-
2-IP: -59.98 ± 2.64mV, n=10, P=0.16, figure 3.7B). Furthermore, no significant 
change  in  the  frequency  of  spontaneous  APs  was  observed  (117.05  ±  10.62% 
compared to control level, n=9, P=0.15, figure 3.7C). Similarly, PAR-2-IP applied 
to  neurones  maintained  at  -65mV  showed  no  change  in  membrane  potential 
(0.61 ± 0.31mV, n=8, P=0.0915, figure 3.8B) or AP frequency (91.55 ± 7.63%, n=8, 
P=0.3049, figure 3.8C).     105 
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Figure 3-7  Action of the PAR-2-IP on cultured hippocampal neurones under autonomous 
resting membrane potential. 
A. Representative recording (cell number 200308/2) illustrating the effect of 100M PAR-2-IP 
on holding current and spontaneous activities in a cultured hippocampal neurone. Excerpts 
before and during PAR-2-IP application as shown on an expanded time  scale below. Note 
absence of any detectable change in membrane potential  or spontaneous action potential 
frequency following PAR-2-IP application. B. Bar chart summarising quantitative analysis of 
membrane potential before and after PAR-2-IP application (n=10, P=0.16C. Bar chart of 
pooled  data  showing  no  significant  change  in  the  frequency  of  spontaneous  action 
potentials following 100M PAR-2-IP application (n=9, P=0.15).      106 
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Figure  3-8  Action  of  the  PAR-2-IP  on  cultured  hippocampal  neurones  normalised  to 
membrane potential of -65mV. 
A. Representative recording (cell number 080409/1) illustrating the effect of 100M PAR-2-IP 
on holding current and spontaneous activities in a cultured hippocampal neurone. Excerpts 
before and during PAR-2-IP application as shown on an expanded time scale below. Note 
that all cells received somatic current injection to set the membrane potential to -65mV prior 
to drug application. B. Time plot showing the action of 100M PAR-2-IP on mean membrane 
potential. Quantitative analysis revealed no significant change in membrane potential (n=8, 
P=0.09, cf. robust depolarisation following PAR-2-AP, blue symbols). C. Time plot showing  
no  significant  change  in  the  frequency  of  sp ontaneous  action  potentials  following  the 
application  of  100M  PAR-2-IP  application  (n=8,  P=0.30,  cf.  robust  decrease  of  action 
potential frequency following PAR-2-AP, blue symbols).      107 
 
3.7 PAR-1  and  PAR-4  activating  peptides  depolarise 
membrane of cultured hippocampal neurones. 
After  establishing  the  fact  that  PAR-2  activation  induced  membrane 
depolarisation and depressed spontaneous AP firings in cultured neurones, my 
investigation extended to assess whether the other two  functional PAR family 
members,  PAR-1  and  PAR-4,  have  modulatory  roles  in  cultured  hippocampal 
neurones. To this end, 100μM PAR-1 activating peptide (PAR-1-AP), TFLLR-NH2, 
was  applied  to  cultured  neurones  under  identical  recording  conditions.  As 
presented  in  figure  3.9,  a  significant  membrane  depolarisation  was  observed 
(11.61±1.50mV, n=8, P=0.0078). However, unlike that seen with PAR-2-AP, the 
PAR-1-AP did not cause any significant change in the frequency of spontaneous 
APs (103.90±9.08%, n=8, P=0.68). This clear membrane depolarisation but lack of 
effect  of  AP  frequency  was  apparent  both  when  cells  where  maintained  at 
resting  membrane  potential  and  at  -65mV  (membrane  depolarisation: 
3.26±0.27mV,  n=12,  P=0.0006,  figure  3.10B;  change  of  firing  frequency: 
105.89±14.06%, n=10, P=0.7301, figure 3.10C).  
Finally, we also assessed the action of the PAR-4-AP, AYPGKF-NH2. These studies 
were hampered by the very limited availability of the peptide but preliminary 
data showed a depolarisation (8.35±5.07mV, n=4, P=0.19, 100μM) but this did 
not achieve statistical significance. Similar to PAR-1 response, no change was 
detected  in  frequency  of  spontaneous  APs  upon  PAR-4-AP  application 
(110.68±13.80%, n=4, P=0.49).      108 
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Figure 3-9 Action of the PAR-1-AP on cultured hippocampal neurones under autonomous 
resting membrane potential. 
A. Representative recording (cell number 111107/3) illustrating the effect of 100M PAR-1-
AP on membrane potential and spontaneous activities in a cultured hippocampal neurone. 
Excerpts before  and during PAR-1-AP application as shown on an expanded time scale  
below. Note the depolarisation and transient decrease in the occurrence of spontaneous 
action  potentials  immediately  following  PAR -1-AP  (100M).  B.  Bar  chart  showing  a 
significant membrane depolarisation following PAR-1-AP application (n=8, P=0.0078). C. In 
contrast, changes in the frequency of spontaneous action potentials following 100M PAR-
1-AP application did not achieve statistical significance (n=8, P=0.68).      109 
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Figure  3-10  Action  of  the  PAR-1-AP  on  cultured  hippocampal  neurones  normalised  to 
membrane potential of -65mV. 
A. Representative recording (cell number 140609/1) illustrating the effect of 100M PAR-1-
AP on membrane potential and spontaneous activities in a cultured hippocampal neurone. 
Excerpts before  and during PAR-1-AP application as shown  on an expanded time scale 
below. Note that all cells received somatic current injection to set the membrane potential to 
-65mV prior to drug application. B. Time plot showing the action of 100 M PAR-1-AP on 
mean membrane potential. Quantitative analysis revealed significant depolarisation upon 
drug  application  (n=12,  P=0.0006).  C.  Time  plot  showing  no  significant  change  in  the 
frequency of spontaneous action potentials following the application of 100 M PAR-1-AP 
application (n=10, P=0.73).      110 
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Figure 3-11 Action of the PAR-4-AP on cultured hippocampal neurones under autonomous 
resting membrane potential. 
A. Representative recording (cell number 090807/1) illustrating the effect of  100M PAR-4-
AP on membrane potential and spontaneous activities in a cultured hippocampal neurone. 
Excerpts before  and during PAR-4-AP application as shown on an expanded time scale 
below. Note the depolarisation  and transient decrease in the occurrence of spontaneous 
action  potentials  immediately  following  PAR -4-AP  (100M).  B.  Bar  chart  showing  no 
significant  membrane  depolarisation  following  PAR-4-AP  application  (n=4,  P=0.19).  C.  In 
contrast, changes in the frequency of spontaneous action potentials following 100M PAR-
4-AP application did not achieve statistical significance (n=4, P=0.49).      111 
3.8 Mechanism  underlying  PAR-2  activation-induced 
membrane  depolarisation  in  cultured  hippocampal 
neurones   
3.8.1 PAR-2 activation-induced neuronal membrane 
depolarisation is dependent on glutamate 
Previous  report  suggests  that  PAR-1  receptors  in  the  brain  may  signal  via 
astrocytes rather than direct neuronal mechanisms (Lee et al., 2007). To test 
this hypothesis, the PAR-2-AP experiments were repeated in the presence of a 
cocktail of ionotropic and metabotropic glutamate receptor antagonists (20M 
NBQX,  100M  DL-APV,  and  500M  MCPG).  Current  clamp  recordings  from 
cultured hippocampal neurones held at -65mV and bathed in a cocktail of these 
glutamate antagonists revealed that application of 100M PAR-2-AP, SLIGRL, was 
no  longer able to induce any  distinguishable  membrane depolarisation in any 
neurones  tested.  (Control:  -64.28±0.26mV,  PAR-2-AP:  -64.39±0.44,  n=8,  mean 
difference=-0.1±0.42mV, P=0.8157). These data are presented in figure 3.12 and 
suggest  that  glutamate  is  indeed  required  to  achieve  a  PAR-2-AP-induced 
neuronal depolarisation. 
After establishing this glutamate dependency, we dissected further into which 
class  of  glutamate  receptors,  either  ionotropic  or  metabotropic,  was 
contributing to the effect. Therefore, the nonselective group I/II metabotropic 
glutamate  receptor  antagonist,  MCPG  was  first  omitted  from  the  glutamate 
antagonists cocktail. As shown in figure 3.13, application of 100M PAR-2-AP, 
SLIGRL,  did  not  cause  significant  depolarisation  of  neuronal  membrane  in 
present  of  ionotropic  glutamate  receptor  blockade  alone  (Control:  -65.26  ± 
0.07mV,  PAR-2-AP:  -65.10  ±  0.18mV,  n=8,  mean  difference=0.16  ±  0.06mV, 
P=0.4678). This data indicated that the PAR-2 modulation of neuroexcitability 
observed in current experimental model was dependent on iontropic glutamate 
receptors.      112 
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Figure 3-12 Glutamate receptor antagonism prevents PAR-2-induced depolarisation. 
A. Representative current clamp recording showing a lack of membrane response to 100M 
PAR-2-AP in a cell bathed in a cocktail of AMPA/Kainate, NMDA and metabotropic glutamate 
receptor  antagonist.  B.  Pooled  data  showing  a  lack  of  any  significant  membrane 
depolarisation (n=8, P=0.82). C. Same data represented as a time plot. Horizontal bars in A 
and C represent time of drug administration.     113 
A
20mV
20s
NBQX+APV
PAR-2-AP
B C
0 300 600 900
-70
-65
-60
-55
-50
NBQX+APV
PAR-2-AP
Time (s)
M
e
m
b
r
a
n
e
 
p
o
t
e
n
t
i
a
l
 
(
m
V
)
Control PAR-2-AP Washout
-60
-40
-20
0
NBQX+APV
M
e
m
b
r
a
n
e
 
p
o
t
e
n
t
i
a
l
 
(
m
V
)
 
Figure 3-13 Iontropic glutamate receptor antagonism prevents PAR-2-induced 
depolarisation. 
A. Representative current clamp recording showing a lack of membrane response to 100M 
PAR-2-AP  in  a  cell  bathed  in  a  cocktail  of  AMPA/Kainate,  NMDA  glutamate  receptor 
antagonist. B. Pooled data showing lack of any significant membrane depolarisation (n= 8, 
P=0.47). C. Same data represented as a time plot. Horizonal bars in A and C represent time 
of drug administration.     114 
3.8.2 PAR-2 activation-induced neuronal membrane 
depolarisation requires normal astrocytic function 
As  glutamate  was  required  for  the  modulation  of  neuroexcitability  by  PAR-2 
activation in current experimental model, a natural question was to investigate 
further  the  possible  source  of  glutamate.  Given  that  glutamate  could  be 
released during normal synaptic transmission, experiments were carried out to 
test  whether  synaptically  released  glutamate  was  responsible  for  this 
dependency. Therefore, current clamp recordings were conducted in neurones 
normalised at -65mV in the presence of the sodium channel blocker tetrodotoxin 
(TTX), which was employed to prevent AP-dependent synaptic transmission. As 
shown  in  figure  3.14,  0.5M  TTX  completely  abolished  the  spontaneous  AP 
activity  as  expected.  However,  surprisingly,  application  of  100M  PAR-2-AP, 
SLIGRL, was still able to produce a significant membrane depolarisation (3.3 ± 
0.62mV,  n=8,  P=0.0011)  in  cultured  neurones  as  presented  in  figure  3.14. 
Considering the fact that PAR-2-induced neuronal depolarisation was glutamate 
dependent,  this  data  strongly  suggested  that  synaptically  released  glutamate 
was not responsible for PAR-2-induced neuronal depolarisation.  
 
After  ruling  out  the  involvement  of  AP-dependent  release  of  glutamate,  the 
possibility of astrocytically released glutamate was next investigated. Several 
studies have demonstrated that activation of GPCRs on astrocytes induce the 
release  of  gliotransmitters, including  glutamate  (Araque,  2008;  Fiacco  et  al., 
2009; Santello & Volterra, 2009). Furthermore, recent publication has proposed 
that activation of PAR-1 in astrocytes led to astrocytic release of glutamate (Lee 
et  al.,  2007).  To  test  the  possible  involvement  of  astrocytically  released 
glutamate  in  our  experiments  we  suppressed  the  metabolic  function  of 
astrocytes  using  fluoroacetate  (FAc) (Fonnum  et  al.,  1997).  This  strategy  has 
been successfully utilised and verified to depress astrocytic functions in a range 
of culture and slice preparations (Swanson & Graham, 1994; Zhang et al., 2003; 
Gordon et al., 2005; Shigetomi et al., 2008; Henneberger et al., 2010).     115 
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Figure 3-14 Blockage of action potential-dependent synaptic transmission failes to prevent 
PAR-2-induced depolarisation. 
A. Representative current clamp recording showing a depolarising membrane response to 
100M PAR-2-AP in a cell bathed in the sodium channel blocker, Tetrodotoxin (500nM). B. 
Pooled data showing modest yet significant membrane depolarisation (n=8, P=0.0011).      116 
Whole-cell current clamp recordings were carried out as described previously in 
neurones that had been preincubated with 10M FAc for 3 hours. As shown in 
figure  3.15B,  application  of  100M  PAR-2-AP,  SLIGRL,  to  such  cells  failed  to 
induce  any  significant  depolarisation  of  neuronal  membrane  (0.19  ±  0.32mV, 
n=10, P=0.5742) In contrast, neurones from the same culture preparation but 
which had not received FAc treatment continued to display a robust depolarising 
response upon 100M SLIGRL application (mean depolarisation = 3.40 ± 0.43mV, 
n=6, P=0.0005). Furthermore, as shown in figure 3.16, no significant change of 
basal spontaneous AP frequency was observed between naïve neurones and FAc 
treated cells (drug free: 1.23 ± 0.08Hz, n=6; FAc treated: 1.30±0.10Hz, n=10, 
P=0.6030), which suggests that the 3 hours incubation with 10M FAc did not 
cause overt physiological damage in cultured neurones.      117 
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Figure 3-15 Inhibition of astrocytic function prevents PAR-2-AP-induced membrane 
depolarisation. 
A. Representative current clamp recordings form FAc treated (upper trace) or naïve (lower 
trace)  neurones  obtained  from  the  same  culture  preparation.  Note  the  presence  of  a 
membrane  depolarisation  in  the  control  but  not  in  the  FAc-treated  cell.  B.  Time  plot 
summarising pooled data confirms 100M PAR-2-AP to produce a depolarisation in naïve 
neurones but not in those treated with FAc (FAc treated, n=10, P=0.57; Naïve, n=6, P=0.0005)     118 
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Figure 3-16 No significant difference in the frequency of basal spontaneous AP firings from 
naïve neurones and those treated with 10M FAc.     119 
3.9 Mechanism  underling  PAR-2  activation-induced 
depression  of  the  frequency  of  spontaneous  AP 
firings in cultured neurones 
As  shown  in  figure  3.5,  PAR-2  activation-induced  neuronal  membrane 
depolarisation was associated with a profound but paradoxical depression of the 
frequency  of  spontaneous  APs.  To  examine  this  phenomenon  further,  we 
investigated the mechanisms underlying the generation of APs in the dissociated 
culture preparation. 
3.9.1 Spontaneous APs are synaptically driven in nature 
It was first noticed that the spontaneous APs were significantly abolished (10.75 
± 2.97% of control, n=7) in the presence of the cocktail of glutamate receptor 
antagonists (20M NBQX, 100M DL-APV, and 500M MCPG) as showed in figure 
3.17. This observation suggested the occurrence of AP firings in these cultured 
neurones was largely dependent on glutamatergic synaptic transmission within 
the  network  of  cultured  neurones.  Indeed,  on  closer  inspection,  recorded 
cultured neurones were found to receive a constant barrage of EPSPs, many of 
which were suprathreshold for the generation of APs (see figure 3.3). In order to 
further  confirm  that  the  majority  of  spontaneously  occurring  APs  were 
synaptically driven, current-induced depolarisation was first applied by current 
injection through micropipette during current-clamp recording to the magnitude 
similar to that seen with PAR-2 activation (from -65mV to -60mV). In contrast to 
the decrease in firing rate caused by PAR-2 activation, this procedure resulted in 
a predicable and significant increase of the frequency of AP firings (220.85 ± 
24.92%  of  control,  n=15,  P=0.0003,  figure  3.18).  This  data  supported  the 
interpretation  that  the  depression  of  AP  firings  seen  associated  with  PAR-2 
receptor activation was not due to a membrane depolarisation per se. We also 
calculated the frequency of sub-threshold EPSPs before and after the application 
of SLIGRL (100M), as shown in figure 3.19. There was a significant reduction of 
sub-threshold EPSP (27.80 ± 5.57% of control, n=7, P=0.0006) occurrence in the 
presence  of  SLIGRL  (100M),  suggesting  there  was  indeed  a  reduction  in  the 
activity of neurones innervating the recorded neurone. Taken together, these     120 
data suggest that the majority of spontaneous APs in the cultured neurones were 
synaptically  driven,  and  furthermore  the  reduction  of  the  frequency  of 
spontaneous  AP  firings  reflected  that  PAR-2  activation  depressed  synaptic 
transmission in the cultured neurones. This question is addressed further in the 
next chapter. 
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Figure 3-17 The occurrence of spontaneous APs is prevented in the presence of glutamate 
antagonism. 
A. Representative recording of experiment B. Real time summary and C. pooled data show 
frequency of APs is depressed upon glutamate antagonism (NBQX+APV+MCPG)     121 
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Figure 3-18 Control experiments showing membrane depolarisation in response to somatic 
current injection is associated with an increased frequency of action potentials. 
A. Representative current clamp recording showing current injection to mimic PAR-2-AP-
induced  depolarisation  results  in  increased  action  potential  dischage  (cf.  the  reduced 
frequency seen in figure 3.6). B. Bar plot of pooled data showing a significant increase of 
spontaneous AP frequency following current injection to shift membrane potential from -
65mV to -60mV (n=15, P=0.0003).     122 
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Figure 3-19 PAR-2-AP depresses frequency of EPSPs. 
A.  Representative  traces  of  one  experiment.  Stars  represent  EPSPs  and  large  positive 
deflections  are  APs.  B.  Real  time  summary  of  depression  of  EPSPs  upon  PAR-2-AP 
application (n=7, P=0.0006)     123 
3.9.2 Glial-neuronal signalling contributes to the PAR-2 activation 
induced  depression  of  the  frequency  of  spontaneous  AP 
firing in cultured neurones 
As  discussed  in  3.8.2,  FAc,  the  selective  astrocytic  function  inhibitor,  was 
employed  to  test  if  glial-neuoronal  signalling  was  involved  in  the  PAR-2 
activation induced depolarisation. Apart from the fact that 3 hours incubation of 
10M FAc completely abolished the PAR-2 activation-induced depolarisation in 
neurones, it was also noticed that the suppression of frequency of spontaneous 
APs  was  reduced.  As  shown  in  figure  3.20,  the  maximal  reduction  of  AP 
suppression observed at the time point of 480 second (67.23 ± 9.12% of control, 
n=8), compared to neurones from naïve cultures (41.63 ± 11.5% of control, n=6), 
was  statistically  significant  (P=0.0308).  However,  the  gross  pattern  of  the 
reduction of AP suppression following FAc treatment was nevertheless modest. 
These data suggest that PAR-2 activation, in addtion to its roles on glial cells, 
may have direct influence on neurones over their intrinsic properties, which are 
responsible for generating APs.          
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Figure 3-20 Depression of the frequency of spontaneous AP firings is modestly reduced in 
neurones treated with FAc. 
Star point shows the time point of statistical significance.     124 
 
3.10 Discussion 
In this chapter, I show, for the first time, that the PAR-2 receptor activation 
modulates  neuroexcitability  and  depresses  spontaneous  APs  in  cultured 
hippocampal  neurones.  Furthermore,  this  PAR-2-mediated  regulation  is 
dependent  on  iontropic  glutamate  receptor  activation  and  normal  astrocytic 
function.  This  latter  result  suggests  that  glial-neuronal  signalling  may  be  an 
important element in PAR-2-mediated actions in the nervous system. 
In  this  chapter,  I  first  demonstrate  that  trypsin,  which  at  the  similar 
concentration (80nM) used is reported to preferentially activate PAR-2 (Bushell 
et  al.,  2006),  induced  significant  depolarisation  of  neuronal  membrane  and 
increased  spontaneous  activities  (APs  and  spontaneous  synaptic  events  under 
both voltage clamp and current clamp configurations (See figure 3.2 and 3.4)). 
These data support our hypothesis that PAR-2 has a modulatory role in central 
neurones under non-disease conditions. These results are distinct from previous 
studies which have tended to focus upon PAR-2 actions being solely related to 
disease conditions (Striggow et al., 2001; Jin et al., 2005; Noorbakhsh et al., 
2005;  Afkhami-Goli  et  al.,  2007;  Lohman  et  al.,  2008).  However,  this 
interpretation could be compromised by serious concerns over the selectivity of 
trypsin for activating PARs and its ‘off target’ effects in terms of digesting other 
surface  proteins.  It  has  been  reported,  at  high  concentrations  (mM  range), 
trypsin could activate PAR-1 and PAR-4, although it is more selective to PAR-2 at 
low  concentration  (EC50=1nM  in  Xenopus  oocytes  (Macfarlane  et  al.,  2001)). 
Therefore, it is difficult to rule out the possible activation of PAR-1 and PAR-4, 
albeit at low levels, in the experiments using 100nM trypsin. In addition to its 
action on PARs, trypsin is a potent digesting enzyme for very many proteins with 
80%  of  proteins  possessing  at  least  one  trypsin-like  proteinase  cleavage  site 
(Southan, 2001; Puente et al., 2003). Taking this into account, the suspicion that 
observed depolarisation upon trypsin application could be due to cleavage  of 
other  membrane  proteins  important  in  regulating  membrane  potential  and 
cellular excitability is credible. In the current clamp recording, overtly, second 
application of 100nM did not cause significant depolarisation in neurones tested 
as shown in figure 3.4E, F. This is consistent with a cleavage of PAR2 receptors     125 
(a ‘one hit’ stimuli) and corresponding membrane depolarisation. However, it is 
possible  that  cleavage  of  off-target  proteins  could  produce  a  similar  one-hit 
response.  Interesting,  3  out  of  7  neurones  did  indeed  responded  to  the  2
nd 
trypsin  application  but  this  was  typically  smaller  and overall  did  not  achieve 
statistical significance. However, this can be explained in terms of the initial 
application causing a partial cleavage of the PAR2 population. Given that the 
second application was 10 minutes following the initial response, this might be 
explained by a number of mechanisms including 1) receptor desensitisation, 2) 
trafficking of new PAR2 receptors to the membrane surface or to downregulation 
of the signalling processes. These possibilities have been considered previously 
for PAR2-induced calcium signalling responses (Bushell et al., 2006). Overall, it 
is  concluded  from the  trypsin  experiments  that  the  membrane depolarisation 
and increased synaptic activities observed upon trypsin treatment are partially 
mediated by PAR-2 activation. However, to confirm this suspicion, all further 
experiments  were  conducted  using  more  selective  PAR-2-AP,  SLIGRL  and  its 
inactive negative controls, PAR-2-IP, LRGILS.  
The neuronal depolarisation observed upon SLIGRL application is consistent with 
previous  trypsin experiments.  Taken together, these experiments  support  the 
interpretation  that  PAR-2  activation  leads  to  membrane  depolarisation  in 
cultured hippocampal neurones. Whilst the finding that PAR-2 induces neuronal 
depolarisation in central neurones is completely novel, it nevertheless mirrors 
previous reports that PAR-2 receptor activation excites dorsal root ganglia (DRG) 
neurones  (Kayssi  et  al.,  2007).  It  also  mirrors  reports  that  PAR-1  receptor 
activation excite hippocampal neurones (Kayssi et al., 2007; Lee et al., 2007). 
Kayssi  and  co-workers  demonstrated  that membrane  depolarisation  in  colonic 
DRG neurone was attributed to PAR-2-induced suppression of delayed rectifier K
+ 
currents (Kayssi et al., 2007). In the current investigation, our primary focus was 
to characterise the overt actions of PAR2 activation on membrane excitability 
(membrane  potential)  and  synaptic  transmission  and  I  did  not  investigate 
possible  intracellular  or  ion  channel  signalling  processes.  Nevertheless,  a 
reduction  in  potassium  conductance  as  seen  in  the  Kayssi  paper  would  be 
consistent with the depolarising responses observed in the current studies.  
In the study by Lee and co-authors, the authors proposed that the membrane 
depolarisation in CA1 hippocampal neurone was in response to glutamate release     126 
from astrocytes upon astrocytic activation by PAR-1 (Lee et al., 2007). In this 
chapter,  I  demonstrated  glutamate  is  also  required  during  PAR-2-mediated 
depolarisation  in  cultured  hippocampal  neurones.  Specifically,  as  ionotropic 
glutamate receptors blockade alone sufficiently prevented this depolarisation, it 
is  highly  likely  that  mGluRs  are  not  required  under  current  experimental 
condition and in contrast, this modulation is dependent on signalling through 
iontropic  glutamate  receptors.  Furthermore,  when  it  comes  to  the  origin  of 
glutamate, the hypothesis that astrocytically released glutamate is underlying 
this glutamate dependency is suggested by the fact that TTX (to block neuronal 
AP- dependent glutamate release) does not block PAR-2-mediated depolarisation. 
This  hypothesis  is  strengthened  by  the  result  that  PAR-2-induced  neuronal 
depolarisation  is  abolished  when  normal  astrocytic  function  is  inhibited  in 
hippocampal  cultures.  In  summary,  these  results  are  consistent  with  a 
dependency for astrocytic (but not neuronal) release of glutamate. 
When  PAR-1  is  investigated,  the  result  that  a  significant  depolarisation  was 
observed upon PAR-1-AP, TFLLR, is consistent with that previously reported (Lee 
et al., 2007) and also consistent with the PAR-2-AP induced responses reported 
for the first time here. Taken together, these data suggest that the membrane 
depolarisation induced by activation of PAR-1 and PAR-2 receptors may share a 
common glial-dependent mechanism. In terms of cellular signalling as a result of 
PAR-1/PAR-2 activation, although PAR-2 and PAR-1 are activated differentially 
by distinct proteinases (both experimentally and presumably under endogenous 
conditions) there could be a common downstream mechanism which underlies 
the way they modulate neuroexcitability in the central neurones. However, it 
was also noticed the depression of spontaneous APs firings associated with PAR-2 
activation, was not seen with PAR-1 activation, suggesting although PAR-1 and 
PAR-2 are in the same receptor family and have potentially common downstream 
modulatory  target  and  mechanism  in  neuroexcitability,  there  may  also  be 
important  differences  in  the  way  they  control  network  excitability  (see  also 
chapter 5).  
In addition to membrane depolarisation brought about by PAR-2 activation, it is 
of  special  interest  to  note  the  paradoxical  decrease  in  the  frequency  of 
spontaneous  APs.  This  was  not  observed  upon  trypsin  treatment  or  upon 
selective  activation  of  PAR-1.  The  reduction  in  AP  frequency  is  unexpected     127 
because a depolarisation usually gives rise to increased APs. Indeed, simulation 
of PAR2-induced depolarisation through intracellular current injection did cause 
an increase in AP frequency. However, it seems that in the cultured neuronal 
preparation, the vast majority of spontaneously generated APs are in fact driven 
by  ongoing  synaptic  activity.  This  is  confirmed  by  the  finding  that  most 
spontaneous  APs  are  prevented  upon  application  of  a  cocktail  of  glutamate 
receptor antagonists shown in figure 3.17. Taken together, data from these two 
series of experiments suggest that the depression of APs seen associated with 
PAR-2 receptor activation was not due to a membrane depolarisation but instead 
the  action  of  PAR-2  receptor  activation  on  synaptic  transmission.  This  is 
addressed experimentally in the following chapter. The finding that inhibiting 
astrocytic  function  modestly  reduced  the  magnitude  of  SLIGRL-induced 
depression of spontaneous APs, as shown in figure 3.20, suggests that astrocytic-
neuronal  signalling  partially  contribute  to  the  reduction  of  APs  upon  PAR-2 
activation.  Considering  the  fact  that  glutamate-dependent  PAR-2-induced 
depolarisation  is  abolished  during  astrocytic  blockade,  this  may  suggest 
astrocytically released glutamate at least partially contribute to PAR-2-mediated 
depression  of  APs  in  cultured  hippocampal  neurones.  Alternatively,  other 
gliaotransmitters, such as ATP, may be involved (Koizumi et al., 2003; Zhang et 
al., 2003). However, the dependency of glutamate receptor activation as shown 
in figure 3.12 in PAR-2-induced neuronal depolarisation suggests that glutamate 
from  astrocytes  is  the  most  likely  the  primary  source  of  the  modulation. 
However, it is also acknowledged that the astrocytic blockade did not abolish 
the PAR-2-mediated depression of APs in cultured neurones (figure 3.20). This 
indicates  PAR-2  activation  may  have  direct  influence  over  neuronal  intrinsic 
properties  by  modulating,  for  instance,  ion  channels.  It  has  been  well 
established that the activation of  GPCRs  has  direct  modulatory  effect on ion 
channel conductances such as two-pore-domain K
+ channels (Mathie, 2007) and 
GIRK channels (Luscher & Slesinger, 2010), which modulate neuronal intrinsic 
properties and ultimately finetune the generation of APs. Moreover, it has been 
demonstrated that PAR-2 activation modulates neuronal K
+ channel conductances 
(Kayssi  et  al.,  2007).  Therefore,  in  order  to  test  this  possibility,  the  input 
resistance of the recorded neurone has to be monitored before and after the 
PAR-2 activator is applied. This input resistance measurement could give a clue 
that whether channel conductances on the neuronal membrane are altered upon     128 
PAR-2 activation. If so, a series of screening experiments could be performed to 
identify  which  ion  channels  are  likely  to  be  modulated  directly  by  PAR-2 
activation. 
In summary, in this chapter, I demonstrated for the first time that the activation 
of  PAR-2  receptor  depolarises  membrane  and  depresses  spontaneous  APs  in 
cultured hippocampal neurones. Furthermore, this PAR-2-mediated regulation of 
neuroexcitability is dependent on iontropic  glutamate receptor activation and 
normal astrocytic function.  It is also suggested that PAR-2-mediated depression 
of spontaneous APs is the consequence of reduced synaptic transmission within 
the network which is modulated by astrocytes.  129 
4  Actions  of  PAR-2  activation  on  synaptic 
transmission  in  acute  hippocampal  slice 
preparations 
4.1 Introduction 
In  addition  to  its  expression  in  neurones  as  well  as  astrocytes  in  primary 
hippocampal  culture,  PAR-2  has  also  been  demonstrated  to  be  present  in 
neurones  of  the  mature  nervous  system  (Bushell  et  al.,  2006).  Specifically, 
immunocytochemistry has revealed PAR-2-immunoreactivity at  both excitatory 
(glutamatergic)  and  interneuronal  (GABAergic)  cell  populations  in  the 
hippocampus (Bushell et al., 2006) as well as GFAP-positive astrocytes. Neuronal 
immunostaining revealed strong dendritic labelling suggesting PAR-2 receptors 
may modulate aspects of synaptic signalling in addition to the intracellular Ca
2+ 
signalling in the cell body reported previously (Bushell et al., 2006). However, 
direct  investigation  of  the  actions  of  PAR-2  receptor  activation  on  synaptic 
transmission in intact brain slices has not previously been investigated. 
Having  conducted  initial  experiments  (chapter  3)  in  a  cultured  system, 
subsequent experiments to assess the action of PAR-2 on synaptic transmission 
was conducted in the acute hippocampal slice preparation. Acute hippocampal 
slices have been extensively employed as an in vitro model in studying neuronal 
and synaptic properties in the CNS thanks to many advantages such as the ability 
for  direct  visualization  of  neuronal  layers  to  allow  precise  manipulation  of 
stimulating or/and recording electrode at defined synapses. Moreover, synapses 
in  the  acute  slice  have  developed  normally  and  are  likely  to  reflect  more 
accurately the properties of synapses in the intact brain. 
Therefore, the specific aim of this chapter was to investigate the actions of PAR-
2 activation on synaptic transmission at the Schaffer collateral-to-CA1 synapse in 
acute  hippocampal  slices  using  established  extracellular  recording  technique. 
This synapse was chosen as it represents a well studied and well characterised 
connection in the brain. It is also a relatively straightforward synapse to isolate 
and  stimulate.  Finally,  our  earlier  immunocytochemistry  data  suggested  that     130 
PAR-2 receptors are expressed both within the dendritic zone in area CA1 as well 
as in CA3 pyramidal cells providing the efferent output. 
 
4.2 PAR-2 activation depresses synaptic transmission at 
the Schaffer collateral-to-CA1 synapse 
To  examine  the  consequences  of  PAR-2  activation  on  synaptic  transmission, 
standard  extracellular  recordings  were  carried  out  in  parasagittal  slices  of 
400m thickness prepared from 16-24 days old Wistar rats. fEPSPs were evoked 
by  single  stimulus  at  a  frequency  of  0.05Hz  through  a  stimulating  electrode 
positioned 2-3mm adjacent to a recording electrode positioned within stratum 
radiatum (see methods chapter). Electrical stimulation of the Schaffer collateral 
afferent evoked  a characteristic  fEPSP  which,  when  recorded  in  mid  stratum 
radiatum, comprised of a 1) stimulus artefact, 2) presynaptic volley, 3) negative 
deflecting EPSP (Figure 4.1A). Slices were deemed acceptable if they produced a 
clear  fEPSP  that  was  stable  (in  amplitude  or  slope  measurement)  over  a  20 
minutes period. Following 20 minutes of stable baseline measurements, drugs 
would then be applied to the bath via the perfusion media. Our initial studies 
attempted to use low concentrations of trypsin as a selective PAR-2 activator. 
However, pilot studies revealed unacceptable toxicity associated with the use of 
trypsin  (100nM-10M)  in  which  synaptic  responses  were  completely  and 
irreversibly abolished (data not shown). This may have been due to digestion of 
glutamate  receptors  (Grosshans  et  al.,  2002)  or  other  essential  membrane 
proteins. However, in light of the pilot experiments it was decided to focus all 
further experiments on the use of non-proteolytic activators of PAR-2. 
As  presented  in  figure  4.1B,  100M  SLIGRL  applied  via  the  perfusate  for  30 
minutes resulted in a slow but profound depression in the slope of fEPSPs to 
80.75  ±  2.54%  of  control  (n=12,  P=0.0008).  These  data  suggest  that  PAR-2 
activation depresses basal glutamatergic synaptic transmission at the Schaffer 
collateral-to-CA1  synapse.  However,  it  was  also  apparent  that  the  SLIGRL-
induced synaptic depression did not recover upon washout of drug, suggesting 
PAR-2  activation  provoked  a  long  lasting  plasticity  (depression)  of  synaptic 
transmission. An alternative possibility was that SLIGRL was neurotoxic to the 
acute slices. To discriminate between these possibilities, a reanalysis of the data     131 
was conducted. Specifically, analysis of the fibre volley, a direct indicator of 
presynaptic input integrity, was conducted in SLIGRL-treated slices to establish 
whether the integrity of axonal / synaptic terminal function was impaired by 
SLIGRL treatment. Overt and unambiguous presynaptic volleys were observed 7 
of 12 slices and were used for subsequent analysis. As presented in figure 4.1B, 
no significant change of fibre volley was noticed (to 101.38 ± 4.82% of control at 
30  minute,  n=7,  P=0.5334),  suggesting  SLIGRL-induced  long  lasting  synaptic 
depression was not a consequence of slice deterioration.  
 
To strengthen this argument, one high frequency stimulation (HFS, 100 stimuli at 
1s) was delivered through the stimulating electrode to produce LTP after SLIGRL-
induced long lasting depression was established. As shown in figure 4.2, the time 
course and the amplitude of responses following HFS were indistinguishable to 
those  obtained  upon  HFS  from  naïve  slices  (naïve  slices:  148.82  ±  9.39%  of 
baseline,  n=9;  PAR-2-AP  treatment:  142.64  ±  7.43%  of  baseline,  n=10,  at  60 
minute  following  HFS,  P=0.6090),  suggesting  the  synaptic  structure  and 
mechanism underlying LTP in the Schaffer collateral-to-CA1 synapse were intact 
in acute hippocampal slices after SLIGRL treatment. 
     132 
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Figure  4-1  SLIGRL  depresses  synaptic  transmission  at  the  Schaffer   collateral-to-CA1 
synapse in acute hippocampal slices. 
A. Representative raw traces of extracellular field EPSPs recorded from stratum radiatum in 
are CA1. Note the presence of a presynaptic volley following the stimulus (artefact removed 
for  clarity  purposes)  which  is  preceded  by  a  negatively  deflecting  field  EPSP.  In  all 
experiments, the magnitude of the response was quantified by measuring the initial slope of 
the fEPSPB using the LTP software.  B. Time plot of p ooled data showing the effect of 
PAP2-AP (SLIGRL, 100M, n=12, period indicated by horizontal bar) on fEPSP slope (red 
symbols).  Note  the  gradual  reduction  in  fEPSP  slope  following  SLIGRL  application. 
Corresponding measurement of presynaptic fibre volleys  (blue symbols, n=7) confirm no 
significant change in the integrity of presynaptic stimulation/input.     133 
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Figure 4-2 Preincubation of slices with PAR-2-AP does not affect the induction of LTP. 
A.  Representative  control  (drug-free)  fEPSPs  before  and  60  minutes  following  high 
frequency stimulation (HFS). B. Similar traces in a slice preincubated with the PAR2 -AP 
SLIGRL (100M) produces a similar robust LTP following HFS. C. Pooled time series data 
showing LTP in control (blue symbols, n=9) and SLIGRL treated (red symbols, n=12) slices 
and revealing no significant difference in the propensity for LTP induction between groups.      134 
In light of the relatively high concentration (100M) of SLIGRL used in the study, 
control  experiments  were  conducted  to  exclude  the  possibly  of  ‘off-target’ 
effect of this peptide. Thus, the biologically inactive reverse peptide, PAR-2-IP, 
LRGILS, which had been successfully used in previous study in primary culture 
(Bushell  et  al.,  2006),  was  employed  as  a  negative  control.  As  presented  in 
figure 4.3, application of 100M LRGILS for 30 minutes did not a cause significant 
change in the slope of fEPSPs (100.87 ± 0.88% of baseline at 30 minute, n=9, 
P=0.8751),  suggesting  LRGILS  has  no  effect  on  synaptic  transmission  at  the 
Schaffer collateral-to-CA1 synapse. This data is consistent with SLIGRL having a 
discrete and specific action on synaptic transmission in the acute slice. 
To further address the concern over selectivity of SLIGRL, we utilised a recently 
reported potent peptide agonist, 2-furoylated-LIRL-NH2 (2f-LIGRL) (Kawabata et 
al.,  2004;  Kawabata  et  al.,  2005;  Kanke  et  al.,  2009).  2f-LIGRL  has  been 
demonstrated to be 10 times more potent relative to the native SLIGRL peptide 
by Ca
2+ signalling assays in cultured cell lines (2f-LIGRL EC50 =1M) (Kawabata et 
al., 2004). In the salivation bioassay in anesthetized mice, 2f-LIGRL was found to 
be  approximately  100  times  more  potent  than  SLIGRL  (2f-LIGRL 
ED50=0.15mol/kg)  (Kawabata  et  al.,  2004).  The  higher  potency  of  2f-LIGRL 
might be explained by its resistance to the degrading enzyme, aminopeptidase 
by virtue of its furoylated C-terminus (Kawabata et al., 2004). As presented in 
figure 4.4, 100M 2f-LIGRL was applied in the perfusate after 20 minutes stable 
baseline was obtained. Interestingly, the application of 2f-LIGRL for 30 minutes 
produced a slow and profound depression of the slope of fEPSPs (82.07 ± 2.42% 
of  control  at  30  minute,  n=9,  P=0.0026),  suggesting  glutamatergic  synaptic 
transmission was depressed. This data was in agreement with the experiments 
employing  the  native  PAR-2-AP,  SLIGRL,  and  further  demonstrated  PAR-2 
activation  induced  a  long  lasting  depression  of  the  Schaffer  collateral-to-CA1 
synapse. However, it was also noticed that the prolonged  synaptic depression 
produced  by  2f-LIGRL  had  similar  time  course  and  magnitude  of  response 
compared with that of SLIGRL-induced depression. In contrast to previous studies 
that 2f-LIGRL was shown 10-100 times more potent than SLIGRL (Kawabata et al., 
2004; Kawabata et al., 2005; Kanke et al., 2009), our data suggest that at the 
concentration tested (100M), 2f-LIGRL and SLIGRL were equally efficacious in 
suppressing synaptic transmission.     135 
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Figure 4-3 The PAR-2-IP LRGILS does not depresses synaptic transmission at the Schaffer 
collateral-to-CA1 synapse. 
A. Representative raw traces of extracellular field EPSPs before (black) and following (blue) 
LRGILS (100M) application. B. Time plot of pooled data showing the effect of  PAP2 -IP 
(period indicated by horizontal bar, n=9) on fEPSP slope (blue symbols). Note the absence 
of any significant change in fEPSP slope following LRGILS application.      136 
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Figure  4-4  2f-LIGRL  depresses  synaptic  transmission  at  the  Schaffer  collateral-to-CA1 
synapse in acute hippocampal slices. 
A. Representative raw traces of extracellular field EPSPs recorded from stratum radiatum in 
are CA1 before (black) and following (red) 2f-LIGRL application. B. Time plot of pooled data 
showing the effect of PAP2-AP (2f-LIGRL, 100M, n= 9, period indicated by horizontal bar) 
on fEPSP slope (red symbols). Note the gradual reduction in fEPSP slope following peptide 
application.     137 
To sum up, in the current study, two independent PAR-2-APs, SLIGRL and 2f-
LIGRL,  induced  a  similar  long  lasting  depression  of  glutamatergic  synaptic 
transmission  at  the  Schaffer  collateral-to-CA1  synapse  in  acute  hippocampal 
slices. This effect was unlikely due to slice deterioration. Furthermore, PAR-2-IP, 
the negative control, did not produce any measurable effect, consistent with the 
PAR-2-APs producing a discrete and specific suppressant action.  
 
4.3 PAR-1  activation  does  not  modulate  synaptic 
transmission  at  the  Schaffer  collateral-to-CA1 
synapse 
After establishing that PAR-2 activation induced synaptic depression in the acute 
slices,  my  investigation  extended  further  to  assess  whether  the  activation  of 
another widely studied member of PAR family, namely, PAR-1, would display a 
role in modulating synaptic transmission in acute hippocampal slices. Therefore, 
the  same  extracellular  recording  configuration  was  used  to  investigate  the 
actions  of  PAR-1  activation.  Application  of  the  selective  PAR-1-AP,  TFLLR 
(100M), for 30 minutes did not cause any significant change of the slope of 
fEPSPs recorded at the Schaffer collateral-to-CA1 synapse in acute hippocampal 
slices (103.10 ± 0.98% of baseline at 30 minute, n=11, P=0.0578, Figure 4.5), 
suggesting PAR-1 did not modulate glutamatergic synaptic transmission at this 
synapse under our experimental conditions.       138 
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Figure 4-5 The PAR-1-AP, TFLLR, does not depresses synaptic transmission at the Schaffer 
collateral-to-CA1 synapse. 
A. Representative raw traces of extracellular field EPSPs before (black) and following (red) 
TFLLR (100M)  application.  B.  Time  plot  of  pooled  data  showing  the  effect  of  PAP1 -AP 
(n=11, period indicated by horizontal bar) on fEPSP slope (red symbols). Note the absence 
of any significant change in fEPSP slope following TFLLR application.      139 
4.4 Mechanisms underlying the PAR-2-induced long term 
depression of synaptic transmission. 
In the following experiments, I investigated further the  potential mechanisms 
underlying  PAR-2  activation-induced  long  lasting  synaptic  depression  at  the 
Schaffer collateral-to-CA1 synapse. 
 
4.4.1 Paired-pulse  facilitation  is  enhanced  during  PAR-2 
activation-induced long lasting synaptic depression 
To  dissect  whether  the  induction  of  this  novel  form  of  long  lasting  synaptic 
depression  triggered  by  PAR-2  activation  was  of  presynaptic  or  postsynaptic 
locus, I examined paired pulse facilitation (PPF) at the Schaffer collateral-to-CA1 
synapse  under  first  naïve  (drug-free)  conditions  and  subsequently  in  the 
presence  of  100M  SLIGRL.  PPF  was  tested  by  measuring  fEPSP  responses 
following two stimuli delivered at short intervals (50 ms). PPF is a commonly 
used paradigm to test presynaptic function, where the response to the second 
stimulus is enhanced due to the residual calcium in the presynaptic terminal 
following  the  first  stimulus  (Malinow  &  Malenka,  2002).  I  examined  PPF  in 
response to a 50ms interval as described previously (Asaka et al., 2006; Moretti 
et al., 2006). Whilst the response to the 1
st stimulus was consistently smaller in 
the  drug-treated  group,  the  degree  of  potentiation  seen  following  the  2
nd 
stimulus was in fact enhanced in the presence of SLIGRL. As presented in figure 
4.6,  the  ratios  of  PPF  was  significantly  increased  in  the  presence  of  100M 
SLIGRL, compared to naïve control baseline (Baseline: 1.41 ± 0.02, n=7; SLIGRL-
LTD: 1.48 ± 0.03, n=7, P=0.0044). However, the absolute value of this change is 
modest. These data may suggest a presynaptic locus of SLIGRL-induced changes 
in synaptic signalling.     140 
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Figure  4-6  SLIGRL-induced  long  lasting  synaptic  depression  is  associated  with  an 
increased short term plasticity as revealed by paired-pulse facilitation. 
A.  Representative  extracellular  recordings  showing  paired  synaptic  responses  at  50  m s 
inter-stimulus  interval.  Note  the  presence  of  paired -pulse  facilitation  as  shown  by  the 
increased amplitude of the second pulse in both naïve and SLIGRL treated slices.  
B. Bar chart of pooled data reveals a modest but significant enhancement in paired -pulse 
facilitation following SLIGRL treatment (Control: n=7, SLIGRL treatment: n=7).      141 
4.4.2 mGluRs  are  not  involved  in  the  PAR-2-mediated  synaptic 
depression 
mGluRs have been suggested to mediate a variety of chemically-induced forms 
of long term depression at the Schaffer collateral-to-CA1 synapse (Palmer et al., 
1997;  Fitzjohn  et  al.,  1999;  Fitzjohn  et  al.,  2001).  Thus,  in  the  following 
experiments, I examined whether mGluR activation was implicated in the PAR-2 
activation-induced  synaptic  depression.  As  presented  in  figure  4.7,  the  non-
selective  group  I/II  mGluR  antagonist,  MCPG  (500M),  did  not  prevent  LTD 
induced by SLIGRL (100M) at these synapses (81.62 ± 2.18% of baseline at 30 
minute, n=8, P=0.0043). And this reduction is not significantly different from 
that observed in SLIGRL-induced LTD in the absence of MCPG (80.75 ± 2.54% of 
control at 30 minutes, n=12, see figure 4.1, P>0.05). Furthermore, as shown in 
figure  4.8,  following  the  establishment  of  well-characterised  form  of  LTD 
induced by group I mGluRs agonist, DHPG at 50M (50.99 ± 6.12% of baseline at 
20 minute, n=4, P=0.0041), the application of 100M SLIGRL was still able to 
elicit further synaptic depression with time course and magnitude similar to that 
observed in naïve slices. (80.64 ± 3.35% of baseline at 30 minute, n=4, P=0.0383, 
figure 4.8 and 4.9). Taken these two sets of experiments together, these results 
strongly suggest that mGluRs are unlikely to be directly involved or required in 
PAR-2 activation-induced LTD.      142 
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Figure  4-7  MCPG  does  not  block  SLIGRL-induced  synaptic  depression  at  the  Schaffer 
collateral-to-CA1 synapse. 
A. Representative fEPSPs before and following SLIGRL treatment in slices preincubated 
with the non-selective group I/II mGluR antagonist MCPG (500M). Colour code: Black-drug 
free, Red: SLIGRL+MCPG B. Time plot of pooled data showing that MCPG does not prevent 
SLIGRL-induced depression (n=8).      143 
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Figure 4-8 DHPG-induced LTD does not occlude SLIGRL-induced synaptic depression at the 
Schaffer collateral-to-CA1 synapse. 
A.  Representative  extracellular  recordings  from  a  single  experiment  in  which  DHPG 
produces  a  robust  synaptic  depression  which  can  increased  by  subsequent  SLIGRL 
application. Colour code: Black-drug free, Blue-DHPG, Red-SLIGRL 
B. Time plot of pooled data showing summation of synaptic depression by sequential DHPG 
(n=4) and SLIGRL (n=4) application. Note there is no evidence for oc clusion of synaptic 
depression by DHPG and indeed the relative depressant action of SLIGRL following DHPG 
treatment is equal to that seen in naïve slices (see text).      144 
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Figure 4-9 Time course and magnitude of SLIGRL-induced LTD following DHPG-LTD (n=4) 
(B) is similar to that observed in naïve tissue (n=12) (A).     145 
4.4.3 PAR-2-mediated synaptic depression is dependent on NR2B 
subunit containing-NMDA receptors 
As NMDA receptor dependency has been found to be a common mechanism in the 
induction of several forms of LTD (Dudek & Bear, 1992; Mulkey & Malenka, 1992), 
after ruling out the involvement of mGluRs in PAR-2 activation-induced LTD, I 
further  tested  whether  NMDA  receptors  were  involved  in  PAR-2  activation 
induced  LTD.  Surprisingly,  as  presented  in  figure  4.10,  application  of  100M 
SLIGRL failed to produce any significant depression at the Schaffer collateral-to-
CA1  synapse  when  applied  in  the  presence  of  the  selective  NMDA  receptor 
antagonist DL-APV (100M, 99.20±1.97% of baseline at 30 minute, n=9, P=0.7852). 
These initial experiments suggest NMDA receptor activation to be an essential 
requirement for PAR-2-induced synaptic depression. To investigate this further, 
100M SLIGRL was co-applied in the presence of the selective NR2B-containing 
NMDA receptor antagonist, Ro 25-6981(3M)(Fischer et al., 1997). Again, under 
these conditions, I observed no detectable or significant change in the slope of 
fEPSPs (100.24±2.35 of baseline at 30 minute, n=5, P=0.9257, figure 4.11). These 
data are consistent with NMDA, and specifically NR2B-subunit containing NMDA 
receptors being an absolute requirement for PAR-2 activation-induced LTD.      146 
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Figure 4-10 DL-APV blocks SLIGRL-induced LTD at the Schaffer collateral-to-CA1 synapse. 
A.  Representative  fEPSPs  before  (black)    and  following  SLIGRL  application  (100 M,  red 
trace) in the presence of the NMDA receptor antagonist D-AP5. B. Time plot of pooled data 
showing PAR2 activation fails to elicit synaptic depression when co-applied in the presence 
of DL-APV (100M, n=9) and suggesting the requirement for NMDA receptor activation in 
PAR-2-induced LTD     147 
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Figure  4-11  Ro  25-6981  blocks  SLIGRL-induced  LTD  at  the  Sch affer  collateral-to-CA1 
synapse. 
A.  Representative  fEPSPs  before  (black)  and  following  SLIGRL  application  (100mM,  red 
trace) in the presence of the NR2B subunit containing NMDA receptor antagonist Ro 25 -
6981 (3M)  B. Time plot of pooled data showing PAR2 activation fails to elicit synaptic 
depression when co-applied in the presence of Ro 25-6981 (3M, n=5) and suggesting the 
requirement for NR2B-contaning NMDA receptor activation in PAR2-induced LTD.     148 
4.4.4 Glial-neuronal signalling contributes to the PAR-2-mediated 
synaptic depression 
It has been demonstrated in previous chapter that glial-neuronal signalling was 
contributing to the PAR-2 activation-induced depression of synaptic transmission 
in  the  cultured  hippocampal  neurones.  Here,  I  examined,  under  more 
physiological conditions, whether glial mechanisms also contribute to the PAR-2- 
induced  synaptic  depression  in  acute  hippocampal  systems.  To  this  end, 
hippocampal slices were preincubated with the selective glial function inhibitor 
FAc (10M) for 3 hours. Initially, in order to test whether this procedure would 
be  detrimental  to  the  health  of  hippocampal  slices,  I  examined  the  general 
properties  of  neurotransmission  in  naïve  and  FAc  treated  slices.  Thus, 
experiments  were  performed  to  record  synaptic  responses  at  the  Schaffer 
collateral-to-CA1 synapse to varying intensities of single electrical stimulation so 
that  an  input-output  relationship  could  be  established.  Increasing  stimulating 
intensity resulted in the expected accompanying increase in fEPSP slope (Figure 
2.5). However, as also shown in figure 4.12, no significant difference in input-
output curve was observed between naïve (drug-free) slices and those treated 
with  FAc  (naïve:  n=12,  FAc  treated:  n=9.  stimulus  intensity:  30A,  P=0.7095; 
60A,  P=0.6659;  90A,  P=0.9440),  suggesting  basal  integrity  of  synaptic 
transmission was not altered by 3 hours treatment of 10M FAc.  
 
After  confirming  the synaptic  integrity  in slices  treated  by  FAc,  extracellular 
recording  was  repeated  as  previous  described.  As  shown  in  figure  4.13,  the 
SLIGRL-induced LTD was significantly reduced in FAc treated slices compared to 
those recorded from naïve slices (naïve: 78.48 ± 3.14% of baseline at 30 minute, 
n=4;  FAc  treated:  94.11  ±  1.48%  of  baseline  at  30  minute,  n=6,  P=0.0287), 
suggesting glial-neuronal signalling was indeed contributing to PAR-2 activation-
induced LTD in hippocampal slices.      149 
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Figure 4-12 Input-output curve in naïve and FAc treated slices. 
A. Representative fEPSPs in response to increasing stimulation (arrowhead) intensity. B. 
Similar experiment in performed in slice preincubated with the astrocyte inhibitor FAc.  
B.  Pooled  input-output  plot  showing  the  characteristic  relationship  between  stimulation 
intensity and fEPSP magnitude. Note there is no significant difference between control (blue 
symbols, n=12) and FAc treated slices (red, n=9).      150 
0.5mV
12.5 ms
A
Stimulus
B
-20 -10 0 10 20 30 40 50
60
70
80
90
100
110
120
SLIGRL
FAc treated
Naive
Time (min)
N
o
r
m
a
l
i
s
e
d
 
f
E
P
S
P
 
s
l
o
p
e
 
(
%
)
Stimulus
 
Figure 4-13 SLIGRL-induced LTD is significantly reduced in FAc treated slices. 
A. Representative fEPSP recordings before and after SLIGRL treatment in naïve slices (blue 
symbols) and in slices preincubtated in FAc (Red symbols). B. Time plot of pooled data 
showing actions of SLIGRL on naïve slices (blue, n=4) and FAc treated slices (n=6). Note a 
significant  reduction  of  the  magnitude  of  SLIGRL -induced  LTD  in  FAc  treated  slices 
(P=0.0287)     151 
4.5 Discussion 
In  this  chapter,  I  demonstrated,  for  the  first  time,  that  activation  of  PAR-2 
induced  a  novel  form  of  long  lasting  depression  of  glutamatergic  synaptic 
transmission  at  the  Schaffer  collateral-to-CA1  synapse  in  acute  hippocampal 
slices. Furthermore, I provided evidences that this PAR-2 activation-induced LTD 
is  dependent  on  NR2B  subunit-containing  NMDA  receptors  and  suppressed  by 
disrupting glial cell function. 
 
In this chapter, I first demonstrate that 100M PAR-2-AP, SLIGRL, which at the 
concentration  used  is  reported  to  elicit  the  maximal  Ca
2+  mobilisation  in 
expression system (Nystedt et al., 1995b), and was similar to previous study in 
investigating  Ca
2+  mobilisation  by  PAR-2  activation  in  cultured  hippocampal 
neurones and astrocytes  (Bushell et al., 2006), induced a novel form of long 
lasting  depression  of glutamatergic  transmission  at  the  Schaffer  collateral-to-
CA1  synapse  (see  figure  4.1).  The  specific  nature  of  the  PAR-2-mediated 
response is confirmed by the lack of effect using the control peptide, 100M 
LRGILS (see figure 4.3). This selectivity is further strengthened by the fact that 
another  independent  PAR-2-AP,  2f-LIGRL,  induces  similar  LTD  at  the  same 
synapses under equivalent conditions (see figure 4.4). Thus, these data support 
our hypothesis that PAR-2 activation modulates basal synaptic transmission and 
agree with the indication discussed in chapter 3 that PAR-2 activation induces a 
reduction of synaptic transmission in the cultured hippocampal neurone network 
(see figure 3.18 and 3.19).  
 
However,  this  interpretation  could  be  hampered  by  the  concern  that  the 
irreversibility  of  PAR-2-induced  LTD  may  be  the  consequence  of  the 
deterioration  of  the  integrity  of  presynaptic  terminals  perhaps  due  to  the 
neurotoxic  effect  of  the  chemical  nature  of  these  peptides.  Therefore,  this 
concern  is  addressed  by  the  reanalysis  of  presynaptic  fibre  volley  amplitude, 
which is an indicator of integrity of presynaptic terminals. My data demonstrated 
no  significant  change  of  presynaptic  fibre  volley  amplitude  during  PAR-2-
mediated  LTD  (see  figure  4.1B),  which  confirms  the  integrity  of  presynaptic 
input. Furthermore, intact LTP induced by HFS in slices conditioned with 100M 
SLIGRL incubation  (see  figure  4.2C) provides  further evidence  to  support  this     152 
interpretation. Thus, the PAR-2-mediated LTD is not due to the deterioration of 
slice quality. 
 
It was recently reported that PAR-2 activation caused a temporary deficit in the 
formation and/or recollection of experience-dependent learning and memory in 
a strain of rat (Lohman et al., 2009). Considering the long term plasticity in the 
brain  is  well  recognised  cellular  basis  for  learning  and  memory  (Bliss  & 
Collingridge, 1993; Martin et al., 2000), it is of special interest to investigate 
into if PAR-2 activation in acute hippocampal slices would modulate long term 
plasticity.  Interestingly,  my  data  show  that  in  the  slices  preconditioned  with 
100M PAR-2-AP, SLIGRL, the LTP is  indistinguishable from that elicited from 
naïve slices (see figure 4.2). Furthermore, this LTP is induced upon previously 
established synaptic depression by PAR-2-AP application. Thus, on one hand, this 
data suggest that the LTD induced by 100M PAR-2-AP is reversible, confirming 
the integrity of the synapses after the concerns over potential neurotoxic effect 
of  relatively  high  concentration  of  PAR-2-AP.  On  the  other  hand,  this  result 
suggests that the activation of PAR-2 before the input-postsynaptic association, 
as  given  by  the  HFS,  has  no  disruption  on  the  mechanisms  underlying  the 
induction  and  expression  of  NMDA-receptor  dependent  LTP  at  the  Schaffer 
collateral-to-CA1 synapse. However, it is acknowledged that in order to address 
the  question  whether  PAR-2  activation  modulates  hippocampal  long  term 
plasticity more convincingly, a better solution is to investigate LTP induction and 
expression in the presence of PAR-2-AP. But this was rather unfeasible in my 
hand, because PAR-2-AP depresses basal synaptic transmission (see figure 4.1). 
Alternatively, LTP could be thoroughly investigated utilising the PAR-2 knockout 
animals (Ferrell et al., 2003) and their littermate controls. However, due to the 
time limit of my PhD, this is the subject of further experimentation.  
 
An unexpected finding in this chapter is, in my hand, the PAR-1 activation has no 
modulatory role in the basal transmission of glutamatergic transmission at the 
Schaffer collateral-to-CA1 synapse in acute hippocampal slices (see figure 4.5). 
This  result  is  in  contrast  to  a  previous  report  which  showed  the  PAR-1-AP, 
SFLLRN (15M), induced a gradual robust increase (50% increase of baseline) of 
fEPSPs  recorded  at  the  Schaffer  collateral-to-CA1  synapse,  which  reach  a 
plateau after 40 minutes, in rat hippocampal slices (Maggio et al., 2008). The     153 
disagreement between these two investigations could be explained by firstly, 
different PAR-1-APs employed in these studies. In my study, I used the TFLLR 
rather than SFLLRN as the PAR-1-AP because the substitution of threonine for 
serine prevents the cross-activation or desensitisation of PAR-2 (Hollenberg et 
al., 1997). Thus, because of the lack of selectivity for PAR-1, theoretically, the 
robust increase of fEPSPs observed by Maggio and co-workers using SFLLRN could 
be a synergy effect of activation of both PAR-1 and PAR-2. If this is the case, 
combining my results, these data suggest the synergy consequence on synaptic 
transmission by dual activation of both PAR-1 and PAR-2 is distinct from that 
upon  activation  of  individual  PARs.  Secondly,  the  concentration  of  PAR-1-AP 
utilised is different. Maggio and co-workers used 15M as working concentration, 
which is close to the concentration used (10M) in investigating PAR-1 action in 
acute hippocampal slices (Gingrich et al., 2000) and slightly higher than the EC50 
of SFLLRN (0.5-6M) (Macfarlane et al., 2001). In contrast, I used a relatively 
high  concentration  of  TFLLR  of  100M  although  the  peptide  itself  is  more 
selective than SFLLRN. To reconcile the disagreement, it is possible that PAR-1 
potentiates synaptic transmission under relatively modest activation upon low 
concentration of activator, whereas, this modulation of basal transmission could 
be  masked  upon  strong  activation  of  the  receptor  itself  through  an  unknown 
mechanism  involving  perhaps  feedback  inhibition.  Considering  that  in  disease 
conditions,  modest  activation  of  PAR-1  tends  to  be  protective  and  strong 
activation of PAR-1 is degenerative (see Chapter 1.3.7.4),  it is reasonable to 
speculate a  scenario that  ‘multi-face’ modulation of synaptic transmission by 
PAR-1 is upon the magnitude of its activation under normal brain physiology. 
 
In this chapter, I investigated further into whether the presynaptic mechanism is 
involved in the expression of the PAR-2-mediated LTD at the Schaffer collateral-
to-CA1 synapse. I demonstrate that the paired-pulse ratio, which is an indicator 
of  presynaptic  involvement,  is  increased  during  the  PAR-2  activation-induced 
LTD, suggesting a presynaptic locus. However, the change of absolute value of 
paired  pulse  ratio  from  1.41  to  1.48  (see  figure  4.6),  though  statistically 
significant, is relatively very modest to support a strong presynaptic contribution 
to the PAR-2-mediated LTD. On the contrary, another interpretation of this data 
is that because the synaptic transmission is reduced during the PAR-2-mediated 
LTD  at the  first place,  the  small  increase  in the  paired  pulse ratio  could  be     154 
attributed to a reduced transmitter release probability at presynaptic terminals 
in agreement with the depressed synaptic transmission, which in turn results in 
an increase of fEPSP amplitude upon second stimulus as a result of  increased 
residual  Ca
2+  in  the  presynaptic  terminals  in  response  to  the  first  stimulus 
corresponding to the paired-pulse paradigm. Nevertheless, in order to clarify the 
presynaptic contribution for PAR-2-mediated LTD, a positive control experiment 
employing, for instance baclofen (1M), the agonist for GABAB receptors which 
locate  presynaptically,  could  be  introduced  to  test  the  magnitude  of  paired 
pulse ratio under identical recording conditions. This experiment will give some 
clues that whether this established presynaptic inhibition (Mott & Lewis, 1994; 
Misgeld et al., 1995) elicits comparable increase of paired pulse ratio as what 
was observed in PAR-2-induced synaptic inhibition.  
 
Finally,  in  this  chapter,  I  investigated  further  into  the  cellular  mechanism 
underlying PAR-2 activation-induced LTD. LTD at the Shaffer collateral-to-CA1 
synapse  has  been  demonstrated  to  be  NMDA-receptor  dependent  or  NMDA-
receptor independent (Dudek & Bear, 1992; Mulkey & Malenka, 1992; Bashir et 
al., 1993; Bashir & Collingridge, 1994; Fitzjohn et al., 1998; Citri & Malenka, 
2008; Rebola et al., 2010). Especially to our interest, a widely reported form of 
chemically-induced LTD expresses at this synapse in response to group I mGluRs 
agonist, DHPG (Palmer et al., 1997; Fitzjohn et al., 1999; Fitzjohn et al., 2001; 
Gladding et al., 2009; Luscher & Huber, 2010). To differentiate whether PAR-2 
activation-induced LTD is dependent on mGluRs, I used two strategies. Firstly, I 
demonstrated 500M MCPG, a non-selective antagonist of group I/II mGluRs, has 
no  effect  on  PAR-2  activation-induced  LTD  (see  figure  4.7).  Secondly,  100M 
SLIGRL still produced a further long lasting depression following LTD induced by 
the group I mGluR agonist, DHPG (50M) (see figure 4.8) with the amplitude of 
this further synaptic depression being similar to that induced in naïve slices (see 
figure  4.9).  Taken  together,  these  data  strongly  suggest  at  least  group  I/II 
mGluRs are not involved in the PAR-2 activation-induced LTD at the Schaffer 
collateral-to-CA1 synapse. Therefore, I tested whether this novel form of LTD is 
NMDA receptor dependent. Surprisingly, the NMDA receptor antagonist DL-APV 
(100M)  completely  abolished  the  SLIGRL-induced  LTD  (see  figure  4.10).  In 
addition, a specific NR2B subunit-containing NMDA receptor antagonist, Ro 25-
6981(3M)  (Fischer  et  al.,  1997)  also  prevented  the  SLIGRL-induced  LTD  (see     155 
figure 4.11). These data suggest the NR2B subunit-containing NMDA receptor is 
required  during  the  PAR-2  activation-induced  LTD.  Previous  studies  showed 
conflicting data regarding the role of NR2B subunit-containing NMDA receptors in 
the induction of LTD (Kutsuwada et al., 1996; Hendricson et al., 2002; Liu et al., 
2004). However, my results here suggest that the NR2B subunit-containing NMDA 
receptors may be important in governing at least PAR-2 activation-induced LTD 
in the hippocampus. As PAR-2-induced LTD is  suggested to be NMDA receptor 
dependent,  it  is  possible  that  PAR-2-mediated  LTD  may  utilise  a  common 
induction mechanism that has been observed in other forms of NMDA receptor 
dependent  LTD.  Clearly  dinstinct  from  mGlu  receptor  dependent  LTD,  NMDA 
receptor dependent LTD requires intracellular Ca
2+ singal (Gladding et al., 2009; 
Collingridge et al., 2010). The Ca
2+ sensor protein, calmodulin, detects the entry 
of  extracellular  Ca
2+  through  NMDA  receptors.  The  binding  of  Ca
2+  with 
calmodulin  activates  protein  phosphatase  2B,  which  in  turn  dephosphorylates 
inhibitor-1  to  activate  protein  phosphatase  1  (Mulkey  et  al.,  1993).  Protein 
phosphatase  1  is  the  key  enzyme  in  NMDA  receptor  dependent  LTD,  as  it 
dephosphorylates  Ser845  on  the  AMPA  receptor  subunit  GluR1,  to  initiate 
clathrin-mediated  endocytosis  of  AMPA  receptors  (Collingridge  et  al.,  2004), 
which leads to LTD. Therefore, it is of special interest to further test whether 
employing protein phosphatase 1 inhibitors, for instance, okadaic acid (1M) or 
calyculin A (1M) (Mulkey et al., 1993), could prevent the synaptic depression 
induced by PAR-2 activation in identical preparations. These experiments are 
likely  to  give  futher  evidences  for  the  NMDA  receptor  dependency  of  PAR-2-
mediated LTD and to shed light on its induction mechanisms. 
 
Based  on  the  suggestion  from  Chapter  3  that  neurone-glial  signalling  may  be 
important in the modulation of neuronal excitability and synaptic transmission 
upon PAR-2 activation in hippocampal cultures, I further investigated into the 
whether this signalling is also contributing the PAR-2 activation-induced LTD in 
acute hippocampal slices. Selective blockade of glial metabolism in acute slices 
by  FAc  (10M)  incubation  significantly  attenuated  the  magnitude  of  SLIGRL-
induced  LTD  (see  figure  4.13).  In  addition,  the  indistinguishable  input-output 
curves  obtained  from  FAc-treated  and  naïve  slices  confirmed  no  significant 
neuronal damage was brought in during the FAc incubation (see figure 4.12). 
These data are in agreement with my observation that neurone-glial signalling     156 
was  important  in  hippocampal  cultures  as  discussed  in  chapter  3.  They  also 
demonstrated that neurone-glial signalling we observed in culture system was 
not a culture artefact that due to in vitro manipulations.   
 
In conclusion, in chapter 4, I demonstrated for the first time that the activation 
of PAR-2 in acute hippocampal slices induces a novel form of LTD at the Schaffer 
collateral-to-CA1 synapse. Furthermore, the PAR-2-mediated LTD is dependent 
on NR2B subunit-containing NMDA receptor activation as well as normal glial-
neuronal signalling.   157 
5  Modulation  of  epileptiform  activity  in  the 
hippocampus by PARs activation 
5.1 Introduction 
PARs are confirmed to be expressed in a variety of cell types, including neurones 
and astrocytes, in the CNS (Bushell et al., 2006; Bushell, 2007; Luo et al., 2007), 
and their involvement in the pathology of the brain has been widely reported 
(Noorbakhsh  et  al.,  2003;  Luo  et  al.,  2007).  In  particular,  recent  evidences 
suggest PARs are crucial players in modulating epileptogenesis both in vivo and 
in  vitro.  One  in  vivo  study  demonstrated that  intravenous  application  of  the 
selective  PAR-2-AP,  SLIGRL  protected  rats  against  kindling-induced  seizures 
(Lohman et al., 2008). This led the authors to conclude that PAR-2 may have a 
protective role during epileptogenesis. This is in contrast with a recent in vitro 
study showing PAR-1 activation to facilitate epilileptogenesis in rat hippocampal 
slices (Maggio et al., 2008), advocating a pro-epilepicactivity role for this PAR 
subtype. These studies suggest, despite being within the same receptor family 
and activation by common mechanisms, though possibly they are activated under 
different conditions, PARs may have differential modulatory effect on cortical 
network  activity  such  as  epilepsy.  Moreover,  the  potential  underlying 
mechanisms  for  this  differential  regulation  are  unclear.  In  this  regard,  this 
chapter makes an initial attempt to assess the influence of both PAR-2 and PAR-1 
on epileptiform activity in vitro in the hope of gaining a better understanding of 
how PAR-2 and PAR-1 modulate cortical networks.  
Acute hippocampal slice preparations have been extensively utilised to develop 
a  range  of  different  in  vitro  pharmacology-based  models  of  experimental 
epileptogenesis  (Jefferys,  1994,  2003).  These  have  been  invaluable  for 
investigating  some  of  the  mechanisms  underlying  the  genesis  and  control  of 
epilepsy-like behaviours in hippocampal circuits (Rutecki et al., 1985; Voskuyl & 
Albus, 1985; Tancredi et al., 1990). Epileptiform activity can be induced in acute 
hippocampal slices by changing the ion composition of the perfusate, or applying 
convulsant agents such as ion channel blockers or modulators of excitatory or 
inhibitory synaptic transmission. Two models of epileptiform activity used in the     158 
current  investigations  were  1.  application  of  4-aminopyridine  (4-AP)/  low 
magnesium  perfusate  and  2.  application  of  bicuculline.  Both  models  produce 
robust  and  stereotyped  patterns  of  epileptiform  activity  (rhythmical 
synchronised  field  potentials)  over  long  periods.  4-AP  is  a  non-selective  K
+ 
channel  blocker,  which  is  used  clinically  in  treating  demyelinating  disorders 
(Hayes, 2004; Judge & Bever, 2006) and used widely as an experimental tool in 
studying K
+ channels (Storm, 1987; Lesage, 2003). It has also be used widely to 
produce epilepsy in vivo (Morales-Villagran et al., 1996; Pena et al., 2002) and 
epilepsy-like  activities  in  acute  hippocampal  slices  (Voskuyl  &  Albus,  1985; 
Roshan-Milani et al., 2003). At least two main factors contribute to 4-AP-induced 
epileptiform  activity:  firstly,  by  blocking  K
+  channels  in  soma-dendritic 
membrane in postsynaptic neurone to depolarise the cells and drive it closer to 
AP  threshold  (Roshan-Milani,  2004).  Secondly,  by  blocking  K
+  channels  in 
presynaptic  axon  terminals,  4-AP  enhances  neurotransmitter  release  by 
prolonging AP duration (Molgo et al., 1977). Omitting Mg
2+ from the perfusate 
removes the voltage-dependent Mg
2+ blockade of NMDA receptors, which in turn 
allows  free  Na
+,  Ca
2+  and  K
+  to  move  through  the  channels  in  response  to 
glutamate and subsequent hyperexcitability. A unique feature of 4-AP-induced 
epileptiform activity is that synchronisation of firings occurs despite normal even 
enhanced  inhibitory  inputs  (Rutecki  et  al.,  1987).  In  contrast,  the  GABAA 
receptor antagonist, bicuculline, produces eplileptiform activity in hippocampal 
slices by simple disinhibition of hippocampal microcircuits which then results in 
synchronised  and  unchecked  firing  of  cells  in  area  CA3  through  recurrent 
excitatory  collaterals.  This  enhancement  is  maintained  by  strengthening 
recurrent  excitatory  synapses  among  CA3  pyramidal  neurones  (plasticity) 
following disinhibition (Miles & Wong, 1983, 1987). As these two models induce 
in vitro epilepsy-like activities by either enhancing gross excitation (4-AP/low 
Mg
2+) or depressing overt inhibition (bicuculline), their combination provides a 
unique  approach  to  assess  whether  PAR-2  activation  modulates  epilepsy-like 
activities differentially through these two opposite mechanisms.  
To sum up, the specific aims of this chapter were to assess whether PAR-2 and 
PAR-1 exert any modulatory influence over pathological network activities under 
conditions where network excitation is enhanced (4-AP/0 Mg
2+ model) or when 
synaptic inhibition is compromised (bicuculline model).     159 
5.2 Characterisation  of  epileptiform  activity  in  4-AP/0 
Mg
2+ model 
Extracellular  recordings  were  obtained  from  the  CA3  stratum  pyramidale  in 
hippocampal  slices  prepared  from  16-24  days  old  Wistar  rats.  No  detectable 
spontaneous field events were recorded during control period (drug free, normal 
ACSF)  in  all  slices  tested  (n=33).  Subsequent  perfusion  with  0  Mg
2+  ACSF 
supplemented  with  4-AP  (100M)  resulted  in  the  gradual  appearance  of 
intermittent,  large  amplitude,  rhythmical  field  events  (see  figure  5.1A,  B). 
These intermittent events of short burst duration mirrored the inter-ictal-like 
activity described in previous reports  (Avoli et al., 1993; Mattia et al., 1994; 
Roshan-Milani et al., 2003).  
Individual inter-ictal-like events (see figure 5.1C) comprised of (1) a large, fast 
negative  deflection  followed  by  (2)  an  initial  fast  and  later  slower  positive 
potential, which overshot baseline to reach peak amplitude and then (3) a slow 
negative potential, some of which were nested by a high frequency oscillatory 
burst  component  (see  figure  5.1).  The  application  of  4-AP  with  0  Mg
2+ACSF 
resulted in the occurrence of inter-ictal-like events within 10-20 minutes. The 
instantaneous frequency of these events increased to eventually plateau at a 
stable and stereotyped discharge with a mean instantaneous frequency of 1.51 ± 
0.16Hz  (n=33).  The  mean  amplitude  of  these  events  was  2.03  ±  0.27mV 
(measured baseline to positive peak; n=33). However, the amplitude was rather 
variable  and  exquisitely  sensitive  to  the  precise  placement  of  the  recording 
electrode. Therefore, all subsequent analyses focused on the temporal domain 
rather and response amplitude.   
The  occasional  appearance  of  prolonged  seizure-like  discharges  or  ‘ictal-like’ 
events was observed only in a small minority of experiments (7 in 33 slices) (see 
figure 5.2). Because the occurrence of ictal-like activity was rare, inconsistent 
and  irregular  across  this  set  of  experiments,  the  following  analysis  of 
epileptiform activity focused on the inter-ictal-like activity.     160 
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Figure 5-1 4-AP/ 0 Mg
2+-induced epileptiform activity in the CA3 area of acute hippocampal 
slices. 
A.  Representative  extracellular  recording  upon  bath  application  of  the  0  Mg
2+  ACSF 
supplemented with convulsant compound, 4-AP (100M) as indicated by the solid bar. Note 
the appearance of rhythmical field events within 10 minutes of 4-AP/0 Mg
2+ application. B. 
Expanded  trace  of  the  same  recording  shows  intermittent  and  coherent  inter-ictal-like 
events. C. Further expansion of trace to resolve the waveform of individual spontaneous 
field events show then to comprise of: (1) a fast negative potential followed by a (2) a series 
of  fast  positive  potentials  (extracellular  action  potential  burst)  followed  by  a  (3)slow 
negative potential.     161 
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Figure 5-2 Examples of two types of 4-AP/0 Mg
2+-induced epileptiform activity in the CA3 
area of acute hippocampal slices. 
A.  Representative  trace  of  intermittent  regular  inter-ictal-like  activity  (spontaneous  field 
bursts) which was the most dominant form of epileptiform activity induced by 4-AP/0 Mg
2+ 
application  (seen  in  all  33  slices).  B.  Example  of  ictal-like  discharge  pattern  which  was 
observed (in addition to inter-ictal bursts) in 7 of 33 slices recorded. Note the prolonged 
burst discharge separated by periods of relative network quiescence. Note that the initial 
response resembles a burst-like response but activity is thereafter on terminated but shows 
a prolonged discharge pattern consistent with a breakdown of inhibition.      162 
5.3 PAR-2 activation depresses the  frequency of 4-AP/0 
Mg
2+-induced  epileptiform  activities  in  acute 
hippocampal slices 
Sustained and regular inter-ictal-like activities were recorded in the CA3 cell 
body  layer  following  the  application  of  0  Mg
2+  ACSF  supplemented  with  4-AP 
(100M). 10 minutes baseline of inter-ictal-like activities with stable bursting 
frequency was required before 100M PAR-2-AP, SLIGRL, was applied through 
the perfusate. As presented in figure 5.3B, application of SLIGRL for 30 minutes 
significantly depressed the bursting frequency of inter-ictal-like activities from 
1.53 ± 0.21Hz to 1.18 ± 0.17Hz (n=13, P=0.0006). Individual experiment time 
plots revealed a gradual yet profound SLIGRL-induced depression of the bursting 
frequency  with  slow  time  course  resembling  that  seen  for  the  depression  of 
evoked synaptic responses reported in chapter 4 (see figure 4.1), (normalised 
burst frequency, control: 100.98 ± 0.90%, drug: 80.46 ± 4.40%, n=13, P=0.0004, 
figure  5.3C).  Furthermore,  this  depression  of  epileptiform  burst  frequency 
persisted following the washout of SLIGRL as was also seen with the synaptic 
depression experiments (chapter 4, see figure 4.1). In contrast, the application 
of negative control, 100M PAR-2-IP, LRGILS, for 30 minutes, did not lead to any 
significant  change  in  4-AP/0  Mg
2+-induced  bursting  activities  (control:  1.60  ± 
0.40Hz, drug:1.71 ± 0.40Hz, n=6, P=0.1721,figure 5.4B). This trend is also seen 
in the normalised pooled data sample as shown in (figure 5.4C, normalised burst 
frequency,  control:  98.40  ±  2.46%,  drug:  106.73  ±  6.14%,  p=0.2043,  n=6). 
Together, these data suggesting the depression of bursting frequency was indeed 
a specific action of PAR-2 activation. 
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Figure  5-3  PAR-2  activation  reduces  the  frequency  of  4 -AP/0  Mg
2+-induced  epileptiform 
activity in the CA3 area of acute hippocampal slices. 
A.  Representative  traces  (20080805/2)  show  the  occurrence  of  inter -ictal-like  activities 
during baseline period (upper trace) and after the PAR-2-AP,  SLIGRL (100M) is applied 
(lower  trace).  Note  the  frequency  of  inter -ictal-like  events  is  reduced  upon  SLIGRL 
application.  B.  Bar  chart  summarising  quantitative  analysis  of  instantaneous  frequency 
before and during SLIGRL application (n=13, P=0.0006). C. Time plot of the same pooled 
experiments normalised to baseline frequency show the gradual but robust reduction of 
epileptiform burst frequency upon SLIGRL application (n=13, P=0.0004, measured at last 
minute of baseline and SLIGRL application).      164 
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Figure 5-4 The PAR-2-IP, LRGILS has no effect on the frequency of 4-AP/0 Mg
2+-induced 
epileptiform activity in hippocampal area CA3. 
A.  Representative  traces  (20080729/1)  show  the  occurrence  of  inter-ictal-like  activities 
during  baseline  period  (upper  trace)  and  after  the  PAR-2-IP,  LRGILS  (100M)  is  applied 
(lower trace). Note the absence of any detectable change in burst frequency upon LRGILS 
application.  B.  Bar  chart  summarising  quantitative  analysis  of  instantaneous  frequency 
before and after LRGILS application (n=6, P=0.1721) C. Time plot showing no significant 
change in mean burst frequency over time as the LRGILS is applied (n=6, P=0.2043). 
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5.4 PAR-1 activation does not affect the frequency of 4-
AP/0  Mg
2+-induced  epileptiform  activities  in  acute 
hippocampal slices 
In order to assess whether PAR-1 activation may have a modulatory role on 4-
AP/0 Mg
2+-induced epileptiform activities, extracellular recording was repeated 
in the CA3 stratum pyramidale in acute hippocampal slices. 10 minutes stable 
inter-ictal-like bursting activities was monitored before 100M PAR-1-AP, TFLLR, 
was applied. As shown in figure 5.5B, no detectable change in bursting frequency 
was observed following TFLLR application (control: 1.10 ± 0.13Hz, drug: 1.14 ± 
0.11Hz,  n=13,  P=0.3730).  Time  plot  analysis  confirmed  the  same  observation 
(normalised  burst  frequency:  control:  101.65  ±  1.19%,  drug:  104.30  ±  3.52%, 
n=13,  P=0.3781,  figure  5.5C).  Overall,  this  experiment  using  the  selective 
activator  of  PAR-1  did  not  modulate  the  frequency  of  4-AP/0  Mg
2+-induced 
epileptiform bursting.     166 
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Figure 5-5 The PAR-1-IP, TFLLR, has no effect on the frequency of 4 -AP/0 Mg
2+-induced 
epileptiform activity in hippocampal area CA3. 
A.  Representative  traces  (20080819/1)  show  the  occurrence  of  inter -ictal-like  activities 
during baseline period (upper trace) and after the PAR-1-IP, TFLLR (100M) is applied (lower 
trace).  Note  the  absence  of  any  detectable  change  in  burst  frequency  upon  TFLLR 
application.  B.  Bar  chart  summarising  quantitative  analysis  of  instantaneous  frequency 
before  and  after  TFLLR  application  (n=13,  P=0.373)  C.  Time  plot  showing  no  significant 
change in mean burst frequency over time as TFLLR is applied (n=13, P=0.378).     167 
5.5 Characterisation of epileptiform activity in bicuculline 
model 
Extracellular  recordings  were  obtained  from  the  CA3  stratum  pyramidale  in 
hippocampal  slices  prepared  from  16-24  days  old  Wistar  rats.  No  detectable 
spontaneous field events were recorded during control period (drug free, normal 
ACSF) in all slices tested (n=10). Subsequent disinhibition by the bath application 
of  GABAA  receptor  antagonist,  bicuculline  (20M),  resulted  in  a  gradual 
appearance of intermittent rhythmical field events. These inter-ictal-like events 
occurred every 9.7±1.1s (n=10) and were 100 times less frequent compared to 
those observed in 4-AP/0 Mg
2+ model (interevent interval: 0.10 ± 0.01s for 4-
AP/0 Mg
2+ model, n=33, 9.7 ± 1.1s for bicuculline model, n=10). 
Bicuculline-induced inter-ictal-like events observed (shown in figure 5.6) were 
different  in  waveform  from  those  seen  in  4-AP/0  Mg
2+  model.  They  were 
typically characterised by a primary large inter-ictal-like event with triphasic 
waveform:  (1)  a  fast  negative  deflection  followed  by  (2)  a  fast  positive 
deflection which overshot baseline to reach peak amplitude (3) slow negative 
decay phase. This was followed by another burst or a train of repetitive smaller 
and  shorter  bursts.  Bicuculline-induced  epileptiform  events  occurred  with  a 
mean  instantaneous  frequency  of  0.40  ±  0.27Hz  (n=10)  and  the  mean  peak 
amplitude (measured from baseline to positive peak) of these events was 2.56 ± 
0.43mV. (n=10).     168 
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Figure 5-6 Bicuculline-induced epileptiform activity in the CA3 area of acute hippocampal 
slices. 
A.  Representative  extracellular  recording  upon  bath  application  of  the  GABAA  receptor 
antagonist  bicuculline  (20M)  as  indicated  by  the  solid  bar.  Note  the  appearance  of 
rhythmical field events within 10 minutes of bicuculline application. B. Expanded trace of 
the  same  recording  shows  intermittent  and  coherent  inter-ictal-like  events.  C.  Further 
expansion of trace to resolve the waveform of individual spontaneous field events show 
then to comprise of: (1) a fast negative potential followed by a (2) a series of fast positive 
potentials (extracellular action potential burst) on top on a (3)slow negative potential.     169 
5.6 Both PAR-2 and PAR-1 activation have no effect on 
the  frequency  or  occurrence  of  bicuculline-induced 
epileptiform activities in hippocampal slices  
Once sustained and regular inter-ictal-like activities were recorded from the CA3 
cell  body  layer  following  the  application  of  20M  bicuculline,  10  minutes 
baseline of inter-ictal-like activities with stable bursting frequency was recorded 
as control period before either the PAR-2-AP (SLIGRL, 100M) or the PAR-1-AP 
(TFLLR,  100M)  was  applied  through  the  perfusate.  Application  of  SLIGRL  or 
TFLLR  for  30  minutes  induced  no  significant  or  detectable  change  in  the 
frequency  of  inter-ictal-like  activities  (0.14  ±  0.03Hz  to  0.13  ±  0.03Hz,  n=6, 
P=0.5282,  figure  5.7B  for  PAR2-AP)  (0.13  ±  0.02Hz  to  0.13  ±  0.02Hz,  n=4, 
P=0.9893, figure 5.8B for PAR1-AP) respectively. Time plot summary confirmed 
the absence of any detectable drug effect over the period of drug application 
(normalised burst frequency, PAR-2-AP: from 98.01 ± 3.21% to 99.85 ± 4.60%, 
n=6, P=0.6043, figure 5.7C; PAR-1-AP: from 96.59 ± 0.35% to 89.28 ± 8.73 n=4, 
P=0.5385, figure 5.8C). These data suggest PAR-2 and PAR-1 activation had no 
modulatory influences on bicuculline-induced epileptiform activities, at lease in 
terms of overt changes in burst frequency.     170 
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Figure 5-7 The PAR-2-AP, SLIGRL, has no effect on the frequency of bicuculline-induced 
epileptiform activity in hippocampal area CA3. 
A.  Representative  traces  (20080812/1)  show  the  occ urrence  of  inter-ictal-like  activities 
during baseline period (upper trace) and after the PAR -2-AP, SLIGRL (100M) is applied 
(lower trace). Note the absence of any detectable change in burst frequency upon SLIGRL 
application.  Stippled  indicated  matching  o f  traces  indicative  of  no  change  in  burst 
frequency.  B.  Bar  chart  summarising  quantitative  analysis  of  instantaneous  frequency 
before and after SLIGRL application (n=6, P=0.5281) C. Time plot showing no significant 
change in mean burst frequency over time as the SLIGRL is applied (n=6, P=0.604).     171 
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Figure  5-8  The  PAR-1-AP,  TFLLR  has  no  effect  on  the  frequency  of  bicuculline -induced 
epileptiform activity in hippocampal area CA3. 
A.  Representative  traces  (20081017/1)  show  the  occurrence  of  inter -ictal-like  activities 
during  baseline  period  (upper  trace)  and  after  the  PAR -1-AP,  TFLLR  (100M)  is  applied 
(lower trace). Note the absence of any detectable change in burst frequency upon TFL LR 
application.  Stippled  indicated  matching  of  traces  indicative  of  no  change  in  burst 
frequency.  B.  Bar  chart  summarising  quantitative  analysis  of  instantaneous  frequency 
before  and  after  TFLLR  application  (n=4,  P=0.989)  C.  Time  plot  showing  no  significan t 
change in mean burst frequency over time as the TFLLR is applied (n=4, P=0.539).     172 
 
5.7 Discussion 
In  this  chapter,  I  demonstrated,  for  the  first  time,  that  activation  of  PAR-2 
significantly  depresses  the  frequency  of  epileptiform  activities  induced  by  4-
AP/0 Mg
2+ in acute hippocampal slices, suggesting that PAR-2 activation exerts 
an anti-epileptic effect in the 4-AP/0 Mg
2+-induced epilepsy model. In contrast, 
PAR-1 activation is ineffective. Furthermore, neither PAR-2 nor PAR-1 activation 
changes the frequency of epileptiform activities induced by bicuculline.  
 
In  this  chapter,  I  first  demonstrate  that  PAR-2  activation  depresses  the 
frequency of epileptiform activities in 4-AP/0 Mg
2+ induced epilepsy (see figure 
5.3). This result is in agreement with previous report that PAR-2 activation is 
protective against seizure in vivo (Lohman et al., 2008). Considering the fact 
that enhanced excitatory input in the network is the main driving force to the 
epileptogenesis  in  4-AP/0  Mg
2+-induced  epileptiform  activities  in  slices,  the 
observed depression of epileptiform activities may reflect the nature that PAR-2 
activation  reduces  excitatory  synaptic  transmission,  which  has  been 
demonstrated in chapter 3, and 4 (see figure 3.17,3.19 and 4.1). Therefore, one 
rational  interpretation  based  on  this  result  is  PAR-2  activation  weakens 
excitatory synaptic transmission, which in turn reduces excitatory driving force, 
and thus depresses the frequency of epileptiform activity in 4-AP/0 Mg
2+ model. 
In stark contrast, PAR-2 activation has no detectable effect on the frequency of 
bursting in bicuculline-induced epileptiform activities. This inconsistency may be 
explained  by  considering  the  mechanism  underlying  bicuculline-induced 
epileptiform activity. In this model, epileptiform activity is induced as a result 
of the collapsed balance of excitation and inhibition due to silenced inhibition by 
GABAA receptor blockade. Thus, as the disinhibition dominates the driving force 
for epileptogenesis in bicuculline model, a modest reduction of excitatory input 
as expected from PAR-2 activation (about 20%, see figure 5.3 and figure 4.1) may 
not be able to compensate the gross loss of inhibition. Therefore, no observable 
effect by PAR-2 activation could be rationalised.  
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It is surprising to notice in this chapter that PAR-1 activation has no detectable 
effect  on  the  frequency  of  epileptiform  activity  in  either  4-AP/Mg
2+  or 
bicuculline  model.  Although  this  observation  is  consistent  with  the  results 
reported  in  Chapter  4  (see  figure  4.5)  that  PAR-1-AP,  TFFLR  (100M)  has  no 
detectable  effect  on  synaptic  transmission  at  the  Schaffer  collateral-to-CA1 
synapse, it is, at first glance, inconsistent with the previous report that PAR-1 
activation facilitates epileptogenesis in hippocampal slices (Maggio et al., 2008).  
This disagreement could be reconciled by the following consideration. Maggio 
and co-workers investigated the frequency of spontaneous spikes under normal 
saline  solution  and  the  threshold  of  seizures  by  elevating  extracellular  K
+ 
concentration  (Maggio  et  al.,  2008).  Therefore,  the  interpretation  from  their 
results is PAR-1 may facilitate the occurrence of epileptiform activity. However, 
in their report, it remains void that whether PAR-1 modulates the epileptiform 
activity once it is established. My result, on the other hand, suggests PAR-1 has 
no regulatory role after the establishment of epileptiform activity. To conclude, 
PAR-1 activation may facilitate epileptogenesis, but it may not have modulatory 
role in established epilepsy. 
Taken  together,  in  chapter  5,  I  demonstrate  that  PAR-2  may  suppress 
epileptiform activities in the area of CA3 in acute hippocampal slices due to 
heightened excitation but does not regulate epileptiform activities as a result of 
disinhibition of hippocampal circuits.  
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6  General discussion 
The main purpose of this thesis was to investigate whether activation of PAR-2 in 
the  hippocampus  under  non-diseased  conditions  modulates  neuronal  intrinsic 
properties, synaptic transmission and plasticity as well as network activities. The 
central hypothesis of this investigation was that PAR-2, by its unique activation 
mechanism, may serve as ‘molecular switch’ in tuning neuronal signalling in the 
hippocampus, a brain structure important in aspects of learning and memory. It 
was hoped that by examining neuronal excitability and synaptic transmission in 
primary hippocampal culture and acute hippocampal slice preparations, such in 
vitro investigations would provide valuable insights about the action of PAR-2 
activation in the cells of the CNS. It was hoped that these experiments might 
ultimately  provide  experimental  evidence  to  whether  PAR-2  is  a  plausible 
candidate for therapeutic interventions. Thus, in the final chapter, I will firstly 
summarise  the  major  findings  of  this  investigation  with  highlighted  novel 
discoveries.  Then,  I  will  discuss  the  significance  of  this  investigation,  in 
particular in relation to established knowledge of PARs in the CNS as well as 
modulators of neural transmission and plasticity. Furthermore, I will reflect the 
limitations  of  this  project  in  terms  of  methodology,  data  interpretation,  and 
completeness. Finally, I will make suggestions to directions that future studies 
could take based on my current data. 
6.1 Major findings 
The major findings reported in the thesis are the following: 
Firstly, from primary hippocampal culture experiments 
1.  Trypsin  depolarises  cultured  hippocampal  neurones  and  increases  the 
occurrence of spontaneous APs. 
2.  Spontaneous APs are synaptically driven in nature. 
3.  The  PAR-2-AP  (SLIGRL)  but  not  PAR-2-IP  (LRGILS)  depolarises  cultured 
hippocampal neurones and depresses spontaneous occurring APs. 
4.  The  PAR-1-AP  (TFLLR)  and  PAR-4-AP  (AYPGKF)  depolarises  cultured 
hippocampal  neurones.  However,  neither  PAR-1-AP  nor  PAR-4-AP     175 
significantly changes the frequency of spontaneous AP firings. 
5.  SLIGRL-induced neuronal depolarisation is dependent on glutamate. 
6.  SLIGRL-induced  neuronal  depolarisation  requires  normal  astrocytic 
function. 
7.  Astrocytic-neuronal  signalling  contributes  to  SLIGRL-induced  depression 
of spontaneous AP firing. 
 
Secondly, from acute hippocampal slice experiments 
 
1.  Two independent PAR-2-APs, SLIGRL and 2f-LIGRL, but not the PAR-2-IP 
(LRGILS)  induce  LTD  of  glutamatergic  synaptic  transmission  at  the 
Schaffer collateral-to-CA1 synapse. 
2.  mGluRs are not required in the induction of PAR-2 activation-induced LTD 
3.  PAR-2 activation-induced LTD is dependent on NR2B subunit-containing 
NMDA receptors 
4.  Glial-neuronal signalling contributes to PAR-2-mediated LTD. 
5.  The  PAR-1-AP  (TFLLR)  has  no  effect  on  basal  glutamatergic  synaptic 
transmission at the Schaffer collateral-to-CA1 synapse. 
 
Finally, from pilot study investigating PAR-1 and PAR-2 actions in in vitro 
models of epilepsy 
 
1.  The  PAR-2-AP  (SLIGRL)  but  not  the  PAR-2-IP  (LRGILS)  depresses  the 
frequency  of  4-AP/0  Mg
2+-induced  epileptiform  activity  in  the  CA3  of 
acute rat hippocampal slices. 
2.  The  PAR-1-AP (TFLLR) has no effect on the frequency of 4-AP/0 Mg
2+-
induced epileptiform activity in the CA3 of acute hippocampal slices. 
3.  Neither PAR-2-AP (SLIGRL) nor PAR-1-AP (TFLLR) has any effect on the 
frequency of bicuculline-induced epileptiform events in the area CA3 of 
acute rat hippocampal slices. 
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6.1.1 PAR-2-mediated  neuronal  depolarisation  in  hippocampal 
culture 
In my thesis, firstly, I demonstrate that activation of PAR-2 leads to membrane 
depolarisation of cultured hippocampal neurones. To my knowledge, this is the 
first report that a member of PAR family modulates the excitability (membrane 
potential) of  a central neurone. However, the data is nevertheless consistant 
with  previous  studies  showing  PAR-2  activation  to  depolarise  membrane  of 
submucosal neurones (Reed et al., 2003), colonic DRG neurones (Kayssi et al., 
2007) in the digestive tract as well as nociceptive DRG neurones (Amadesi et al., 
2004)  in  the  spinal  cord,  in  response  to  50  to  100M  PAR-2-AP,  SLIGRL, 
application.  In  addition,  the average  magnitude  of  depolarisation  reported in 
these  studies  is  all  in  the  range  between  5  to  10mV  (from  normal  resting 
conditions), which is comparable to that I observe in my preparation. Thus, my 
result  reported  here  is  in  agreement  with  previous  observations  in  other 
neuronal  types.  Furthermore,  considering  PAR-2-mediated  neuronal 
depolarisation is independently verified in four neuronal types in three systems 
(submucosal neurones, colonic DRG neurones in the digesting tract, nociceptive 
DRG neurones in the spinal cord, and hippocampal neurones in the brain), it is 
suggesting  that  the  modulation  of  neuronal  excitability  is  perhaps  a  common 
regulatory role that PAR-2 plays in tuning neuronal function. However, it is also 
noticed  that  the  proposed  mechanism  underlying  neuronal  depolarisation 
mediated by PAR-2 activation in all four types of neurones may not be the same. 
Reed  and  co-workers  showed  the  depolarisation  observed  in  submucosal 
neurones were associated with an increase of input resistant of the recorded 
neurone (Reed et al., 2003), and this association was also apparent when colonic 
DRG  neurones  were  tested  (Kayssi  et  al.,  2007).  In  the  later  study,  it  was 
demonstrated that PAR-2-mediated depolarisation together with the increase of 
input resistance was due the blockade of delayed rectifier K
+ channels (Kayssi et 
al.,  2007),  arguing  a  direct  channel-modulating  effect  by  the  activation  of 
neuronal  PAR-2.  In  contrast,  my  results  suggest  PAR-2-mediated  neuronal 
depolarisation in the cultured hippocampal neurones is dependent on glutamate 
release from nearby astrocytes, favouring an indirect effect from the activation 
of  astrocytic  PAR-2.  Indeed  the  phenomena  that  gliotransmitters  release, 
including glutamate, in response to GPCR activation on glial cells is very well     177 
established (see Chapter 1.8). Notably, several recent publications reported that 
PAR-1, another member of PAR family, produced neuronal activity (enhancing 
neuronal  NMDA  receptor  mediated  component  of  mEPSCs  (Lee  et  al.,  2007), 
eliciting NMDA receptor mediated SIC (Shigetomi et al., 2008), and evoking Ca
2+ 
signal in neurones from the nucleus of the solitary tract (Hermann et al., 2009) 
respectively)  through  its  activation  on  astrocytes  in  diverse  experimental 
preparations,  including  hippocampal  culture  as  well  as  hippocampal  and 
medullary slice preparations. Thus, in terms of the mechanism underlying PAR-2-
mediated neuronal depolarisation, my result is in agreement with the previously 
established  astrocytic  PAR-1-to  neurone  pathway.  However,  regarding 
neuroexcitability, it has to be acknowledged that the possibility that a direct 
influence on neuronal ion channels following neuronal or/and astrocytic PAR-2 
activation, which is not examined in the current study, has to be considered. 
Ca
2+  imaging  experiments  have  demonstrated  a  small  yet  significant  rise  of 
intracellular Ca
2+ upon SLIGRL application in the cultured hippocampal neurones 
(Dr.  Sam  Greenwood,  unpublished  data),  suggesting  a  possible  modulation  of 
channels  whose  activation  may  need  the  Ca
2+  signal,  for  instance  the  Ca
2+-
activated K
+ channels.  
Therefore, taking all these considerations into account, it is reasonable to make 
a general suggestion that neuronal depolarisation is maybe a common feature of 
PAR-2-mediated  modulation  of  neuronal  excitability.  But  at  lease  two 
independent  or  overlapping  mechanisms  could  underlie  this,  either  a  direct 
effect of neuronal PAR-2 activation (via ion channels) or/and an indirect effect 
of astrocytic PAR-2 activation (via glutamate receptors).  
6.1.2 PAR-2-mediated depression of the frequency of 
spontaneous firings 
Another  novel  finding  from  my  thesis  is  that  in  the  cultured  hippocampal 
neurones,  a  transient  modest  depolarisation  is  associated  with  paradoxically 
reduction  of  AP  firing  frequency  upon  PAR-2  activation  (see  figure  3.6).  This 
observation is unusual because a membrane depolarisation normally results in 
increased  excitability,  therefore  facilitating  the  occurrence  of  APs.  Thus,  in 
order to address the mechanism underlying this paradox. I first demonstrate that     178 
the  AP  firing  is  largely  dependent  on  glutamatergic  synaptic  transmission 
because  a  cocktail  of  glutamate  receptor  antagonists  totally  prevents  the 
generation of APs (see figure 3.17). Secondly, I confirm the recorded neurone 
receives a constant barrage of EPSPs, many of which are suprathreshold for the 
generation of APs (see figure 3.3). Moreover, within closer inspection, I show the 
frequency  of  sub-threshold  EPSPs  are  significantly  reduced  following  PAR-2 
activation (see figure 3.19). Thirdly, when somatic current injection is applied to 
depolarise neuronal membrane from -65mV to -60mV, the magnitude similar to 
that seen upon PAR-2 activation, a predictable and significant increase of APs is 
observed (see figure 3.18). Taken together, these data from my thesis, although 
indirect, suggest the occurrence of APs in the cultured hippocampal neurone is 
largely  not  intrinsic,  but  synaptically  driven.  Therefore,  the  reduction  of 
spontaneous  AP  firings  may  be  as  a  result  of  significant  reduction  of 
glutamatergic  synaptic  transmission  onto  the  recorded  cell.  To  combine  the 
observed depolarisation data, this paradox that depolarisation associated with a 
reduction of AP firings could be rationalised by dissecting this simultaneously 
occurring  event  by  separate  mechanisms.  That  is  PAR-2-mediated  neuronal 
depolarisation is due to astrocytic release of glutamate, whereby, at the same 
time,  PAR-2  activation  depresses  glutamatergic  synaptic  transmission  in  the 
network formed within the cultured hippocampal neurones.  
 
The  precise  mechanisms  underlying  the  PAR-2-mediated  depression  of 
glutamatergic  synaptic  transmission  in  the  cultures  was  not  established  in 
unequivocal  terms  during  the  course  of  this  thesis.  Nevertheless,  my  data  in 
Chapter  3  again  favours  an  indirect  action  of  PAR-2  activation  whereby 
glutamate of  astrocytic origin results in the suppression of fast glutamatergic 
synaptic transmission. Consistent with this, glutamate released from astrocytes 
have  been  demonstrated  to  depress  excitatory  synaptic  transmission  in 
hippocampal  culture  following  activation  by  a  number  of  other  G-protein 
coupled  receptors  including  presynaptic  MAP-4  sensitive  group  III  mGluRs 
(Araque  et  al.,  1998).  Group  I  (Gereau  &  Conn,  1995)  and  group  II  mGluRs 
(Bushell et al., 1996) can also be potential candidates as their involvement have 
been confirmed depending on types of synapses, animal age and species. Thus, it 
is of special interest to examine if presynaptic mGluRs are contributing to this 
PAR-2-mediated synaptic depression in culture using selective mGluR antagonists.     179 
Moreover,  as  the  rise  of  intracellular  Ca
2+  is  confirmed  in  astrocytes  in  our 
primary hippocampal culture in response to PAR-2 activation (unpublished data 
by  Dr.  Sam  Greenwood),  it  is  reasonable  to  expect  that  gliotransmitters, 
including  glutamate,  could  be  released  upon  astrocytic  PAR-2  activation. 
Therefore, the depression of synaptic transmission in the culture system could 
be as a result of other molecules. One potentially plausible candidate would be 
astrocytically  released  ATP.  Recent  studies  demonstrated  that  ATP  released 
from astrocytes induces synaptic depression in cultured hippocampal neurones 
via presynaptic purinergic receptors (Koizumi et al., 2003; Zhang et al., 2003). 
Thus, it would be interesting to employ purinergic antagonists to examine the 
consequence  of  the  frequency  of  spontaneous  APs  and  EPSPs  in  the  culture 
system upon application of PAR-2-AP. 
 
Although  all  my  results  support  the  explanation  that  a  reduction  of 
glutamatergic synaptic transmission leads to the depression of the frequency of 
synaptcally driven APs, alternative mechanisms for the reduction of spontaneous 
AP firings upon PAR-2 activation may still exist in parallel because the proposed 
mechanism  with  reduced  glutamatergic  synaptic  transmission  may  not  be  the 
sole contributing factor. One possibility is perhaps the direct modulation of ion 
channel  conductances,  most  likely  enhanced  potassium  conductances  via 
activation  of  Ca
2+-activated  potassium  channels,  and  perhaps  decreased  Ca
2+ 
conductances.  It has been demonstrated that PAR-2 activation could modulate 
membrane channels (Kayssi et al., 2007). In order to test this hypothesis, one 
may have to first inspect the input resistance of the recorded neurone before 
and after the application of PAR-2-AP, SLIGRL.  
 
6.1.3 PAR-2-mediated long term depression 
In  the  acute  slice  preparation,  I  demonstrate  for  the  first  time  that  the 
application  of  PAR-2-AP  induces  a  long  lasting  depression  of  glutamatergic 
synaptic  transmission  at  the  Schaffer  collateral-to-CA1  synapse.  This  PAR-2- 
mediated depression of glutamatergic synaptic transmission seen in acute slices 
is consistent with my interpretation in chaper 3 that PAR-2 activation depresses 
glutamatergic  synaptic  transmission  in  the  cultured  hippocampal  neurones  as     180 
demonstrated  by  the  reduction  of  synaptically-driven  APs  upon  PAR-2-AP 
application (see figure 3.6,17,18 and 19.). However, it is also noticed that the 
timecourse of PAR-2-induced synaptic depression is different under these two 
experimental conditions. In the cultured system, the PAR-2-mediated depression 
of  synaptic  transmission  is  rather  transient  as  the  frequency  of  synaptically-
driven APs return to control level after 5 minutes PAR-2-AP perfusion (see figure 
3.6),  whereas,  in  acute  slices,  PAP-2-AP  produced  a  relatively  long  term 
depression (up to 30mins) and this depression is not reversible upon washout 
PAR-2-AP.  This  timecourse  difference  may  be  explained  by  the  fact  that  the 
cultured neurones have much less exposure time to PAR-2-AP (5mins) compared 
to neurones in slices (30mins). If this was the case, this might suggest that a 
short time exposure to PAR-2 activation leads to transient synaptic depression, 
whereas  long  term  exposure  gives  rise  to  long  lasting  effect.  However,  this 
timecourse  difference  in  two  systems  may  also  suggest  there  could  be  two 
independent  mechanisms  underlying  short  term  modulation  and  long  term 
modulation  of  basal  synaptic  transmission  by  PAR-2  activation,  which  would 
require perhaps differential signalling pathways and molecules. But nevertheless, 
a depression of glutamatergic synaptic transmission is observed in both culture 
and slice preparations. A recent publication demonstrated that certain serine 
proteinases are capable of inducing LTD at the Schafer collateral-to-CA1 synapse 
(MacGregor  et  al.,  2007).  Considering  PAR-2  is  very  likely  endogenously 
activated  by  proteinases,  it  is  of  interest  to  speculate  that  PAR-2  might  be 
activated tonically by the endogenous ligand and that this enduring action might 
indeed be able to modulate basal excitatory synaptic transmission in vivo, which 
would provide a novel target for pharmacological and therapeutic intervention. 
In  addition,  it  is  also  acknowledged  that  in  this  study,  only  the  Shaffer 
collateral-to-CA1 synapse is investigated. However, whether this PAR-2-induced 
long  lasting  synaptic  depression  is  universal  to  all  excitatory  synapses  in  the 
hippocampus  is  unkonwn.  Furthermore,  it  would  be  also  interesting  to  know 
whether PAR-2 activation modulate inhibitory synapses.  
It  is  noticed  in  the  slice  preparation  that  the  PAR-2-mediated  long  lasting 
synaptic depression is irreversible. After ruling out that the irreversibility is due 
to the deterioration of slice quality in the process of  these experiments (see 
figure 4.1, and figure 4.2), this feature may indicate that PAR-2-mediated LTD     181 
could persist even without the ligand binding. In terms of mechanisms underlying 
this phenomenon, it might be plausible to firstly consider possible postsynaptic 
modifications  associated  with  this  form  of  LTD  once  established  via  PAR-2 
activation, because the magnitude of paired-pulse ratio alteration upon PAR-2-
AP  application,  though  statistically  significant,  is  relatively  very  modest  (see 
figure 4.6). Thus, immediate speculations would include, for instance, a reduced 
number  of  functioning  postsynaptic  iontropic  glutamate  receptors.  Because 
AMPA receptor internalisation has been widely proposed as the cellular response 
upon the expression of different forms of LTD (Malinow & Malenka, 2002; Kessels 
& Malinow, 2009), it may be of interest to compare the membrane expression 
level  of  AMPA  receptors  during  normal  synaptic  transmission  and  the  PAR-2-
mediated  LTD.  Another  aspect  consider  would  be  a  possible  modulation  of 
shapes and numbers of postsynaptic spines following PAR-2 activation because 
structural plasticity, which associates with different forms of synaptic plasticity 
including LTD, has been manifested by the dynamics of spines (Bourne & Harris, 
2008; De Roo et al., 2008; Bhatt et al., 2009; Yang & Zhou, 2009) and this has 
not yet been investigated in the PAR-2 knockout mouse.  
Finally,  a  question  emerged  from  the  PAR-2-mediated  LTD  is  whether  it  is 
functionally  physiological  or  pathophysiological.  It  has  been  recently 
demonstrated  in  our  group  that  PAR-2  activation  is  neuroprotective  in  slice 
culture preparations (Greenwood & Bushell, 2010). My data in Chapter 4 may 
support this hypothesis from a synaptic aspect that a reduced excitatory synaptic 
transmission  upon  PAR-2  activation  might  be  beneficial  in  nature  for  certain 
pathological  conditions,  for  instance,  in  ischaemia  and  epilepsy.  It  has  been 
widely documented that the penumbra surrounding stroke regions show aberrant 
plasticity (Calabresi et al., 2003; Di Filippo et al., 2008) and it is possible that 
this is accounted for by region experiencing PAR-2 activation as an upregulation 
of  PAR-2  expression  in  neurones  has  been  recorded  in  a  mouse  model  of 
ischaemia  (Jin  et  al.,  2005).  Furthermore,  during  these  insults,  the  gross 
excitability in the neural network increases due to a pathologically increased 
glutamate level, and it has been confirmed excessive excitability is harmful to 
neurones  and  synapses  (Arundine  &  Tymianski,  2004;  Greenwood  &  Connolly, 
2007).  Therefore,  it  seems  logical  that  PAR-2  activation  reduces  global 
excitability  by  depressing  excitatory  synaptic  transmission  in  the  synapses  as     182 
well as network (see Chapter 5), which in turn protects the functionality of the 
synaptic  signalling  within  the  network.  Furthermore,  as  PAR-2  might  be 
activated  endogenously,  this  mechanism  could  be  utilised  to  provide  tonic 
inhibiting force for the synapses against trauma-induced hyperexcitability insults. 
6.1.4 Glial  involvement  in  the  PAR-2-mediated  modulation  of 
neuronal signalling 
In my thesis, the involvement of glial function has been strongly indicated by 
experimental data from both primary culture and acute slice preparations. This 
consistency may suggest glial cells  are indeed underlying the PAR-2-mediated 
modulation  of  neuroexcitability  and  synaptic  transmission.  In  the  culture 
experiments, my data strongly suggest that astrocytically released glutamate is 
causing membrane depolarisation and at least is contributing to the depression 
of spontaneous APs in neurones (see Chapter 3). In the acute slice experiments, 
normal glial function is at least partially contributing to the PAR-2-mediated LTD 
(see Chapter 4). However, it has to be acknowledged that this hypothesis suffers 
significantly  due  to  the  lack  of  direct  evidence  of  astrocytically  released 
gliotransmitters,  most  notably,  glutamate.  Without  a  direct  measurement  of 
glutamate,  or  perhaps  other  gliotransmitters,  released  from  astrocytes,  the 
basic  conclusion  that  astrocytically  released  glutamate  is  contributing  to  the 
PAR-2-mediated  modulation  is  only  suggestive.  Initial  screen  of  astrocytic 
release of glutamate has been conducted in primary culture but the sensitivity of 
this  assay  was  not  optimal  (unpublished  observations,  Dr.  Sam  Greenwood). 
However, several approaches are available to address this question, for instance 
the  high-pressure  liquid  chromatography  (HPLC)  analysis,  radioactive  labelled 
glutamate  assay,  and  perhaps  ‘sniffer-patch’  technique  (Allen,  1997). 
Nevertheless, several indirect but independent evidences from both culture and 
acute slice preparations (see figure 3.14, 3.15, 3.20, 4.13) point to a role of glial 
cells actively contributing to the PAR-2-mediated modulation.   
6.2 Significance of this study 
The importance of this investigation is outlined as following key points.     183 
 
1.  My thesis provides first evidence to address what is the physiological function 
of PAR-2 in the CNS at single neurone and synaptic levels, which is urgently 
needed as biochemical studies of PAR-2 in the CNS are already abundant. 
2.  My  thesis  reveals  a  novel  form  of  chemically-induced  LTD  which  is  NR2B 
subunit-containing NMDA receptor dependent. 
3.  My thesis provides evidence for a potentially unique new form of synaptic 
modulation  which  might  be  endogenously  activated  upon  enzymatic 
activation  of  PAR-2  to  act  as  tonic  suppressor  for  excitatory  synaptic 
transmission.  
4.  By  studying  the  mechanisms  underlying  the  modulatory  role  of  PAR-2  in 
neuronal signalling, my thesis strongly suggests the functional importance of 
glial cells which provide key molecules to regulate neuronal excitability and 
synaptic transmission.   
 
6.3 Technical considerations 
From the aspect of methodology, the major disadvantage of this study is  the 
concern over the selectivity of pharmacological manipulations. As discussed in 
the  introduction,  the  selectivity  of  the  PAR-2-AP,  SLIGRL,  when  applied  at  a 
relatively high concentration at 100M, is the first consideration. Because at this 
concentration  (100M),  SLIGRL  has  been  demonstrated  to  elicit  the  maximal 
responses  in different  cell  types  and tissue  preparations  (al-Ani  et  al.,  1995; 
Saifeddine et al., 1996; Kawabata et al., 2004) as its EC50 is approximately 5M 
in rat aortic ring preparation and in rat gastric longitudinal muscle preparations 
respectively (al-Ani et al., 1995; Saifeddine et al., 1996). In order to minimise 
the potential ‘off-target’ effect at this high concentration, I carefully employed 
the  ‘control  peptide’,  PAR-2-IP,  LRGILS  at  same  concentration  of  100M,  as 
vehicle control. Furthermore, I utilised PAR-2-AP from different sources to avoid 
potential ‘false positive’ responses due to purity or different solvents employed 
in the production process. Finally, in the slice preparation, I utilised a new PAR-
2-AP, 2f-LIGRL, whose potency relative to SLIGRL is approximately 10,20 and 100 
as determined by the Ca
2+ singnalling assay in cell line, the vasorelaxation assay 
in  rat  superior  mesenteric  artery  and  the  in  vivo  salivation  assay  in  mice 
(Kawabata et al., 2004; Kawabata et al., 2005), to independently confirm the     184 
observed  phenomenon.  However,  it  is  acknowledged  that  all  these 
considerations are in the aspect of pharmacological manipulation. In order to 
make  firm  conclusions,  one  might  need  to  repeat  the  whole  experiments 
employing the PAR-2 knockout mouse (Ferrell et al., 2003) (discussed further in 
6.4). 
Additional consideration is the employment of the glial cell metabolism inhibitor, 
FAc. Although it has been confirmed to selectively block the Krebs circle enzyme, 
aconitase (Fonnum et al., 1997), and it has been extensively used to depress 
glial functions in both culture and acute slice preparations in a variety of studies 
(Swanson & Graham, 1994; Zhang et al., 2003; Gordon et al., 2005; Shigetomi et 
al., 2008; Henneberger et al., 2010), the selectivity towards glial cells are still 
debated (unpublished communications during peer-review). In order to overcome 
this  disadvantage,  one  may  have  to  repeat  culture  experiments  using  a  pure 
neuronal culture preparation (Bushell et al., 1999; Zhang et al., 2003). However, 
preliminary experiments suggest that this approach may be problematic as the 
procedure still results in a residual glial component in the culture. In the acute 
slice preparations, one may have to perform experiments using transgenic mouse 
whose glial cells are genetically silenced (Fiacco et al., 2007; Petravicz et al., 
2008; Agulhon et al., 2010). Alternatively, one might be able to locally inhibit 
astrocytes  by  loading  Ca
2+  chelator  BAPTA  into  visually  identified  astrocytes 
(Shigetomi et al., 2008).  
6.4 Future studies 
The studies detailed in this thesis has opened the window for a full investigation 
of PARs involvement in modulating neuronal as well as synaptic properties with a 
detailed  characterisation  of  underlying  mechanisms.  These  pioneering 
experiments have laid the groundwork for future more detailed studies. Several 
further  experiments  needed  urgently  emerged  from  this  thesis  have  been 
indicated in previous discussion. Here are a few  unresolved questions may be 
worth further efforts: 
1.  Is  it  possible  to  provide  unequivocal  evidence  for  the  modulation  of 
neurones/synaptic  transmission  by  PAR-2  activation?  Strategies  to  address     185 
this  would  be  the  development  of  new  more  selective  peptide  and  non-
peptide ligands. Especially, the development of potent PAR-2 antagonist is 
urgently  required,  which  is  currently  lacking.  Additionally,  several 
experiments could be repeated in the PAR-2 knockout mouse preparations. 
These  would  require  repeating  whole  cell  recordings  from  hippocampal 
culture prepared from PAR-2 knockout mouse and its wildtype littermate. It 
is  expected  to  observe  similar  membrane  depolarisation/reduction  of 
spontaneous APs in the cultured neurones upon SLIGRL application from the 
wildtype littermate but not from the PAR-2 knockout mouse. Subsequently, it 
would be a strong evidence to demonstrate that there is comparable LTD at 
the Schafer collateral-to-CA1 synapses upon SLIGRL application in the acute 
slices prepared from wildtype littermate but not from PAR-2 knockout mouse.  
2.  Does PAR-2 receptor modulate all excitatory synapses in the hippocampus? Is 
there synapse-specific differences? Further field recording experiments will 
perhaps look at other major synapses such as  mossy fibre-to-CA3 synapses 
and perforant path-to-granule cell synapses.  
 
3.  Does  PAR-2  activation  modulate  inhibitory  synapses?  Whole  cell  recording 
could be used to examine evoked pharmacologically isolated IPSCs at CA1 
pyramidal neuones to start with. 
 
4.  In  order  to  have  single  cell  resolution  of  PAR-2-mediated  modulation  of 
neuronal intrinsic properties and synaptic transmission in situ, the following 
experiments  would  be  interesting  to  consider:  Whole-cell  patch  clamp 
recordings using intracellular solution supplemented  with biocytin in acute 
slices  prepared  from  PAR-2  knockout  mouse  and  its  littermate  control  to 
characterise: 
a.  The  cell  type  of  recorded  neurones  following  morphological 
reconstruction. 
b.  Basic  intrinsic  properties  of  each  neurone  including  current-voltage 
relationship,  input  resistance,  maximal  firing  frequency,  ‘Sag’,  etc., 
before and following the application of PAR-2-AP. 
c.  Evoked  EPSCs  upon  long  term  application  of  PAR-2-AP  to  have  better 
resolution of the PAR-2-mediated LTD with possible pre and post synaptic     186 
manipulation to distinguish pre or post synaptic mechanism. 
 
In summary, it is clear that the current investigation has opened up a new area 
of research that PAR-2 has an overt action on central neurones and synapses. 
Clearly,  this  research  has  laid  a  strong  foundation  for  a  number  of  other 
important questions which will need to be resolved in the coming years if we are 
to understand fully the role and significance of PAR-2 actions in the physiology 
and  diseases  in  the  brain  and  indeed  where  there  are  potential  therapeutic 
applications.187 
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